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The 3-1actog1obulin (BLG) gene encodes a major whey protein in the milk of 
ruminants. Studies of the ovine BLG gene demonstrated that the gene was expressed 
specifically and efficiently in the mammary gland of transgenic mice. The promoter of 
the BLG gene has been used to target the expression of human proteins to the 
mammary gland in both transgenic mice and transgenic sheep. High levels of 
expression of some foreign proteins were obtained in some cases but many of the 
hybrid transgenes were expressed poorly and appeared susceptible to position effects. 
The aim of this work was to test whether the chromosomal sequences flanking an 
efficiently expressed transgenic locus could be used to improve transgene expression. 
The AATB transgene comprising 4.2 kb of the ovine BLG promoter sequences 
linked to human al-antitrypsin (hAAT) genomie sequences gave high levels of hAAT 
expression in the mouse mammary. One line in particular (AATB 46.2) expressed 
hAAT at 6-8 mg/ml. This line was reported to have low transgene copy number, that 
could have been accommodated in a single cosmid vector. The aim of this work was 
to investigate the role of the flanking murine sequences in the high expression of the 
AATB transgene for this line. 
This thesis details the restriction characterisation of the AATB 46.2 genomic 
locus and the cloning of most (if not all) of the locus in several cosmids. A total of 
4.6 kb of the 5' flanking muiine sequences and 4.7 kb of the 3' flanking murine DNA 
were successfully isolated in separate cosmid clones. Comparison of the clones with 
genomic DNA demonstrated the locus had been cloned without rearrangement. Two 
secondary transgenes TAB and TA were constructed from these clones. TAB 
comprised the cloned 5' and 3' sequences flanking a single AATB transgene, while 
TA comprised the AATB transgene with only the 3' muiine DNA from the AATB 
46.2 locus. Transgenic mice were generated using these constructs. 
Expression of hAAT in the TAB transgenic mice was found to be improved 
compared with the AATB transgenic mice. Also the frequency of expression of the 
human protein by transgenic mice was increased. Ten of eleven transgenic 
founders/lines expressed the transgene at greater than 40pg4ml compared with eleven 
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of twenty four for AATB. The levels of hAAT expression in the secondary transgenic 
mice were generally very high and appeared to correlate with transgene copy number. 
By contrast expression of hAAT was not observed in any of the TA transgethc lines. 
The presence of either the 5, murine DNA alone or both the 5' and 3' murine DNA, 
may be required to bring about the improved expression of the biomedical transgene. 
The cloned murine sequences confer improved expression upon the AATB 
transgene. it now remains to be seen if they can improve the expression of other 
biomedical transgenes regulated by the BLG promoter, and transgenes regulated by 
other promoters that direct expression in tissues other than the mammary gland 
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CHAPTER 1: INTRODUCTION 
111: Transgenic Biology 
Transgenic animals are animals that have integrated foreign DNA into their 
germ line as a consequence of experimental introduction of DNA (Pal -niter and 
Brinster, 1985). Transgenic animals not only exhibit unique phenotypes, but they also 
pass those traits to their offspring (Paliniter and Brinster, 1985,1986; Jaenisch 1988). 
The development of methods for engineering and introducing functional foreign genes 
into whole organisms has contributed to understanding the factors which control the 
expression of specific genes and in the identification of genes and processes which 
regulate cell proliferation, differentiation and interactions. Transgenic livestock have 
been produced that express economically important proteins in their blood and milk. 
Following the isolation of mouse embryonic stem cells it has been possible to 
make defmed mutations in the murine genome by homologous recombination. This 
technology has enabled the generation of transgenic mice carrying mutations in specific 
genes (Hasty et al., 1991) and more recently to replace genes with a similar gene from 
another species (Stacey et al., 1994). 
The following sections review the techniques used to generate transgenic 
animals, factors affecting transgene expression and the current state of production of 
economically important proteins in transgenic livestock. 
1.1.2: The Generation Of Transgenic Animals By Retroviral Insertion Of DNA 
The production of transgenic animals has been ongoing since 1976. The first 
transgenic mouse strain generated had the Moloney Leukaemia retrovirus DNA stably 
integrated into the germ line (Jaenisch 1976). The method used was to infect mouse 
embryos with retroviruses early in development. This method of generating transgenic 
animals had several disadvantages. The integration of the foreign DNA into the 
genome occurred at various stages of embryonic development, and thus the foreign 
DNA was not always integrated in all somatic tissues or the germ line. In addition the 
transgenic animals generated using this approach often contained more than one site of 
insertion because more than one cell in the early embryo was infected with the virus. 
This required the strains of mice to be outbred to segregate the loci and generate 
animals harbouring only one site of insertion. Furthermore the amount of foreign 
DNA that can be accommodated within a retroviral vector is limited to approximately 
8kb, and this is inadequate for many transgenic experiments. 
1.1.3.1: The Generation Of Transgenic Animals By Pronuclear Injection 
In 1980 a breakthrough in the generation of transgenic mice hailed the advent 
of a new and exciting means of using whole animals to analyse gene expression. The 
technique was to inject naked DNA into the pronucleus of a newly fertilised mouse 
egg (Gordon et al., 1980). It was found, using this technique, that the injected DNA 
integrated into the genome, and could be inherited by the offspring of the founder 
transgenic animals. By injecting into the pronucleus the introduced DNA could 
integrate into the genome before or at the first round of DNA replication and cleavage, 
and could thus contribute to the genome of all somatic tissues and of the germ line. 
Integration of the foreign DNA can also occur after the first zygotic division, this is 
shown by the generation of mosaic founder animals that, on average, harbour less than 
one copy of the transgene per cell and the generation of founder animals that transmit 
the transgene at a frequency significantly less than 50% (Wilkie et al., 1986). 
1.1.3.2: Efficiency Of Generating Transgenic Animals By Pronuclear Injection 
The efficiency of generating transgenic animals by pronuclear injection is 
dependent on a number of parameters. As with any new technique the parameters 
were at first poorly defined. In early experiments Brinster and co-workers carried out 
a fairly detailed study of factors that affect the efficiency of generating transgenic 
foetuses by pronuclear injection (Brinster et al., 1985). The study investigated the 
effect of (i) DNA concentration, (ii) buffer, (iii) nuclear versus cytoplasmic injection, 
(iv) plasmid form, and (v) genetic background. 
The experiment was performed using a single 4.8 kb plasmid. The plasmid 
was injected in four different forms, supercoiled, restricted and blunt ended, restricted 
with a single enzyme generating compatible ends, and restricted with two enzymes 
giving dissimilar ends. Plasmid form was found to have an effect on the efficiency of 
generating transgenic foetuses. The finding was that the injection of linear DNA was 
five times more efficient than supercoiled DNA. No significant difference was found 
between the linear molecules that had similar or dissimilar ends. Although the data 
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was not conclusive there was a suggestion that blunt ended DNA fragments may be 
less efficient that those with staggered ends. 
Generally the foreign DNA was found to integrate at a single site in the 
genome. The site of integration of the transgene was thought to be random. The 
number of copies of the foreign DNA molecule was found to vary between 1 and 
several hundred copies and these copies were usually found to be orientated in a head 
to tail manner. The predominance of this arrangement of transgenes within transgenic 
animals relative to tail to tail or head to head arrangements led to the proposal that the 
arrays of transgenes were formed by homologous recombination between the injected 
fragments of DNA (Brinster et al., 1981; Pahniter et al., 1982; Palmiter and Brinster, 
1985). 
In the early transgenic experiments expression of most transgenes were 
obtained but the levels of expression and the tissue specificity of expression were often 
unpredictable and variable. This was generally a consequence of transgene design and 
transgenic animals soon provided much information about gene expression and the 
regulatory sequences required for appropriate gene expression. The purpose of many 
transgenic studies is to elucidate the involvement of a gene in normal developmental 
processes. The analysis of transgene expression can demonstrate the presence or lack 
of the required cis-acting sequences for its appropriate and abundant expression. 
Although the pattern of expression of some of the early transgenes showed 
correct tissue specificity in the lines that expressed the gene, levels of expression were 
often disappointing. Frequently many of the lines generated did not detectably express 
the transgene. Such difficulties with transgene expression were believed to be a result 
of the repressive effects of the chromatin structure of the genomic DNA into which 
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they had integrated. This was termed the position effect and is discussed widely in the 
literature (e.g. see Al Shawi and Bishop 1990) although the nature of these effects are 
still understood incompletely. Some transgenes, however, were less susceptible to 
position effects than others and it soon became evident that position effects could be 
minimised by the inclusion of sufficient regulatory sequences within the transgene 
(Section 1.4 and references within). 
Pronuclear injection is, nevertheless, an inefficient process even in mice. Many 
fertilised ova are required, which necessitates the use of large numbers of donor 
animals. Of the embryos that survive the injection procedure only ten percent give rise 
to transgenic offspring even in the hands of a practised microinjectionist. 
When the technique is used to generate transgenic large animals it is even more 
inefficient and the number of fertilised ova surviving the injection procedure and 
giving rise to transgenic animals is less than in mice (Clark et al., 1990). Unlike mice, 
many large domestic animals such as cows, sheep and goats have only one or two 
offspring (Pigs are an exception in this respect). Thus the number of donor and 
recipient animals required is considerably greater than for a transgenic mouse 
experiments and the production of large transgenic animals is, overall, very inefficient 
and expensive. 
1.1.4: Generation Of Transgenic Animals By Sperm Mediated Transfer 
Sperm mediated transfer involves incubating the transgene DNA with 
spermatozoa which are then used to fertilise eggs in vitro. Only one publication to 
date claims to have produced transgenic mice using this method (Lavitrano et al., 
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1989). The result has never been successfully repeated even by those experienced in 
the generation of transgenic animals (Blister et al., 1989). Six years on other groups 
are still trying to use this technique to produce transgenic animals, particularly in 
livestock species, despite this there remains no published evidence of its effectiveness 
for the generation of transgenic animals. 
1.1.5.1: Modification of the Germline By Homologous Recombination 
Yeast is used extensively for genetic studies. Although it is unicellular, it is a 
lower eukaiyote, and its genetics are thus thought to be more representative of the 
higher eukaryotes than prokaryotes. Indeed, many of the findings in yeast have been 
extrapolated and found to bear relevance to higher eukaryotic systems. 
Notwithstanding the similarities a major difference between yeast and 
mammals is the frequency with which homologous recombination occurs between 
experimentally introduced DNA and the genome. In yeast homologous recombination 
events are at least ten times more frequent than random integration events (Hinnen et 
al 1978). In mammals the ratio is less than 1:100 (Roth and Wilson 1988). A number 
of factors are likely to be responsible for the 1000 fold difference in the frequency of 
homologous recombination. One obvious factor that may be significant is a substantial 
difference in genome size between Saccharornyces cerevisiae and higher eukaryotes 
(14x10' and 3x109 bp respectively), thus the target genomic sequence is more dilute. 
Thus unlike yeast, mammalian cells integrate foreign DNA into their genome 
principally by non homologous, or illegitimate recombination. 
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A number of experiments studying  homologous recombination have been done 
in established mammalian cell tines. In these experiments defined genetic changes 
were introduced and mutation of both selectable genes and cellular genes (using 
selectable markers) have been performed successfully (Foiger et al., 1982). Such 
experiments demonstrated the feasibility of creating defined mutations in mammalian 
cells and proved useful in the elucidation of the mechanisms of homologous 
recombination in mammalian cells, although their usefulness in the study of gene 
function in the whole animal was limited. 
1.1.5.2 : Mouse Embryonic Stem Cells 
The isolation of proliferating mouse embryonic stem (ES) cells opened new 
possibilities for the study of gene function in transgenic animals. ES cells were derived 
from the inner cell mass of the mouse blastocyst and maintained in culture in the 
undifferentiated state. When re-introduced into a recipient b!astocyst, they contributed 
efficiently to the fOrmation of all tissues in a chimeric mouse, including the germline 
(Evans and Kaufman, 1981;  Martin, 1981). 
LS cells could be manipulated in vitro without losing their ability to contribute 
to the germ line of chimeras. Robertson et al., (1986) demonstrated that ES cells 
could generate gerrnline chimeras even after transfection with the neomycin resistance 
gene and selection for G418 resistant cells. Similarly ES cells which had been selected 
for spontaneous mutation of the H--,V-R-  gene by growth in media containing 6 
thioguanine were shown to be able to generate germhne chimeras (Hooper et al., 
19W/). 
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1.1.5.3 Specific Modifications can be Made to the Murine Genome by Gene 
Targeting in ES cells 
The first targeted disruption of a murine gene was performed by Thomas and 
Capecehi (1987). These workers targeted the endogenous HPRT gene in ES cells. 
This gene is on the X chromosome, therefore, only one mutant copy was required to 
generate the HPRT - phenotype in male ES cells. ES cells harbouring the disrupted 
HIPRT gene could be selected by growth in the presence of 6-thioguanine (6T-G, the 
cytotoxic base analogue). 
The experiments were executed using two types of gene targeting vector: the 
replacement vector and the insertion vector. Replacement vectors recombine into the 
genome by homologous double cross-over or gene conversion resulting in the 
replacement of endogenous DNA by exogenous sequences (see figure 1 A). By 
contrast insertion vectors recombine into the genome by a crossover resulting in the 
insertion of the entire vector sequences into the endogenous locus. This type of vector 
results in direct repeats at either side of the selectable marker (see figure 1 B). 
In these experiments the selectable marker was the neomycin resistance gene 
and cells surviving in the presence of G148 and 6-TG were found to have lost HPRT 
activity due to targeted disruption of the HPRT gene. Unfortunately unlike the HIPRT 
gene most cellular genes are not selectable. Targeting of non-selectable endogenous 
genes requires screening of large numbers of cells for novel endogenous/vector 
junctions by either Southern blotting or PCR. As previously discussed the frequency 
of homologous recombination in mammalian cells is low and screening for 
homologous recombination in events is a significant undertaking. 
Using ES cell technology it has been possible to introduce null mutations in 
endogenous mouse genes by integration of a selectable marker into the gene of 
interest. Many hundreds of so called 'knockout' mice have been generated to test the 
function of endogenous genes. A recent comprehensive list of knockout targeting 
experiments has been produced by Brandon et al., (1995). 
A double replacement technique has been used to replace the mouse a-
lactalbumin (c-lac) gene with its human counterpart (Stacey et al., 1994). In this work 
the entire mouse gene was replaced with its human counterpart leaving no vector 
sequences at the target locus. The work was performed in HPRT-deficient ES cell line 
(HM-1) which remain totipotent in culture in the absence of feeder cells (Magin et al., 
1992). The use of these cells permitted the exchange of the mouse a-lac sequences 
for the HPRT gene followed by a second replacement of the targeted HPRT gene with 
the human a-lac sequences. This approach exploits the ability to select first for and 
then against HPRT expression in the HM-1 cell line. 
This type of approach could be used to study transcriptional regulation of 
endogenous mouse genes by the introduction of subtle mutations in the regulatory 
regions or protein structure and function by the introduction of amino acid changes 
through mutation of the protein coding regions. 
VE 
Figure 1.1 
The figure shows the differences between insertion and replacement targeting 
vectors. sm = a selectable marker (e.g. the neomycin gene resistance (neo 
r)  gene) 
that can be selected for in cultured cells. Insertion of the selectable marker into an 
essential part of the target gene inactivates it. 
Insertion Vectors 
The figure gives a diagrammatic representation of insertion of an insertion vector 
into the genome via homologous recombination. Insertion vectors are designed such 
that the regions of homology at the ends of the linearised vector are adjacent to each 
other in the genomic target. Homologous recombination occurs via a single 
crossover event resulting in duplication of the regions of homology flanking the site 
of insertion 
Replacement Vectors 
The figure shows a diagrammatic representation of insertion of a replacement vector 
into the genome via homologous recombination. The regions of homology at either 
end of the linearised vector are not adjacent to each other in the genomic target and 
insertion occurs via a double cross over or gene replacement event resulting in 
insertion of the entire vector at the target site. Unlike insertion vectors the targeting 
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1.1.5.4: The Efficiency Of Producing Transgenic Mice By Homologous 
Recombination 
The use of a single selectable marker does not differentiate between random 
insertion of the exogenous DNA and insertion via homologous recombination. 
Because of the low frequency of homologous recombination that occurs in ES cells 
strategies have been devised to enrich for homologous recombination events. 
Positive negative selection (PNS) involves the use of two selectable markers 
(see Capecchi, 1989 for a review). One of which can be selected for (positively 
selected) and the other which can be selected against (negatively selected). The vector 
must be of the replacement type (see previous section and figure 1 A). The positive 
selection marker is placed between the arms of homology to the target gene (figure 1.2 
A). Thus upon homologous recombination into the genome it is retained., whereas the 
negative selectable marker is placed outside the arms of homology and is lost in 
homologous recombination events (figure 1.2 A). By contrast on random insertion (by 
non homologous recombination) into the genome the negative selectable marker is 
retained (figure 1.2. B), resulting in cell death when this marker is selected against. 
A 2000 fold enrichment for ES cells containing targeted disruptions of the 
HPRT and int-2 genes over the total number of neomycin resistant cells was reported 
by Mansour et a! (1988) using PNS. However other workers have reported 
considerably lower levels of enrichment using this type of approach (Li et al., 1992, 
Stacey et al., 1994). Nevertheless, adoption of a positive negative selection system 






Figure 1.2 : Positive Negative Selection For Homologous Recombination in Gene 
Targeting Experiments 
The frequency of homologous recombination events in mammalian cells is low 
compared with random insertion events. Positive negative selection has been 
employed by some workers to enrich for cells that have integrated the targeting 
vector via homologous recombination. The approach uses two selectable markers, 
one that can he selected for and another that can be selected against. +ve sm = a 
selectable marker that can be selected for (e.g. nea r), - ye sm = a selectable marker 
that can be selected against (e.g. HSV-tk). The vector is always of the replacement 
type. The positive selectable marker is placed within the arms of homology to the 
target genomic locus and the -ye selectable marker is placed at one end of the vector 
outwit/i the regions of homology. 
Homologous Recombination 
The figure shows integration of a replacement vector designed for PATS into the 
genome by homologous recombination (HR). The targeting event occurs via a 
double cross over resulting in the homologous regions of the vector and all 
sequences between them being inserted into the genome. Since the negative 
selectable marker is not flanked on both sides by sequences homologous to the 
genomic target it is lost. Cells that have undergone a targeting event thus survive 
negative selection. 
Random Integration 
The figure  shows integration of a replacement vector designed for PATS into the 
genome by illegitimate recombination (ZR). Illegitimate recombination occurs 
through the ends of the linearised DNA and results in the insertion of the entire 
vector into the genome. Both selectable markers are present and cells that have 
undergone integration of the vector by this mechanism should not survive selection 
against the negative selectable marker. 
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1.1.5.5: ES Like Cells of Large Animals Could Have Applications in 
Biotechnology 
The ability to insert transgenes at a known locus in large domestic animals has 
many advantages. The availability of large animal embryos is limiting, and the 
technique of pronuclear injection is considerably less efficient in farm animals than in 
mice. Thus the ability to maintain targeted ES cells in culture affords the thorough 
analysis of positive ES cell colonies prior to blastocoel injection and implantation. By 
targeting transgenes into a specific permissive site position effects that repress 
transgene expression could be minimised. However to date the only true embryonic 
stem cell that has been isolated is that of the mouse. Despite intensive research a true 
embryonic stem cell has not been isolated from any other mammal (Wilmut and 
Campbell, 1994, Clark, 1996). 
Cell lines that resemble embryonic stem cells have been isolated from sheep 
(Clark et al., 1992). This cell line (designated TNT 4) was obtained by micro-
dissection and explanation of the embryonic discs of early sheep embryos. Unlike 
mouse ES cells these cells have a flattened morphology and express markers associated 
with differentiation such as cytokeratm, and nuclear lamin A/C. Recently, however, 
live lambs have been obtained by nuclear transfer from the TNT 4 cell line into 
enucleated sheep oocytes (Campbell et al., 1996). 
It has not yet been demonstrated that these cells can be genetically manipulated 
in culture as mouse ES cells can be. However it is possible that domestic animals 
harbouring targeted transgene insertions will be available sometime in the foreseeable 
future using this and/or similar cell lines and nuclear transfer technology. 
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L 1.5.6 Summan' 
Transgernc animals that carry foreign DNA in their genome as a result of 
experimental manipulation have now been generated by a number of techniques. 
Insertion of genes using retroviral vectors allows one single copy of the transgene to 
integrate randomly into the genome. However this method often results in multiple 
integration sites and the amount of DNA that can be inserted is limited. Retroviruses 
also exhibit species specificity which also limits the use of this approach For these 
reasons among others this method is not widely used for the generation of transgenic 
animals. 
Pronuclear injection is currently the most commonly used technique for the 
generation of transgenic animals. Large transgenes can be introduced to the germline 
using this technique. Unfortunately the efficiency of generating transgenic animals 
using this technique is low, particularly in livestock. The injected DNA generally 
integrates at a single site and the number of integrated transgenes varies from one to 
hundreds of copies. Like retroviral insertion the site of integration is thought to be 
random. Many transgenes exhibit "position effects" which are thought to result from 
the influence of local chromatin structure on the integrated transgenes. 
With the development of mouse embryonic stem cells it has become possible to 
target the insertion of transgenes to a particular genomic site via homologous 
recombination. This technology allows precise mutations to be made in the mouse 
genome and offers great potential for the study of gene regulation and protein 
function. However to date targeted mutation of the genome is only possible in the 
mouse. 
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1.2 THE MECHANISM OF TRANSGENE INTEGRATION 
1.2.1: Characteristics Of Integrated Foreign DNA 
Outlined previously were some of the characteristics of transgenic animals 
produced by pronuclear injection. Analyses of the transgene loci indicate the 
integration of a single transgene is a rare event and transgenes are generally integrated 
as an array. The number of transgenes within the array varies from two to several 
hundred and they are normally orientated in a head to tail manner (e.g. Brinster et al., 
1981; Palniiter et a! 1982). These characteristics have also been demonstrated for the 
loci of foreign DNA inserted into the chromosomes of cultured cells that have been 
stably transfected by a variety of techniques (calcium phosphate co-precipitation, 
DEAE-dextran treatment, and direct niicroinjection). Thus it has been proposed that 
the mechanisms underlying the integration of foreign DNA in both systems are the 
same (Bishop and Smith 1989). The mechanisms by which the arrays of foreign DNA 
are built up and the mechanisms involved in chromosomal insertion have been the 
subject of numerous studies. Based on these studies mechanisms for both concatamer 
formation of the foreign DNA and integration of the DNA into the host genome have 
been proposed (Bishop and Smith, 1989. Wall and Seidel 1992). 
1.2.2: Fate Of Experimentally Introduced DNA In Mammalian Cells 
Since the predominant arrangement of transgenes in integrated arrays is head 
to tail it has been proposed that the arrays must be established by homologous 
recombination between the injected molecules (Paliniter et al.. 1982). Homologous 
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recombination occurring between similar linear fragments would only regenerate linear 
fragments; yet linear input DNA has been found to integrate more efficiently than 
circular DNA and has been demonstrated to integrate as concatamers (Brinster et al., 
1981). These concatatners cannot be formed from linear fragments unless they 
undergo changes within the cell, following injection (Brinster et al., 1981; Palmiter and 
Brinster, 1985; Bishop and Smith, 1989). 
Many studies have been performed that have investigated the fate of foreign 
DNA after entry into the cell. The studies have been performed mainly in culture cells 
and generally using viral genomes to characterise the changes that occur in the DNA 
upon transfection, electroporation and microinjection. These studies have been 
extensively reviewed by Bishop and Smith (1989). 
That circularisation of linear input molecules occurs upon entry into cultured 
cells has of course been established using the SV40 viral genome. The life cycle of the 
SV40 virus requires that the viral genome be in the form of a circular molecule. if the 
viral genome is lineansed prior to injection then the SV40 virus is still capable of 
eliciting infection demonstrating that the circularisation must have occurred following 
transfection (Wake et al. 1985) 
Southern and Berg, (1982), performed a study in which they introduced a 
plasmid pSV2neo (comprising pBR322 and SV40 sequences with an inserted 
neomycin resistance gene: into COS7 cells. Transfections were performed with 
linearised plasmid and supercoiled plasmid. The results demonstrated that the cells 
transfected with linear plasmid now harboured populations of supercoiled DNA linear 
DNA and open circle DNA. It was evident that circularisation of the linear input DNA 
had occurred within the cells. Restriction of the nuclear DNA with two enzymes, 
demonstrated that some of the input DNA was still in the original linear form. The 
importance of these studies is that they demonstrate that circularisation of input DNA 
does occur upon entry to the cell. 
1.2.3: Efficiency Of Circularisation Of Foreign DNA 
The efficiency of circularisation of introduced DNA following transfection or 
microinjection was performed by Kopchick and Stacey (1984). In this study the avian 
sarcoma virus was used. The avian sarcoma virus has viral genes gag, poi, env, and 
src flanked by LTR's. The virus molecule was cloned into the pBR322 plasmid. The 
plasmid and virus was introduced by transfection or microinjection in three states (i) 
circular (ii) linearised within the plasmid sequences and (iii) linearised within the pal 
sequences of the viral DNA. The molecules were introduced into cultured avian cells. 
The circular molecules and those linearised within the plasmid sequences were capable 
of yielding full length viral mRNA initiated and terminated at the LTRs. Molecules 
linearised within the pol sequences of the viral genome would only give rise to the full 
length viral genome if ligation occurs. Mutation of the pol region inactivates the gene, 
which prevents virus infection. 
Cytoplasmic microinjection of these three types of molecule gave similar virus 
titres indicating that the pol gene had been efficiently and accurately ligated within the 
cells. By comparison, transfection of the three differently treated molecules 
demonstrated that the virus titres of the circular molecule and those linearised within 
the plasmid sequences were similar but those linearised within the pol viral sequences 
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gave a 95% reduction in activity. This was found not to be the result of inefficient 
ligation but rather the introduction of mutations over several base pairs upon ligation. 
Thus mutation occurred upon ligation of transfected molecules whereas 
microinjected molecules linearised within the pOI sequences did not undergo mutation. 
Analysis of a molecule linearised within the pol gene using restriction enzymes with 
non complementary ends prevented the production of functional env mRNA which 
indicates that single stranded protruding ends of microinjected molecules need to be 
complementary in order to undergo efficient ligation within microinjected cells. In 
contrast transfected molecules treated in the same way were ligated regardless of their 
structure 
Numerous other studies utilising the SV40 viral genome have demonstrated 
clearly that ligation of linear input DNA occurs within cells (Wilson et al., 1982; Wake 
et al., 1984; Roth et al., 1985). The study by Kopchick and co-workers (1984) in 
particular, indicates that this ligation event is particularly accurate and efficient when 
the input DNA is microinjected and has compatible ends. In the experiment the DNA 
was microinjected into the cytoplasm of mammalian cells in culture. By contrast 
production of transgenic animals involves the injection of DNA directly into the male 
pro-nucleus. Palmiter et al., (1982) reported the circularisation of linear input DNA 
following nuclear injection in mouse eggs. It may be that DNA injected directly into 
the nucleus of embryos undergoes the same processes as DNA injected into the 
cytoplasm of cultured mammalian cells. 
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1.2.4: The Mechanism Of Concatamer Formation 
Analysis of transgene arrays in transgenic mice have clearly shown that the 
arrays are predominantly arranged in a head to tail orientation. The relative paucity of 
head to head and tail to tail orientations lead to the proposal that the mechanism of 
concatamer formation must be via homologous recombination (Brinster et al., 1981; 
Palmiter et al., 1982) 
Bishop and Smith (1989), proposed that the concatamers are formed by 
homologous recombination between either circularised input molecules and linear 
molecules, or between circularly permuted molecules and linear molecules. Circularly 
permuted molecules are molecules formed by random breakage of circularised input 
DNA (see figure 1.3). If this is so then the transgene-transgene junctions would be the 
self ligated ends of the input molecule and the integrity of the transgene-transgene 
junction will depend on damage sustained to the ends of the input molecule before self 
ligation occurs. Studies outlined in the two previous sections (Kopchick and Stacey, 
1984; Palmiter et al., 1982) have demonstrated that circularization of the input DNA 
occurs upon introduction of linear DNA to the cell or embryo, Finally, the nature of 
the ends of the input molecules may have important consequences for the efficiency of 
this process and thus the integrity of the transgene-transgene junctions. 
1.2.5: Studies Of Integrated Transgene Loci 
Clues to the mechanism of concatamer formation and integration can be 
gleaned from detailed analysis of integrated transgene arrays. A number of detailed 
studies of integrated transgene loci have been performed. Three studies have shown 
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the regeneration of a restriction site between transgenes in arrays present in transgenic 
animals (Pal -niter et al., 1982; Yamamura et al., 1985). The transgene ends in each 
cases were compatible. 	This is consistent with the efficient self ligation of 
microinjected DNA. 
A study of seven transgene-transgene junctions obtained by PCR amplification 
of the junctions from two concatameric integrants of the RSVCat gene demonstrated 
the transgene ends at junctions were missing 1 to 62 bases (Rohan et al. 1990). It has 
been demonstrated that compatible ends are required for the efficient ligation of 
microinjected input DNA in cultured cells (see section 2.3) The ends of the injected 
transgene in the Rohan study were non compatible and minimal exonuclease activity 
appears to have occurred at all transgene-transgene junctions suggesting the efficient 
self ligation of microinjected DNA is homology dependent. 
Two other transgene loci have been cloned and the fine detail of the junctions 
both transgene-transgene and transgene-chromosomal have been determined (Hamada 
et al., 1993). In total, three transgene-transgene junctions were analysed in this study, 
all of which were virtually intact. Two nucleotide deletions occurred in two of the 
three junctions. The transgene in this study was restricted using Pvul and was blunt 
ended prior to injection. As in the Rohan study, the transgene ends lacked homology. 
It cannot be ruled out that the lack of homology at the transgene ends reduced the 
efficiency of self ligation of the microinjected transgene and was causative in the two 
nucleotide deletion that occurred at two of the transgene-transgene junctions. 
In the Hamada study four transgene-chromosomal junctions were analysed (see 
figure 1.3 for maps of the integrants). Two integrants were analysed, each had two 
transgene-chromosome junctions. Only one of the four transgene-chromosome 
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junctions occurred well within the transgene (Junction 1 Figure 1.3). The other three 
junctions occurred within four nucleotides of the ends of the transgene. The maps of 
the integrants are given in Figure 1.3. 
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Figure 1.3: Structure of two Integrated Transgene Loci 
The above diagram is a representation of the two transgene integrants analysed by 
Ham ada et al., (1993). The upper diagram represents the transgene used to generate 
the transgenic mice. Below this is a representation of the first transgene integrant 
which comprises one nearly intact copy of the transgene and at the 5' end of this is 
233-235 bp of the 3 end of another transgene. It has two transgene/genome 
junctions (1 and 3), and one transgene/transgene junction (2). The second integrant 
contains three transgenes. It has two transgene/transgene junctions (5 and 6) and 
two transgene/genome junctions (4 and 7). Only minor deletions of up to 3 
nucleotides had occurred at all three transgene/transgene junctions. Three of the 
four transgene/genome junctions occur within 1-4 nucleotides of the 5' or 3' end of 













The authors propose the pre-integration concatamer is linear since the 
chromosome/transgene junctions occur mainly at the ends of transgenes. A circularly 
permuted concatamer would generate junctions at random positions within the 
transgene. They propose that the linear concatamer is built up by the homologous 
recombination between linear and circular molecules. They also propose that the small 
nucleotide deletions occurring at the transgene-transgene junctions occurred by limited 
exonuclease activity at the ends of the transgenes prior to self ligation. 
1.2.6: Concatarner Integration Into The Host Genome 
It has been proposed the integration of transgenes occurs randomly at 
chromosomal break points (Brinster et al., 1985). Limited information is available 
about the pre-integration site of transgene loci, and much of the available information 
comes from studies where the phenotype of the transgenic mouse has been abnormal. 
Many of the flanking genomic sequences that have been studied have undergone 
rearrangement of some form, including insertion, duplication and deletion. In fact to 
date no transgene locus has been demonstrated to be a straightforward insertion of a 
transgene array into the host genome. No extensive homology has been demonstrated 
to occur between the host genomic sequences of transgene loci and the transgene 
sequences. On studying two transgene loci Harnada et al. (1993) propose that the 
integration of the transgene array into the host genome occurs by end ligation of the 
transgene concatamer and chromosome breakage which may be stabilised initially by 
limited 2 to 3 nucleotide homologies that occur between the transgene and genome 
ends 
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1.3 POSITION EFFECTS IN TRANSGENIC ANIMALS 
1.3.1: Position Effects 
A transgenic experiment involves the generation of several lines harbouring the 
same transgene. Each transgenic founder animal is the result of a unique set of 
molecular events. The copy number of the transgene and the position of insertion into 
the genome will differ for each founder animal. Expression of the transgene is usually 
similar in all individuals of a given line but expression between lines varies. The range 
of tissues in which a given transgene is expressed is generally constant throughout the 
lines generated but the level of transgene expression more often than not bears no 
relationship to the transgene copy number. 
The variability in the expression levels of the same transgene in different lines 
is thought to be the result of the effects of the neighbouring chromosomal DNA at the 
integration site. For many transgenes the expression level of the transgene is poor; and 
it is thought that the chromatin structure of the host genome at the region of insertion 
represses the transgene promoter (Paliniter and Brinster, 1986; Wilson et al., 1990). 
Such effects, where the chromosomal location of a transgene is thought to modulate its 
expression are termed "position effects". Position effect has been used to explain poor 
levels of expression, aberrant expression and variability of expression within a single 
line. In most cases although the assumption is reasonable our understanding of these 
effects is lacking. 
Only one study to date has formally demonstrated that the aberrant expression 
in a line of transgenic mice was the result of a position effect. Transgenic mice 
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harbouring a transgene with the MIJP promoter, and HSV TK coding region show 
high levels TK expression in the liver, the testes, and the preputial gland (Al-Shawi et 
al., 1990). Of five lines generated only one did not express the transgene in the 
preputial gland. The locus of this line was cloned and used to generate secondary 
transgenic mice. Very little surrounding genomic DNA was included in the secondary 
transgene. All of the secondary transgenic lines generated expressed the transgene at 
high levels in the liver, testes and preputial gland demonstrating that the lack of 
preputial expression in primary transgenic line was a consequence of its genomic 
environment and not the result of a mutation in the transgene. 
1.3.2 : Position Effect And Transgene Methylation 
It has been proposed that the methylation of DNA in animals is involved in 
general repression of transcription (for a review see Ceder, 1988). Methylation of 
genomic DNA occurs on cytosine residues at CpG sequences. Regions of DNA 
within the genome have been shown to be particularly rich in such CpG methylatable 
sequences; these regions have been termed CpG islands (Bird et al., 1985). The 
distribution of methylated cytosine residues in DNA undergoes characteristic changes 
during differentiation of a cell lineage and the loss of methylated cytosines from 
promoter regions correlates with activation of many tissue specific genes during 
differentiation in vivo (Ceder, 1988, Jaenisch and Jabner 1984). Methylation of 
promoter regions of endogenous genes on the inactive X-chromosome has been 
proposed to have a role in repressing gene expression, the corresponding allele of the 
active X chromosome is found to be unmethylated (Swain et al., 1987). However the 
role of methylation in transcriptional repression of genes is not clear. The mechanisms 
of de novo methylation are poorly understood and there remains some debate as to 
whether methylation is a cause of gene repression or a consequence of the same. 
However transgene repression has been demonstrated to correlate with 
methylation in a number of cases (Hadchouel et al., 1987; Allen, et al., 1990). The 
transcriptional state of the transgene in these studies has been shown to be dependent 
on the parental origin of the transgene. The activity of the transgenes have been 
shown to correlate directly with the methylation status, in that methylation of the 
transgene inactivated the transgene. McGowan and co-workers (1989) have studied a 
line of transgenic mice harbouring a lac Z reporter transgene. This transgene was 
shown to exhibit cellular mosaic expression and the level of mosaicism was shown to 
correlate inversely with the transgenes methylation. 
1.3.3: Transgenes And Position Effect Variegation 
The phenomenon of position effect variegation (PEV) has been widely studied 
in Drosophila (Henikoff, (1994) and references therein). This effect is typically 
associated with chromosomal rearrangements that place a gene, normally positioned 
within euchromatic chromatin, in close proximity to heterochromatin. 
Heterochromatin is normally associated with and limited to specific regions of the 
genome, predominantly the centromeres and telomeres. Centromeric and telomeric 
DNA is rich in satellite sequences, and the non histone protein composition of these 
regions differs from the rest of the chromatin. Much of the DNA within 
heterochromatin is thought to be transcriptionally inactive. It is not known what 
mechanisms delimit the regions of constitutive heterochromatin but it is clear from 
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studies in Drosophila that a germline translocation event may allow the spread of 
heterochromatin into regions which are normally euchromatic causing their repression. 
This repression is not exhibited in all cells and the transcriptional state of the gene 
varies in individual cells, giving rise to a variegated phenotype. 
The variability in transgene expression between lines of transgenic mice 
harbouring the same construct has not been usually studied at the level of the 
individual cell. Two possibilities exist for the variation in transgene expression in a 
given tissue. Firstly the rate of transcription of the transgene from the promoter varies 
between the lines. Secondly that the level of expression of the transgene is the same 
for each copy but the number of cells within the tissue expressing the transgene differs 
between the lines. 	Such heterocellular expression of a transgene has been 
demonstrated in transgenic mice harbouring a transgene encoding 3-galactosidase 
driven by the promoter and upstream regulatory regions of the a-globin gene 
(Robertson et al. 1995). This study demonstrates clearly the heterocellular pattern of 
expression normally associated with PEV but does not investigate the underlying cause 
of the variegated expression. 
The BLG transgene is normally expressed in a predictable position independent 
manner and at stable levels within a given line. However two lines of mice harbouring 
this transgene demonstrated variability of transgene expression within individuals of the 
line. In situ hybridisation of metaphase chromosome spreads has demonstrated that 
the transgene array in this instance has integrated close to the centromere (Dobie. et 
al., 1996). In situ hybridisation of mammary tissue from individuals of these lines 
demonstrate variegation of transgene expression within the tissue. In the light of their 
results and that of others Dobie and colleagues have suggested that both the integration 
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site and large copy number of some transgene loci may pre-dispose transgenes to PEV 
resulting in variable expression within individual transgenic lines. The frequency of 
PEV occurring at transgene loci is not known but it may have important implications 
for the application of transgenic technology. 
1.3.4: Positive Position Effects 
Transgenes generally comprise a cell type specific promoter and either 
homologous or heterologous protein coding sequences. Generally transgenes are 
expressed in the target tissue but often they are also expressed in tissues in which the 
promoter is not normally active. The ovine BLG gene (Farini and Whitelaw, 1995) 
and human 3-globin gene exhibits such ectopic expression (Blom van Assendeift et al., 
1989). This type of expression is referred to as positive position effects and is thought 
to be a position dependent phenomenon, because only a percentage of transgenic lines 
harbouring the same transgene exhibit ectopic expression. Positive position effects can 
arise as a result of integration close to an enhancer type element or from a lack of 
repression. However, this type of low level aberrant expression of transgenes has not 
been studied in detail. 
14: ELEMENTS IN VOL VED IN GENE AND TRANSGENE REGULA TION 
1.4.1: Elements other than the Basic Promoter are Required for Appropriate 
Transcription of Eukaryotic Genes 
Before the advent of transgenic animals many of the basic features of genes 
involved in transcription had been elucidated. Promoter regions had been detected and 
31 
sequences within them required for polymerase binding had been defined. The 
discrepancy in size between precursor RNA's and the mRNA's had led to the 
discovery of the intron/exon architecture of eukaryotic genes and thus to the 
machinery involved in RNA splicing. The transcription termination and poly A site 
had also been delineated. 
The analysis of transgene expression has contributed to the elucidation of 
additional elements involved in gene regulation. Many early transgenes were 
expressed poorly. At least two reasons for this have been identified. Firstly, the lack 
of sufficient regulatory sequences within the injected DNA and, secondly, the 
repression of transgene expression by the chromatin structure of the neighbouring 
genomic DNA. The latter reflects position effects and is discussed earlier in the 
introduction to this thesis. 
A number of transgenic animal experiments have demonstrated the expected 
tissue-specific (e.g The oc-globin gene cluster, Sharpe et al., 1993) and temporal profile 
of expression (e.g. the BLG gene, Simons et a! 1987) and freedom from position 
effects (e.g. The -globin gene with LCR elements, Grosveld et a! 1987). Analysis of 
such transgenes has elucidated the function a number of elements involved in gene 
regulation. These elements are found both within and outwith the transcription unit, 
some of them are many kilobases away from the transcription initiation site of the gene 
(see sections 1.4.2 - 1.4.6 for discussion). 
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1.4.2: The Role Of Introns In Transgene Expression 
Prokaryotic genes comprise uninterrupted stretches of coding DNA sequence. 
By contrast most eukaryotic genes have protein coding regions (exons) that are 
interrupted by non coding DNA sequences (introns) (Breatlinach et al., 1977 and 
Jeffreys and Flavell 1977). Eukaryotic genes are also transcribed from the 
transcription initiation site to the termination site giving rise to a precursor RNA. The 
final messenger RNA (mRNA), however, is only a fraction of the size of the primary 
transcript as it contains only the protein coding sequences (exons) plus additional 5' 
and 3' untranslated regions (UTRs). All other sequences (the introns) are removed 
during nuclear RNA processing (splicing). The basic machinery involved in RNA 
splicing has been elucidated (for a review see Watson et al., 1987). Sequences at exon 
intron junctions are usually well conserved and consensus sequences have been 
determined for splice donor and splice acceptor sites (Breathnach and Chambon, 
1981). Splicing progresses by formation of an intermediate termed a lariat (Keller, 
1984) and the formation of this intermediate involves sequences 20- 55 nucleotides 
upstream of the splice acceptor site (reviewed by Padgett et al., 1986). Many 
components are required to form an active splicing complex (spliceosome) including 
Ui and U2snRNPs (Black et al., 1985). The processes of nuclear RNA processing 
remain the focus of intensive research efforts. Nevertheless, there are still many 
aspects of intron splicing that are not understood. 
Reed and Maniatis (1986) have shown that sequences adjacent to the splice site 
can affect the accuracy and efficiency of splice site selection. It has also been 
demonstrated that the selection of splice sites is dependent on their location within the 
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pre-mRNA (Nelson and Green, 1988). Pre-mRNA's are likely to have defined 
structures and the context of the splice site may influence the nuclear splicing process. 
Yull et al., (1995 (a)) have observed aberrant splicing of RNA transcribed 
from a transgene expressing factor IX from a eDNA construct driven by the BLG 
promoter. The RNA was properly processed in the liver (the normal site of factor IX 
production) but was spliced using a cryptic splice site in the mammary gland. These 
authors suggest that there may be tissue specific differences in the trans-acting factors 
involved in nuclear RNA processing. 
It has been demonstrated that for some genes introns carry important 
regulatory elements. An enhancer region has been found in intron 2 of the 
apolipoprotein B gene (Brooks et a! 1994) and intragenic regulatory regions have been 
reported in numerous other genes; these include human growth hormone gene (Moor 
et al., 1985), rat growth hormone gene (Sap et al., 1990), PDGF-B (Franklin et a! 
1991). 
The ovine BLG gene appears to require introns for efficient expression. The 
entire gene was expressed efficiently in the mammary gland of mice and appeared to 
be expressed in a position independent and copy number dependent manner (Whitelaw 
et al., 1992). However intronless BLG transgenes were much less efficiently expressed 
(Whitelaw et al., 1991). Less than 50% of the transgenic lines expressed BLG and 
levels were twenty fold reduced on that of the entire gene. This suggests the introns of 
BLG harbour important regulatory elements or serve some structural function for the 
efficient transcription of the gene. 
Many proteins are transcribed from very large genes (e.g. factor Vffl, Davie 
1986) or genes which have not yet been cloned. The cDNA for such genes can more 
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readily be obtained and thus used experimentally. Transgenic animal experiments 
utilising eDNA sequences attached to a heterologous promoter have not usually been 
very successful (Simons et al., 1988; Shani et al., 1992; Velander et al., 1992). A 
number of experiments have been performed where the inclusion of introns within a 
transgene have elevated expression or proven to be essential for expression of the 
transgene (Bnnster et al., 1988; Buchman and Berg 1988; Archibald et al., 1990; 
Whitelaw et al., 1991). Heterologous introns have been inserted into transgenes and in 
some cases have been found to have a small positive effect on transgene expression 
(Palmiter et al., 1991, Choi et al., 1991) but this approach is not universally effective 
suggesting that the role of introns in transgene expression is more than a simple 
requirement to enter the RNA splicing pathway. The mechanisms underlying this 
effect are not fully understood. 
1.4.3 Enhancers 
Our initial understanding of gene regulation was obtained from studies of 
bacterial genes. The initial characterisation of eukaryotic promoters revealed similar 
arrangements of sequence elements to that discovered in prokaryotic genes. Many 
eukaryotic promoters possess the conserved TATAAT motif placed 20 to 30 bp 
upstream of the transcriptional start site. This motif is essential not for transcription 
per Se, but for the accurate placement of RNA polymerase II at the transcriptional start 
site Other promoter sequences found immediately upstream of the start site in 
prokaryotes have also been conserved in some eukaryotic genes. Such sequences 
immediately surrounding the start site were found to be sufficient to direct RNA 
polymerase to the start site and drive efficient expression of genes in prokaryotes. The 
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TATA box and upstream conserved sequences collectively specified the promoter 
(Hawley and McLure, 1983). Not surprisingly studies of eukaryotic gene regulation in 
cell culture demonstrated that the basic promoter, as defined in prokaryotes, was not 
sufficient to regulate the often complex expression of eukaryotic genes. 
The transcription of viral genes in infected culture cells was the subject of the 
early studies of transcriptional regulation in eukaryotic cells. Viruses are unable to 
replicate DNA or synthesise protein outwith the host cell and thus rely almost entirely 
on host factors for the transcription of their genes and translation of their RNA. SV40 
genes are transcribed efficiently in many culture cells and thus provided a model for 
eukaryotic gene transcription. Experiments using the SV40 virus demonstrated that 
efficient transcription of viral genes did not occur if 150 bp upstream of the basal 
promoter was deleted (Benoist and Chambon 1981). 
Within this region a 72 bp element occurred twice. Deletion of one of the 
repeated elements did not adversely affect transcription of the viral genes, where as 
deletion of both 72 bp elements drastically reduced gene expression. These regions of 
DNA which were not part of the basic promoter but were nonetheless required for 
efficient transcription, were termed enhancers. Functional assays of viral gene 
expression in cell culture defined the characteristics of the viral enhancers (reviewed by 
Atchison, 1988). 
It was found that viral enhancers could only increase transcription if they were 
present in cis. Nevertheless such sequences could exert their effect over distances of 
several kilobases. The orientation of the sequences with respect to the basal promoter 
elements did not appear to be important for them to exert their effect and enhancers 
were able to drive the efficient expression of genes other than those with which they 
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are normally associated. The orientation of the enhancer also appeared to be 
unimportant (Banerji et al., 1981). 
Subsequently sequences which exert an enhancing effect on gene expression 
were also found in cellular genes. An enhancer element was found to be present in the 
immunoglobulin heavy chain gene (Banerji et al., 1983, Gillies et al., 1983). Efficient 
expression of the Ig heavy chain requires the locus to undergo rearrangement. This 
rearrangement event is B-cell specific and precedes the expression of the Ig heavy 
chain. Analysis of this phenomenon lead to the discovery of an enhancer positioned 
between the (D) and (C) regions. Rearrangement of the gene locus brings a promoter 
of the (V) region to within 2.5kb of the enhancer resulting in elevated expression of 
VK. 
In order to investigate the effect the enhancer had on a heterologous promoter 
the Ig heavy chain enhancer was linked to 3-globin gene (Banerji et al., 1983). This 
gene is normally expressed in erythroid tissue not in lymphoid tissue. The expression 
of the gene was increased dramatically by the presence of the Ig heavy chain enhancer 
in cell lines of lymphoid derivation. Moreover the positioning of the enhancer with 
respect to the 13-globin promoter was of no importance. Thus the Ig heavy chain 
enhancer can (i) enhance expression of heterologous promoters, (ii) enhance 
expression of a gene regardless of its position with respect to the promoter and (iii) 
exert its effect over long distances. These characteristics are consistent with those of 
viral enhancers. Importantly it only enhances expression in cells of lymphoid 
derivation. 
Numerous other enhancers have now been identified in eukaryotic genes by 
their ability to increase transcription of cellular genes in transfection assays. Detailed 
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analysis of enhancers, both viral and mammalian, demonstrate they are composed of 
multiple genetic elements (modules), each of which binds one or more transcriptional 
activator proteins (Dynan, 1989 and references therein). The factors bound at the 
enhancer site are generally a combination of ubiquitous and cell specific DNA binding 
proteins. 
Evidence is accruing that the binding of unrelated transcriptional activator 
proteins to enhancer modules is co-operative (Adams and Workman 1995). It is 
currently thought that the binding of tissue specific factors to the enhancer region 
initiates the binding of other DNA binding factors to sites in the immediate vicinity, in 
a co-operative fashion. The binding of the trans activating factors is proposed to 
displace nucleosomes and via this mechanism may alter the chromatin structure of the 
region making it more accessible to other trans acting factors. Experimentally this is 
demonstrated by a general increase in DNAse I sensitivity and accessibility of DNA to 
restriction endonucleases upon factor binding to the enhancer. Currently it is thought 
that the proteins bound at different enhancer modules interact via protein-protein 
contacts to form a three dimensional structure which then interacts with RNA 
polymerase H. 
The ability of enhancers to confer a cell type and temporally specific profile of 
expression upon a gene is likely to be the key to understanding the differential 
expression of genes throughout development. Thus experiments have been devised to 
identify enhancer elements and analyse the expression profile they bestow on reporter 
gene constructs harbouring a minimal promoter. Enhancer trapping experiments were 
first devised in Drosophila (O'Kane & Gehring, 1987) and have subsequently been 
adapted for the mouse (Gossler et al., 1989). This approach allows the detection of 
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enhancers which display an interesting expression profile throughout development, and 
the subsequent analysis of the genes with which they are normally associated. 
It is likely that enhancer elements play a central role in the opening of a 
chromatin domain and activation of genes (Ellis et al., 1996). Nevertheless even in the 
presence of enhancer elements transgenes are often still poorly expressed in the whole 
animal. Thus it is clear that enhancers are necessary elements for the temporal and cell 
type specific expression of eukaryotic genes but may not be sufficient for copy number 
dependent expression of transgenes. 
1.4.4: Locus Control Region 
Using various approaches a number of different types of element have been 
demonstrated to be essential for accurate and abundant gene expression. Nevertheless 
expression of transgenes even in the presence of enhancers was still unpredictable. 
The first predictable expression of a transgene in transgenic mice was 
demonstrated by Grosveld and his colleagues (Grosveld et al., 1987). The group were 
studying the regulatory sequences of the human -globin like gene cluster. This is a 
cluster of 5 genes 5' 	 3' which span 70 kb in total. The genes are 
expressed throughout development in the order in which they occur in the genome. 
Early transgenic experiments showed disappointing expression of the human 13-
globin transgene in mice (Magram et al., 1985, Townes et al., 1985, Koffias et al., 
1986, 1987). The expression was low and highly variable. A group of genetic 
diseases termed the thalassemias are associated with mutations throughout the gene 
cluster (see Weatherall 1993 and 1995 for a review). The study of the Dutch 'yf3 
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thalassemia demonstrated that the disease was the result of a 100 kb deletion extending 
into the 3-globin like gene locus (Taramelli et al 1986). This deletion did not include 
the 3-globin gene or any of its immediate 5' regulatory regions. Despite the gene 
being intact no 13-globin gene expression was obtained from the affected allele. DNAse 
I sensitivity studies demonstrated that the chromatin of the affected allele was 
maintained in an inactive (closed) conformation and thus was not expressed (Kioussis 
et al., 1983). This suggested that sequences other than those immediately 5' and 3' of 
the 3-globin gene controlled its activation. 
Clusters of tissue specific DNAse I superhypersensitive (HS) sites had been 
detected at each end of the locus 5' of the c-globin gene and 3' of the -globin gene 
(Tuan et al., 1985; Forrester et al., 1986). These sites were considered to be candidate 
sites for regulation of the -globin like gene locus. The effect of their inclusion in a f3-
globin transgene was analysed in transgenic mice (Grosveld et al., 1987). The 
transgene comprised the HS cluster from the 5' end of the locus, the human 3-globin 
gene and the 3' HS cluster form the locus. The profile of expression of this globin 
gene minilocus was very predictable. The transgene was consistently expressed in 
transgenic foetuses and related to the transgene copy number. The results of this 
experiment gave rise to the concept of the Locus Control Region (LCR). 
The LCR is defined as a DNA sequence which confers transgene expression 
that is independent of its site of integration in the host genome, but dependent on its 
copy number. As with the definition of other gene regulatory elements this definition 
reflects the nature of the functional assay used. The mechanisms by which these 
sequences bring about this effect remain the subject of intensive research. 
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All four 5' HS sites have been cloned and sequenced. Footprinting analysis of 
the HS sites have demonstrated binding sites for numerous DNA-binding proteins, 
both ubiquitous and erythroid specific, in each of the HS regions (Talbot et al., 1991; 
Lowrey et al., 1992; Philipsen et al., 1993; Stamatoyanopoulos et al., 1995; Kotow 
and Orkin 1995). Functional analysis of constructs harbouring specific wild type 
5'HS's have demonstrated that although two of the HS sites 5'HS2 (Ellis et al., 1993, 
Caterina et al 1994) and 5'HS3 (Fraser et al., 1990; Philpsen et al., 1993) show partial 
LCR activity, no single HS gives the full LCR effect. Both 5'FIS2 and 5'HS3 can 
drive position independent expression of 3-globin transgenes when more than one 
copy of the transgene is present, but only at a fraction of the level expressed by the full 
LCR (Grosveld et al., 1987, Strouboulis et al., 1992). 
Since no single LCR element has been identified that drives high level, position 
independent and copy number independent expression of the 3-g1obin transgene, it is 
thought that all four HS elements are required for the full expression of all genes in the 
locus. It has been proposed that the individual elements within the LCR combine to 
form a single large nucleoprotein complex that interacts with and thus activates each of 
the genes in the locus (Fraser et al., 1993). In this model, the promoters of the 
different genes in the locus would be in competition for the LCR (Bebringer et al., 
1990). By default, promoters closest to the LCR would be the most frequently 
expressed. Thus 8-globin would be the most frequently expressed gene. Down 
regulation of the more proximal genes is thought to occur by the sequential expression 
of repressors of the more proximal genes throughout development. Studies of some of 
the thalassemias suggested the presence of such repressors and more recently the DNA 
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binding proteins GATA-1 and YY1 have both been found to be repressors of the 6-
globin gene (Raich et al., 1995). 
The 13-globin LCR has been shown to enhance the expression of the Thy 1 
gene and tk-neo in MEL cells but not in non erythroid cells so the globin LCR confers 
its effect in an erythroid specific manner (Blom van Assendeiff et al., 1989). This is 
not entirely surprising since some of the trans-acting factors bound to the HS sites 
have been demonstrated to be erythroid specific and essential for LCR activity (Kotow 
and Orkin, 1995). The LCR has no effect on the expression of transgenes in other 
non eiythroid tissues. 
The profile of expression conferred on transgenes by the globin LCR could 
also conceivably be produced by the presence of an insulator element. This possibility 
has been excluded by studying single copy insertions of the 3-globin minigene in 
transgenic mice. The high level tissue specific expression of the single integrants was 
observed but positive position effects resulted in low levels of expression in other 
tissues demonstrating that the single copy transgenes are not insulated (Ellis et al., 
1993). Moreover transgenes containing partial LCR fragments are capable of position 
independent expression (Fraser et al., 1990) and position effects are seen in -globin 
constructs that do and do not contain the LCR. Also the generalised DNAse 
sensitivity exhibited by the f3-globin locus (Forrester et al., 1990) extends well beyond 
the regions used in the transgenic mice experiments. Thus the ability of the LCR to 
override repressive position effects, but not prevent positive position effects, suggests 
that the globin LCR functions by a dominant positive activation mechanism as opposed 
to providing a boundary function (Dillon and Grosveld., 1993). 
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The j3-globin LCR regulates the expression of a multigene family. It 
determines (i) the erythroid specific expression (ii) developmental expression of the 
genes (gene switching) and (iii) the level at which the genes are expressed. Although 
the 3-globin LCR is now the paradigm of LCR function it regulates the expression of a 
highly complex multigene locus and is thus unlikely to be typical of other regulatory 
regions that confer a similar LCR effect on less complex gene loci. 
Other LCR like elements have been identified by their ability to produce high 
level, position independent, copy number dependent expression on genes expressed in 
transgenic mice. The human CDC2 gene exhibits copy number related expression in 
transgenic experiments (Greaves et al., 1989), as do the human ADA gene (Arnow, et 
al., 1995), 13-myosin heavy chain gene (Knotts et al., 1995), mouse tyrosinase gene 
(Schedi et al., 1993), PEPCK gene (Cheyette et a! 1992) and chicken lysozyme gene 
(Bonifer et al., 1990). The regulatory regions of all of these genes correlate with 
DNAse I HS sites. The chicken lysozyme transgene harboured the putative domain 
boundaries which are thought to insulate the transgene from position effects. 
Subsequent experiments (Bonifer et al., 1994) demonstrated that the putative domain 
boundaries were not required for the position independent expression of the chicken 
lysozyme transgene but did appear to reduce the level of ectopic expression of the 
transgene in other tissues. No boundary elements have as yet been identified for any 
of the other aforementioned genes. However regulatory regions outwith the immediate 
HS region are required to confer the LCR effect on the ADA gene in transgenic mice 
(Aranow et al., 1995). It has been proposed by these workers that sequences other 
than the enhancer are present in the regulatory region which facilitate the enhancer 
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function. These regions have been termed "facilitators" but their mechanism of action 
is unknown. 
1.4.5: Scaffold/Matrix Attachment Regions 
Microscopic examination of the lampbrush chromosome from the oocyte using 
phase contrast light microscopy demonstrated the chromosome consisted of a dense 
longitudinal axis from which loops of DNA emanated (Gall 1956, reviewed in Watson 
et al 1988). Visualisation of these structures led Gall and others to propose that a 
further level of DNA compaction (beyond that achieved by the sequestering of DNA 
on histone octamers) is brought about by the folding of the chromatin fibre into loops 
attached at their bases to a central support. 
Further electron microscopy studies on histone depleted metaphase 
chromosomes of HeLa cells showed loops of DNA attached to a central protein 
scaffold. Similar findings were obtained from interphase nuclei. (Paulson & Laemmli 
1977). These findings provided further support for the putative loop arrangement of 
DNA in chromosomes. 
Studies were performed which began to shed light on the nature of the 
supporting structure of chromosomes. The nuclear matrix is the insoluble structure 
which remains after the treatment of isolated nuclei with DNAse I and the extraction 
of proteins (the histone proteins in particular) using high salt solutions. It is the same 
size and shape as the nucleus, contains the nuclear lamina, remnants of the nucleoli 
and an internal proteinaceous network (Berezny and Coffey, 1974). The nuclear 
scaffold is obtained by treatment of isolated nuclei with a mild detergent lithium 
diiodosalicylate (Mirkovitch et al., 1984). This removes the histones and some non 
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histone proteins. Although similar to the matrix it differs in its overall protein 
composition (Beigrader et al., 1991). 
In 1985 Berrios et al., established that topoisomerase II is a component of the 
nuclear matrix of Drosophila nuclei. Previously a protein of 170 kd had been 
identified as the major component of the metaphase scaffold in HeLa cells. (Lewis & 
Laemmli, 1982). This protein was subsequently demonstrated to be topoisomerase II. 
Immunolocalisation of topoisomerase II has shown that it is located within an element 
forming the longitudinal axis of the chromatid in both 'native like' and histone depleted 
chromosomes (Berrios et al., 1985). 
Genomic DNA sequences that bind the nuclear scaffold (SAR's) were 
identified using the nuclear 'halo' mapping procedure (Mirkovitch et al., 1984). Matrix 
binding sequences in cloned DNA (MAR's) were identified by Cockerill and Garrard 
(1986). Both MAR's and SAR's were found to be AT rich stretches of DNA ranging 
from 100 bp to several hundred bp long. 
These findings were consistent with the findings of Moreau et a! (1982). 
These workers demonstrated the systematic punctuation of DNA with early melting 
zones which they termed 'A+T rich linkers'. These regions were AT rich, 800bp long 
(on average) and were clustered or spaced at intervals of 10 to 40 kb. To correlate this 
with function they analysed cloned genomic DNA from chick and Drosophila, and 
demonstrated that A+T linkers flanked the 15 kb chick c-globin gene cluster. The 15 
kb of DNA within the linkers correlated well with extent of DNAse I sensitivity 
previously established for this gene. The chick 3-globin gene cluster was also framed 
5' by a single A+T rich linker and a cluster of four such linkers at the 3' end. 
Similarly the ecdysone inducible P1 protein gene from Drosophila was shown to be 
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delimited by A+T rich linkers. It was proposed by these workers that the A+T rich 
linkers defined domains of the eukaryo tic genome that may correlate with putative 
functional units. S/MAR's are AT rich sequences that have been shown to coincide 
with the boundaries of actively transcribed genes (Gasser and Laemmli, 1986) it may 
be that the AT linkers described by Moreau and colleagues are S/MAR's since they are 
AT rich and are located at the boundaries of genes. 
It has been shown that genes are preferentially sensitive to DNAse I digestion 
in tissues in which they are transcribed.(Weintraub and Gourdine, 1976; Phi-Van and 
Stratling, 1988; Levy-Wilson and Fortier, 1989). Chromatin which is sensitive to 
DNAse I digestion is referred to as open chromatin, that which relatively refractory to 
DNAse I digestion is referred to as closed chromatin. The region of DNAse I 
sensitivity is not restricted to the coding region of active genes but extends to the 
flanking regions. The extent of general DNAse I sensitivity of a number of genes has 
been mapped. The DNAse I sensitivity of the chicken lysozyme gene has been 
rigorously studied in parallel with matrix binding studies. There is no sudden 
demarcation of the open and closed chromatin of the chicken lysozyme gene, rather 
the level of sensitivity gradually declines both in the 5' and 3' direction for some 
distance from the transcription unit of the gene, which is centrally placed within the 
DNase 1 sensitive region. The regions of the chicken lysozyme gene found to bind 
nuclear matrix co-localised with the 5'boundary of the DNAse I sensitive domain 
(Jantzen et al., 1986 ; Phi-Van and StrAtling, 1988). Similar findings were obtained 
with parallel DNAse I and MAR mapping of the human apolipoprotein B gene (Levy-
Wilson and Fortier, 1989). The finding that S/MAR regions are positioned on the 
boundaries of open and closed chromatin of actively transcribed genes implied that 
S/MAR's may have a functional role in gene transcription. 
The S/MAR regions of the chicken lysozyme gene have been called "A 
elements". The assessment of their possible function was carried out using a mini- 
domain with the enhancer region and promoter of the chicken lysozyme gene driving 
the expression of a CAT (chioramphenicol acelyltransferase) reporter gene. Two 
minidomains were tested for expression in transfection assays. The mini-domain 
described above and another identical but with the 5' A element of the chicken 
lysozyme gene placed at each end of the construct. In transient transfection assays of 
chicken promacrophage cells no difference in expression was detected between the 
two constructs suggesting that the A element was not a classical enhancer. However in 
stable transfection assays the A elements significantly enhanced expression of the 
reporter gene over that of the minidomain lacking the A elements (SteW et al., 1989). 
The A elements conferred position independent expression of the reporter gene from 
the chicken lysozyme enhancer and promoter. The 5' A element was also capable of 
augmenting transcription of heterologous enhancer-promoter elements (Phi-Van et al., 
1990; Sippel et al., 1992). Further examination of the effect of A elements on 
expression indicated that the A element could only augment expression of the gene if a 
functioning regulatory unit is present between the A elements (Sippel et at., 1992). 
The results of the transfection studies suggested that the A elements have an important 
role in the position independent expression of the associated gene. 
McKnight et a! (1992) tested the effect of the 5' A element of the expression of 
WAP transgenes in transgenic mice. The WAP transgene had been tested previously 
in transgenic mice and expression was observed in only 50 % of the lines at low levels 
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and its regulation did not mimic that of the endogenous gene (Burdon et al., 1991). 
The transgenic mice harbouring the A elements and WAP transgene were produced by 
co-injection of the A elements and the transgene since stable plasmid constructions 
could not be obtained. The A elements did not increase the level WAP expression in 
the lines but did allow low level WAP expression in all lines. The inclusion of the A 
elements also appeared to permit regulation of the WAP transgene throughout lactation 
in a manner that paralleled the endogenous WAP gene. The authors claimed that these 
results demonstrated the MAR could establish independent genetic domains in 
transgenic mice, but the expression of the WAP gene in these experiments was not 
copy number dependent indicating that the A elements did not fully insulate the WAP 
transgenes. 
The role of the A elements in chicken lysozyme gene expression have also 
been tested in transgenic mice (Bonifer et al., 1990). The transgenic mice harbouring 
the entire chicken lysozyme gene including the 5' and 3' A elements expressed the 
transgene in a tissue specific manner. The expression levels were directly related to the 
transgene copy number in all of the founder animals. The study demonstrated that the 
chicken lysozyme gene locus behaves as a regulatory unit independent of its 
chromosomal position. However, further experiments (Bonifer et al., 1994) 
demonstrated that the removal of the A element did not significantly affect the position 
independent copy number dependent expression of the gene in transgenic mice and 
resulted only in an increase in ectopic expression. Therefore it has not been 
conclusively demonstrated that the 5' A element of the chicken lysozyme gene acts as 
an insulating element in vivo. SAR sequences from the human f3-interferon putative 
boundary domains (Bode and Maass, 1988) have also been tested in transgenic mice 
for their ability to act as boundary elements for a construct containing the murine 
HSP70. 1 promoter linked to a firefly luciferase reporter gene (Thompson et al 1994). 
Neither elevated expression, copy number dependence nor elimination of position 
effects was observed in differentiated tissues suggesting that these sequences were 
unable to act as boundary elements. Currently there is no strong evidence for MAR's 
functioning as boundary elements in vivo. 
A number of proteins have now been identified that bind to S/MAR's. These 
include; histone deacetylase (Hedzel et al., 1991), ARBP (von Kries et al., 1991), 
SATBI (Dickson et al., 1992), SAF A (Romig et al., 1992), ATF transcription factor 
Dworetzky et al., 1992) CHD1 (Stokes and Perry, 1995), nucleolin (Dickson and 
Kohwi-Shigematsu, 1995) and Bright (Herrscher et al., 1995). The functions of these 
proteins in vivo are as yet undetermined. Some of them have been demonstrated to be 
an integral part of the nuclear matrix (Histone deacetylase, ARBP, SAF-A and 
SATh 1). Others have been found to be partitioned between the insoluble matrix 
fraction and soluble fraction of nuclear proteins (nucleolin and Bright) and CHD 1 has 
been shown to be associated with bulk chromatin rather than the nuclear matrix. 
ARBP and SAF-A are abundant nuclear proteins and for this reason have been 
proposed to have a structural role in the looping of DNA. SAF-A seffpolymerises and 
has been demonstrated, using electron microscopy, to form looped structures in DNA. 
SATB 1 and Bright are tissue specific MAR proteins expressed in the human thymus 
and B cells respectively. The presence of tissue specific MAR binding proteins 
suggests that MARs have a role in gene transcription. Bright has a domain that shares 
identity with S %V11, a component of the S WIYSNF complex of trans-activating factors. 
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CHD1 contains both a chromatin organisation modifier (chromo) domain and a 
helicase/ATPase domain. The binding of such proteins which are capable of affecting 
local chromatin structure is consistent with MARs having a role in the control of local 
chromatin structure and consequently a role in transcriptional control. 
1.4.6: Non MAR Boundary Elements 
Putative boundary elements were found at the 5' and 3' ends of the Drosophila 
87A7 heat shock locus (Udvardy et al., 1985). These unusual nucleoprotein structures 
were named specialised chromatin structures or scs elements. The scs elements are 
not matrix bound. Each of the scs elements (scs' and scs) have two DNase 1 
hypersensitive sites flanking a DNAse I resistant core of 250-230 bp (Kellum and 
Schedi, 1991). The ability of the scs elements to insulate a transgene from position 
effects was demonstrated using the Drosophila white gene as a reporter (Kellum and 
Schedl, 1991). The white gene functions autonomously in each cell of the Drosophila 
eye. The level of white gene expression is reflected in eye colour which is easily 
measured and the white gene has been shown to be susceptible to position effects. 
Comparison of the white transgene flanked with the scs elements with the reporter 
gene that was not flanked with the scs elements clearly demonstrated that the 
Drosophila scs elements were capable of insulating a reporter transgene from position 
effects. These same workers then demonstrate further the ability of the scs elements 
to function as domain boundaries by an Enhancer blocking assay (Kellum and Schedi. 
1992). A MAR sequence was unable to prevent the action of an enhancer when placed 
between the enhancer and the promoter elements suggesting that not all sequences that 
bind to the matrix can function as insulators. Studies are now being performed to 
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isolate proteins which bind to the scs elements. Zhao et al., (1995) have isolated a 
protein BEAF 32 which binds scs'. Ongoing work to identify further proteins which 
are associated with the scs elements may explain the molecular mechanism by which 
the elements exert their effect. 
The 5' HS4 site of the chicken 13-globin gene has also been proposed to act as 
a boundary element (Chung et al., 1993). This region of the chicken p-globin gene 
locus is characterised by a constitutive HS site in all tissues. The presence of a 
constitutive HS site at the 5' end of the 3-g!obin locus appears conserved in human 
mice and chicken and it has been proposed to act as an insulator preventing the 
influence of the potent LCR spreading in the 5' direction. The element has not been 
demonstrated to bind to the nuclear matrix and it may be quite different from the 
MARs that have been proposed to function as boundary elements Chung et al 
performed an enhancer blocking assay in erythroleukemia cells to demonstrate the HS 
site functioned as a boundary and found it insulated a reporter gene from the influence 
of a nearby LCR, when positioned between them They also assayed the ability of the 
HS site to insulate the white gene in Drosophila and found that the element insulated 
the gene from position effects. However a single HS site was not able to provide 
complete insulation in either of these experiments. Moreover the element has not been 
tested in transgenic mice which would appear to be the most rigorous system for 
testing the function of putative boundary elements. 
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1.5: TRANSGENIC ANIMALS IN THE PRODUCTION OF BIOMEDICAL 
PROTEINS 
Many human diseases arise from a lack of functional proteins which fulfil 
important physiological roles. For such diseases simple replacement therapy can 
alleviate the symptoms of the disease and in some instances slow its progression. 
Widespread replacement therapy of such physiologically active proteins requires 
adequate volumes of the protein be synthesised and purified at low cost. For proteins 
required in high dosage (eg. human c 1-antitrypsin) the volumes required can be 
considerable. 
Some proteins for replacement therapy have traditionally been isolated from 
animal sources. Examples of this are insulin and calcitonin (Bowman and Rand 1984). 
Much of the insulin used clinically, until quite recently, was extracted from either 
porcine or bovine pancreas. Molecular species differences are too small to influence 
its metabolic activity as human insulin differs from porcine and bovine insulin by only 
one and three amino acids, respectively. Nevertheless they are foreign proteins and 
allergic reactions do occur as a result of prolonged administration of the foreign insulin 
or other co-purified protein impurities. 
For blood disorders such as the haemophilia's the required biomedical proteins 
are purified from human blood. There is of course a significant risk of disease agents 
being transmitted from the blood donor to the recipient of the purified blood product. 
For these reasons among others alternative methods of producing important 
biomedical proteins have been sought. 
Human proteins can be made by recombinant bacteria (Pestka 1983) 
(Johnson, 1983) or yeast (Sleep et al., 1987, Casolaro et al., 1987) Unfortunately such 
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systems are only suitable for the production of relatively simple proteins that do not 
require post translational modification. Human insulin, which is non-antigenic, is now 
available as a result of recombinant technology (Johnson 1983), and is now routinely 
used. The production of more complex mammalian proteins using bacteria or yeast 
generally results in a product of low biological activity and/or stability, as prokaryotes 
and lower eukaryotes are incapable of carrying out the post translational modifications 
normally present on many mammalian proteins. 
Culture systems of transformed mammalian cells, hybridomas and insect cell 
lines have also been employed for the production of biomedical proteins. Such cell 
culture systems are capable of performing post translational modification of proteins 
and have produced some biomedical proteins with high efficacy (Garver et al., 1987; 
Pavirani et al., 1987; Ogonah et al., 1996). One of the difficulties with mammalian 
cell systems is striking a balance between the high protein production per cell and high 
cell density (Hodgson, 1991,1992). Such systems are currently used to produce 
biomedical proteins but the cost of this method of production is generally high. 
Transgenic animals have been used to produce biomedical proteins directly. It 
was proposed soon after the production of the first transgenic mice that transgenic 
farm animals could be used as bioreactors for the production of important biomedical 
proteins (Palmiter et al., 1982, Lovel-Badge 1985). With the use of specific promoters 
the protein could be secreted into body fluids which could then be harvested for 
purification of the biomedical protein. Candidate fluids were blood saliva,, urine and 
milk. The protein could be purified from the fluid and the transgenic animals would 
provide an infinitely replenishable source of the protein. 
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The expression of biomedical proteins in the blood is problematical in that the 
biologically active protein has access to all body tissues and may have serious harmful 
effects. Nevertheless transgenes encoding human haemoglobin have been successfully 
expressed in the blood of transgenic swine (Swanson et al., 1992) with no apparent 
deleterious effects. Expression of transgenes in the mammary gland and the targeting 
of the secreted biomedical protein to milk has attracted much attention (reviewed by 
Maga and Murray, 1995). The volume of milk produced during lactation is 
considerable, particularly in ruminants the amount of protein production attainable 
during one lactation in dairy cows is approximately 240 kg/animal/lactation and in 
dairy sheep approximately 12 kg/animal/lactation (Clark et al., 1990). Given these 
characteristics it seemed reasonable that dairy animals could be used as bioreactors for 
the production of biomedical proteins. By targeting the expression of a given gene to 
the mammary gland using a milk protein gene promoter the protein of interest could 
pass through a mammalian cell capable of carrying out post translational modifications 
that may be required and secreting the protein in a medium from which it should be 
relatively easily harvested. 
The mammary gland is an organ which is relatively autonomous. Thus the 
expression of the transgene in this organ should have little opportunity to interfere with 
the wider physiology of the transgenic animal. Throughout lactation milk protein genes 
are abundantly expressed, and are thus candidates genes to provide the promoter to 
drive efficient expression of transgenes encoding biomedical proteins, in the mammary 
gland. 
A number of transgenes have now been expressed in the milk of large domestic 
animals under the direction of milk protein gene promoters (Wright et al., 1991, 
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Greenberg et al., 1991, Velander et al., 1992). Large numbers of transgenic animals 
can be produced from a single transgenic founder which expresses the protein at 
commercially viable levels. All offspring of a given founder as a rule produce the 
protein at similar levels. Consistent and high levels of expression of the protein of 
interest in milk facilitate large scale purification. 
1.6. LACTATION 
The mammalian mammary gland undergoes extensive changes during lactation 
and pregnancy. During pregnancy the mammary gland grows a large lobule-alveolar 
epithelial tissue and ductal network, during late gestation the gland differentiates and 
alveolar structures are formed at the ends of the ductal tree. The differentiation 
accompanies the acquisition of the ability of the epithelial cells to synthesise milk 
proteins and secrete milk (Topper and Freeman 1980). After parturition the volume of 
milk secreted increases to a maximum and then gradually declines with time 
Lactation is influenced by a number of endocrine hormones, cell-cell interactions and 
external stimuli such as milk removal and temperature. 
The composition of milk is species dependent and the regulation of milk 
production has been demonstrated to vary from species to species (Jenness, 1982). 
Because of the large cost involved in the production of transgenic large animals 
transgenes are more often than not tested in the mouse.. The effects of species 
variation in the hormonal control of lactation need to be considered for the meaningful 
analysis of pilot transgenic experiments in mice. 
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1.7 1: The Hormonal Regulation Of Milk Protein Genes 
The tissue and developmental stage-specific regulation of milk protein gene 
expression is influenced by a variety of factors including peptide and steroid hormones, 
cell-cell, and cell substratum interactions. Lactogenesis in the mammary gland requires 
a large quantitative increase in the synthesis of enzymes, metabolites and messenger 
RNA's associated with the secretion of the unique components of milk. There is no 
single hormone that initiates lactation. Rather, a cascade of events occurs in the 
endocrine system during the third trimester of gestation that prepares the mammary 
gland for the secretion of milk. The secretion of milk is closely integrated with 
parturition (Tucker, 1988). In cows the levels of glucocorticoids and growth hormone 
peak at parturition. The level of prolactin peaks just prior to this at about three or two 
days before parturition as do the levels of estradiol-17P and the level of prostaglandin 
F also peaks about one day before parturition (Tucker, 1988). The combination of 
changes in the levels of these factors is thought to bring about the second stage of 
lactation. Importantly the levels of progesterone in the serum fall dramatically at about 
five days prior to parturition and coincide with the rise in the levels of these other 
lactogenic factors. Progesterone has been demonstrated to be an inhibitor of lactation 
(reviewed by Tucker, 1988 ). The following paragraphs review some of the most 
recent transgenic work on the regulation of milk protein genes. It seems that there are 
important similarities in milk protein gene promoters and similar DNA motifs are 
present within the promoter and enhancer regions but there appear to be important 
differences in the detailed mechanisms of regulation of different milk protein genes. 
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1.7.2: The Casein Genes 
The casein genes are a family of genes that are present in a cluster. This gene 
cluster is present on chromosome 6 in the cow and on chromosome 5 in the mouse. 
The bovine casein gene cluster has been reported to be within a 185-kb locus 
(Threadgill and Womack, 1990) and the genes are arranged c, 13, aS2 and K casein. 
It is believed that the casein genes are co-ordinately regulated and that this regulation 
may involve elements similar to the LCR of the globin gene cluster (Maga and Murray 
1995). This proposal is supported by transgenic experiments using the rat 13-casein 
gene as a transgene in mice. In these studies the casein gene was expressed in a tissue 
specific manner that was developmentally regulated but the maximal level of 
expression of the transgene was 100 fold less than that of the endogenous mouse 13-
casein gene (Lee et al., 1988). The CAT reporter constructs driven by the 13-casein 
gene promoter were susceptible to position effects and demonstrated a 500-fold range 
of expression in the CAT activity of the lines generated (Lee et al., 1989 ). These 
studies showed that the minimal promoter fragment encompassing 0.5-kb of 5' 
flanking sequence, non coding exon 1 and 0.5 kb intron A was sufficient for the 
mammary specific expression during lactation but it was clear that other cis-acting 
sequences required for the normal high level of expression of this gene during lactation 
were lacking in these transgenes. In pseudopregnant rabbit 13-casein gene induction is 
seen on administration of the pituitary hormone prolactin. Rabbit mammary tissue 
appears to be more sensitive to 13-casein gene induction by prolactin than mammary 
tissue from other animals. The reason for this is thought to be that prolactin increases 
the secretion of progesterone from the corpus luteum in rats and mice and 
progesterone then acts as an inhibitor of lactogenesis. When progesterone is absent 
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from the system prolactin is shown to be lactogenic. Thus it would appear that the 
induction of the casein genes in many species is indeed dependent on the presence of 
prolactin (Reviewed by Tucker, 1988). Studies on the rabbit as,-casein have shown 
that the transcription of this gene is induced by prolactin (and the workers 
demonstrated that the region responsible for this responsiveness was contained within a 
655-bp fragment located 5' of the coding sequences). In subsequent studies on this 
fragment an MGF like binding sequence was found within the fragment (see section 
1.7.4) 
1.7.3 The Rodent Whey Acidic Protein (WAP) Gene 
Studies of the hormonal requirements for WAP gene regulation performed on 
various explant and cell culture systems have indicated that WAP induction is 
dependent upon the synergistic action of, glucocorticoids, insulin, and prolactin. The 
molecular mechanisms by which these factors interact to regulate WAP gene 
expression are only now beginning to be understood. In the previous section it was 
highlighted that prolactin appears to be one of the major determinants in the regulation 
of the casein genes. However the induction of WAP gene expression in the absence of 
prolactin is considerably more sensitive to glucocorticoids than is the case for the 
casein genes. A 68 fold increase in the level of WAP mRNA was obtained when 
insulin and hydrocortisone were added to mammary explant cultures this compared 
with only minimal increase in casein gene mRNA (Hobbs et al., 1982) Thus it appears 
that although prolactin is required for optimal WAP gene expression the induction of 
this gene is less sensitive to prolactin but is considerably more sensitive to 
glucocorticoids than the casein genes. A recent study identified glucocorticoid receptor 
binding sites flanking NFl sites that have been demonstrated to be within a previously 
identified hypersensitive site in the 5' flanking region of the rat WAP gene (Li and 
Rosen 1994). These sites were identified using in vitro DNAse I footprinting. It was 
demonstrated that these sites were able to confer dexamethasone inducibility to a 
construct with a minimal thymidine kinase promoter driving the expression of a CAT 
(chioramphenicol acetyltransferase) reporter gene. Transgenic mice harbouring the rat 
WAP transgene were adrenalectomised and administration of dexamethasone was 
demonstrated to be essential for the maintenance of the expression of the transgene, a 
correlation of the glucocorticoid induction of the WAP gene and the appearance of a 
DNAse I hypersensitive site was demonstrated. The workers conclude that the 
hormone induced chromatin changes in the 5' flanking regions of the WAP gene are a 
direct consequence of the binding of the glucocorticoid receptor to the glucocorticoid 
half sites identified by the footprinting assay. The glucocorticoid receptor binding sites 
did not conform to the accepted consensus binding sequence for glucocorticoid 
receptor but the identified footprint site did contain GR binding half sites. It is thought 
that the binding of the GR to these sites is cooperative and may involve interaction 
with other nuclear factors involved in WAP gene transcription. 
1.7.4: The Ovine BLG Gene 
As with many other milk protein genes the molecular mechanisms regulating 
the tissue specific and developmental control of the ovine BLG gene are only just 
beginning to be understood. Studies on this milk protein promoter in combination 
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with studies done using the -casein gene have helped to elucidate a pathway by which 
the prolactin receptor mediates effects on milk protein gene promoters. 
The prolactin receptor is a member of the cytokine receptor superfamily. A 
variety of cytokines, lymphokines and growth factors function by interacting with 
receptors that are members of this receptor family. These receptors share extracellular 
motifs and have limited similarity in their cytoplasmic domains. Although unlike the 
protein tyrosine kinase receptors, the receptors of the cytokine receptor family do not 
possess a catalytic domain, binding of these receptors to their ligand induces tyrosine 
phosphorylation via a family of cytoplasmic protein tyrosine kinases named the Janus 
kinase family or JAKs. JAKs are phosphorylated on tyrosine residues upon binding of 
a cytokine to its receptor causing an upregulation of the JAK enzymatic activity. The 
activation of the JAK in turn leads to the phosphorylation of the receptor and 
activation of a transcription factor belonging to the STAT family. These STAT 
transcription factors bind to GAS sites in some gene promoters bringing about an 
effect on gene transcription. The prolactin receptor has been demonstrated to be 
associated with the JAK2 tyrosine kinase (Rui ci al., 1994). 
A factor that was originally thought to be mammary specific was found to bind 
to the promoter region of the ovine BLG gene (Watson. et al., 1991) This factor 
named MPBF was thought to be related to the factor identified by (Schmitt-Ney. et  
al., 1991) that bound to the promoter of the -casein gene. The factor in that study 
was called MGF. The binding sites for these two factors were found to be very 
similar. The MPBFIMGF sites were also found to be present within an enhancer 
implicated in substratum dependent prolactin induction of the -casein promoter 
driving the expression of reporter genes in the CJD9 mammary cell line (Schmidhauser 
et al., 1992). 
Three MPBF sites occur within the 410-hp promoter of the ovine BLG 
promoter that has been demonstrated to be sufficient to drive the tissue specific and 
position independent expression of the BLG transgene in mice (Whitelaw et al., 1992). 
The MPBF sites in the BLG transgene have been further studied to elucidate their role 
in ovine BLG transgene expression in the mouse. Mobility shift assays were 
performed to identify mutations in the three MPBF binding sites that abolished binding 
of the factor (Burdon et al., 1994). The three sites had different affinities for the 
MPBF transcription factor. One site designated STM had a high affinity for the 
factor, another site designated A3 had an intermediate affinity for the factor and the 
third site Al only weakly bound the factor. Three transgenes harbouring mutations 
were used to generate transgenic mice. One transgene harboured a mutation that 
abolished binding in the high affinity site only, another transgene harboured mutations 
in the two weakest binding sites Al and A3 and the third transgene harboured 
mutations that abolished binding in all three binding sites. Analysis of the BLG RNA 
levels in eight transgenic lines for each transgene demonstrated that the mutations did 
not abolish expression of the transgene but the level of expression of the A1/A3 
mutation was reduced by half and with all three binding sites mutated the level of 
expression was reduced four fold. Thus the MPBF binding sites were demonstrated to 
be necessary for the maximal expression of the BLG gene driven by the -410 -bp 
promoter. The transgene was still expressed in a position independent manner. 
Ectopic expression of BLG was detected in the salivary gland but the level of 
expression in this tissue was very low. It was demonstrated that the MPBF factor is 
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also present at low levels in the salivary gland and in the liver at 2% and 4% 
respectively of the levels of MPBF in the lactating mammary gland. 
The MGF factor has since been shown to be STAT 5 (Wakao et al., 1994). 
Suggesting that the prolactin receptor signals via the JAK/STAT signalling pathway. 
The receptor is associated with JAK2 and JAK2 phosphorylates STAT5 activated 
STAT5 then binds the MPBF/MGF sites present in milk protein gene promoters. 
These MGF binding sites closely resemble the GAS binding site consensus sequence. 
It is likely that maximal expression of BLG is brought about by the synergistic effects 
of a number of different binding factors influenced by a number of different signalling 
pathways. 
1.8: OVINE /3-LA CTOGLOBULIN A S A TRANSGENE IN MICE 
The milk protein gene promoter of interest in this study is that of the ovine 1-
lactoglobulin (BLG) gene (All and Clark 1988). The BLG gene encodes one of the 
major whey proteins in ruminants. This gene was first studied as a potential gene to 
provide a promoter to drive the expression of heterologous biomedical proteins in the 
milk of sheep. Test studies were performed in mice using the entire ovine BLG gene 
and a considerable amount of its 5' regulatory sequences as a transgene. Despite the 
fact that the rodent possesses no endogenous BLG gene the ovine BLG protein was 
expressed efficiently in the mammary gland of transgenic mice. Nearly all lines of 
mice generated which harboured this transgene expressed the protein in their milk-
(Simons. 
il
s. et al., 1987). Thus the transgene was expressed in a position independent 
manner. Moreover the expression level of the protein in the milk correlated with the 
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copy number of the transgene in any given line (Whitelaw et al., 1992). Thus the 
expression of the transgene was also copy number dependent. The profile of 
expression of the protein throughout pregnancy and lactation was similar to that in 
sheep. Thus despite the fact that rodents do not normally express this protein during 
lactogenesis the regulatory sequences of this ovine gene are correctly interpreted in the 
murine mammary gland. 
The expression of the BLG gene on the whole was at first thought to be tissue 
specific but recent data shows that the protein is expressed at very low levels in other 
tissues Farini and Whitelaw, 1995). The low level ectopic expression of this 
transgene in mice may well be the consequence of the lack of a repressor that is 
normally present in sheep as ectopic expression of BLG was not detected in sheep 
(All, 1989). Thus in this respect the mouse may not be the ideal model for testing this 
promoter when linked to biomedical proteins that may have either a pharmacological 
or deleterious effect because of ectopic expression. 
The high levels of mammary specific expression of the ovine BLG transgene in 
transgenic mice demonstrated that this was a good promoter for driving high level 
expression of biomedical proteins in the milk of domestic farm animals. In order to 
test the ability of the BLG promoter to drive the expression of heterologous proteins a 
number of experiments were conducted using the promoter and 5'flanking sequences 
of the ovine BLG gene fused a heterologous protein coding region. 
1.9 AA TB THE TRANSGENE 
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The AATB transgene encodes human cu-antitrypsin. This protein is a major 
protease inhibitor of a number of human serine proteases including elastase, trypsin, 
chymotiypsin, thrombin, and bacterial proteases. The most important inhibitor action 
is that against neutrophil elastase, a protease which degrades elastin of the alveolar 
walls as well as other structural proteins of a variety of tissues. Insufficient circulating 
levels of cu-antitrypsin result in lung tissue damage, leading eventually to the chronic 
and debilitating disease emphysema. The serum concentration of cti-antitiypsin in 
humans is normally about 1.3 mg/ml. 
(xi-antitrypsin shows a considerable amount of genetic variability. The M 
variant which can be further classified into subtypes, is the most common allele in all 
populations. The S allele reaches polymorphic frequencies in many populations (this 
allele encodes protein which has reduced stability) as does the Z allele, (which encodes 
protein which is poorly secreted). Both the S and Z alleles are associated with reduced 
circulating levels of the protease inhibitor and with emphysema. Simple replacement 
therapy of the protein considerably slows the advance of the disease. 
cu-antitrypsin is a single chain glycoprotein. It has three N-linked carbohydrate 
side chains. The side chains are not essential for its biological activity, but synthetic 
AAT produced in bacteria and yeast lack the carbohydrate moieties and display a 
markedly reduced half life (Casolaro et al., 1987). Mammalian culture cells produce 
correctly glycosylated MAT but the yields are low, and overall, the technology 
expensive This is problematic when the protein is required in high dosage for 
replacement therapy. It was thought that the expression of the gene in the mammary 
gland of transgenic sheep could lead to the secretion of correctly glycosvlated protein 
into the milk from where it could be easily harvested. 
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The AATB transgene contains 4.2 kb of 5'untranslated sequences from the 
ovine BLG gene. The coding sequences are genornic hAAT Ml sequences minus 
intron one (Archibald et al., 1990). The intron was removed by using an hAAT 
cDNA to provide the first 80 bp of the hAAT "minigene". Jntrons were included in 
the transgene because they have been shown to influence the efficiency of expression 
of some transgenes and previous transgenic mouse experiments, using the BLG 
promoter and an hAAT cDNA, were not successful (Archibald unpublished data). 
Two studies were performed using this transgene. In the original study 
(Archibald et al., 1990) thirteen transgenic lines were analysed for the production of 
the human protein in their milk. Of thirteen lines five expressed the transgene in their 
milk. Three of these expressed the transgene at levels between 0.5 and 1.0 mg/nil. 
Another line AATB 35 gave very good levels of expression (7mg/mi). 
In the second study (Carver et al., 1993) the level of hAAT was assayed from 
the milk of eleven female founder animals. In this study all transgenic animals were 
found to express the protein in their milk. Nevertheless there was a 30 000 fold range 
in the expression of the human protein between the animals. The levels detected most 
of the lines were very low indeed and would not have been detected using the protein 
assays in the original study. Two lines were found to contain high levels of the human 
protein in their milk 8 mg/ml and 21 mg/ml. Overall the results of the two 
independent studies using the AATB transgene correlate very well. 
It is quite clear in both studies that the level of expression of the transgene did 
not correlate in any way with the transgene copy number. Interestingly the two stable 
lines expressing relatively high levels of hAAT, AATB 35 (Archibald et al., 1990) and 
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AATB 46.2 (Carver et al., 1993), appeared to be generated from transgene loci of 
very low copy number (one and three respectively). 
These studies demonstrated that it is possible for the BLG promoter to drive 
high levels of expression of heterologous transgenes in the mammary gland of 
transgenic mice. AATB has also been demonstrated to drive efficient expression of 
MAT in the milk of transgenic sheep (Carver et al., 1993). To date a flock of 
transgenic sheep harbouring the construct have been produced which stably express 
the human protein in their milk at 13-17 gIl. Subject to successful clinical trials MAT 
from transgenic sheep will be available for therapeutic use in the foreseeable future. 
To date AATB has been one of the most successful transgenes for the 
production of a biomedical protein in the mammary gland of transgenic animals. It 
appears that sheep express the AATB transgene more predictably than transgenic 
mice, which is not entirely surprising since the transgene utilises an ovine promoter to 
drive its transcription. Although the ovine BLG promoter gave a position independent 
copy number dependent expression of the genomic BLG gene, the promoter did not 
give the same predictable expression profile for heterologous genes. 
1.10: THE AIM OF THIS WORK 
The production of transgenic animals as bioreactors for the production of 
biomedical proteins was first spoken of in the scientific literature soon after the 
generation of the first transgenic mouse by pro-nuclear injection (Brinster et al 1985). 
Since then numerous studies have been undertaken both in the murine and other 
animals to achieve this aim. 
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The vast majority of transgenes encoding biomedical proteins are subject to 
position effects and the expression levels are erratic and unreliable. Given the high 
Cn— 
cost of generating transgenic live stock a transgene promoter that gives reliable good 
levels of expression in a targeted organ is the ideal promoter. 
The ovine BLG promoter has been demonstrated to be capable of driving the 
high level of expression of human alpha- 1-antitrypsin in the mammary gland of 
transgenic mice and sheep. Two lines of transgenic mice were generated that gave 
unusually high levels of the human protein in their milk. In both cases this was 
thought to be due to the influence of the murine chromosomal DNA surrounding the 
transgene locus. The aim of this study was to investigate the role the flanking murine 
sequences played in expression of the transgene in one of these lines. And hopefully 
isolate through this investigation the sequences responsible for high level expression, 
with a view to using the sequences or the information obtained about their role in 
transgene expression, to improve the predictability of the BLG promoter when used to 
drive the expression of heterologous protein in the mammary gland. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Mice Used 
Deoxyribonucleic acid (DNA) for Southern blot analysis was prepared from 
liver tissue of transgenic mice of lines AATB 35 (Archibald et al., 1990), AATB 46.2 
(Carver et al., 1993) and non transgenic mice (Fl) using method 2.7. DNA for 
construction of the cosmid library was obtained from liver DNA of a transgenic mouse 
of line AATB 46.2 (AATB 46.2.36). 
2.2: Recombinant plasmid clones 
AATB; P-polyl 1 1-I with BLG-ha1AT insert supplied by Dr. A. Archibald 
p8alppg human AAT cDNA clone supplied by Dr. G. Kelsey 
2.3: Non-recombinant plasmid vectors and bacterial host strains used 
Vectors 
Bluescript SK+ ; 2961 bp phagemid carrying ampicilhin resistance gene (Stratagene) 
SuperCos 1; 7937 bp cosmid carrying ampicillin resistance gene, dual cos sites, SV40 
promoter and neomycin resistance gene (Stratagene) 
Lambda DASH II ; was the lambda phage vector used to clone the secondary 
transgene (Stratagene) 
Bacterial host strains and genotypes 
DH5a (F , 480dlacZAM15, A(IqcZYA-ar 	deo rec Al, endAl, hsdRl7(rk 
,Mk), WpE44, )N-1, gyrA96, relAl) 
NM554 (recAl3, araD 139, A(ara-1eu 	ç)17A, giU, g1. 	R, pL(str1), 7696, A(i  
mcrA, mcrB) 
XL1-Blue MIRA (A(mcrA)183, A(mcrCB-hsdSMR-mrr)173, endAl, supE44, thi-1, 
gyA96, !TiAl, c) 
XL1-Blue MIRA (P2) XL1-Blue MRA (P2 lysogen) 
2.4: Enzymes, antibiotics and specialised chemicals 
Amersham : [35S]dATP-o-S 3000 ci!mmol, a22P-CTP 3000 ci/mmol, Hybond N, 
random prime labelling kit, USI3 sequencing kit 
Boehringer Mannheim : proteinase K X-GAL, JPTG, calf intestinal phosphatase 
(CIP), caesium chloride (CsCI), all restriction endonucleases used (unless otherwise 
stated) 
Costar: Spin-X DNA purification columns 
Difco : bactotryptone, yeast extract 
Gibco BRL : DH5x competent cells 
ICN Pharmaceuticals : NZ amine (casein hydrosylate) 
New England Biolabs: -agarase 
Pharmacia : universal primer M13, Klenow fragment DNA polymerase 1 
Promeg4 : Erase-a-Base system 
PRTJ : goat anti a1AT serum 
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SAPU : horseradish peroxidase conjugated sheep/goat IgG antiserum. 
jgma : diethylpyrocarbonate (DEPC), TEM1ED, sodium dodecyl sulphate (SDS) 
ampicillin, human 1-antitiypsin, 4-Chloro-1 -napthol, hydrogen peroxide 
Stratagene : SuperCos 1 cosmid vector kit, Lambda DASH 11 undigested vector kit, 
Gigapack 11 gold in vitro phage packaging extract, Srf 1 restriction endonuclease 
2.5 Media 
Broths 
All E.coli strains were grown in either LBM (lOg tryptone, 5g yeast, 5g NaCl, 2g 
MgCl2.6H20 per litre) or in NZY (lOg NZ Amine, 5g NaCl, 2g MgSO4.7H20, 5g 
yeast extract per litre, adjusted to pH 7.5 with NaOH) liquid medium. 
Plates 
LBM plates for plasmid subcloning were poured using lOg bactotryptone, 5g 
yeast extract, 5g NaCl 15g agar per litre and ampicilhin to a fmal concentration of 
50tg/ml added to cooled medium immediately before pouring. LBM plates for phage 
cloning were prepared as described but with the omission of ampicillin and addition of 
10 ml per litre 1M MgSO4.71 20 just before pouring. Top agar overlays were poured 
from lOg bactotryptone, 5g yeast extract, 8g of agar, 5g NaCl per litre and lOmis 1M 
MgSO4.7H20 added just before pouring. NZY plates for the cosmid library were 
poured using, lOg NZ Amine, 5g NaCl, 2g MgSO4 7H20, 5g yeast extract adjusted to 
pH 7.5 with NaOH with 15g agar per litre and ampicillin at a fmal concentration of 
SOpg"ml. 
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Z 6 Autoradiography and Photography 
Agarose gels stained with 0.5p.g'ml of ethidium bromide were photographed 
using Polaroid type 667 film in a land camera, illuminating from below using a 
transilluminator of wavelength 302nm. 
Autoradiographs were produced using Agfa-Curix fihn RP1. Films were exposed for 
the times stated at either -70°C or room temperature with Dupont intensifying screens 
unless otherwise stated. 
2.7 Preparation of High Molecular Weight DNA from Mouse Liver 
The mouse was dissected and placed immediately into ice-cold SSCT (1 x SSC 
+ 10mM Tris HC1 pH.7.4). The liver tissue was minced and washed several times in 
ice-cold SSCT to remove red blood cells and then resuspended in 6 ml of ice-cold 
RSBE/NP40 (10 mM Tris, 10mM NaCl, 2mM EDTA pH. 7.4, 5% NP40 and 1mM 
PMSF (added just before use)). The minced liver tissue was homogenised using a 10 
ml Dounce homogeniser. Transferred to a 30 ml Corex tube and spun at 45 rpm in 
an SS34 Sorval rotor for 5 minutes at 4°C. The supernatant was discarded and the 
pellet gently resuspended in another 6 ml of RSBE/NP40 (this wash was repeated 
twice more). Finally the nuclei were resuspended in 2 ml of RSBE (10 mM Tris, 
10mM NaCl, 2mM EDTA pH. 7.4) followed by the addition of 2 ml of SNET (1% 
SDS, 0.6 M Na Cl, 10 mM EDTA, 20 mM Tris pH. 7.4) whilst vortexing the 
suspension. Proteinase K was added to a final concentration of 200 pg/mi and the 
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viscous solution was incubated at 37°C for two hours. The DNA was then 
deproteinised by phenol and phenol/chloroform extraction. 
2.8: Isolation of RNA by RNAZOL 
(adapted from Chomczynski and Sacchi, 1987) 
All solutions, glassware and plastics were soaked in 0.1% solution of DEPC, then 
autoclaved. 
Solution 
23.64 g Guanidinium Thiocyanate (4M) 
1.25 mis of 1M Na Citrate pH. 7.0 (25 riM) 
0.5 g Sarcosyl (1%) 
Made up to 50 mis with distilled deionised water 
360 i.l of p-mercaptoethanol (0.1 M) 
For use in RNA isolation one volume of water saturated phenol was added to one 
volume of the above solution along with 0.1 volumes of 2M Na Acetate pH. 4.0 
Method. 
Tissues were dissected from mice of lines AATB 46.2 and TAB 36.2 and snap 
frozen in liquid nitrogen. The samples (approximately 100mg) were slightly thawed 
for ten minutes on ice before addition of 2mls of RNAZOL stock solution and 
homogenised at high speed for 1 minute. The homogenate was transferred to 
Eppendorf tubes in 1 ml aliquots and 100 il of chloroform added to each. The 
samples were shaken vigorously and left on ice for15 minutes. They were then 
centrifuged for 15 minutes at 4°C. The upper aqueous phase was removed and an 
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equal volume of isopropanol added before placing the samples at -20'C for 45 
minutes. The samples were then spun at high speed for 15 minutes in an Eppendorf 
microfuge. The resultant pellet was washed twice with 75% ethanol and air dried. 
The RNA pellet was then dissolved in 300 jil of DEPC treated distilled deionised 
water. 
2.9: Deproteinisation of nucleic acids using phenol/chloroform 
extraction 
General protocol 
DNA samples were deproteinised using phenol/chloroform extraction. The 
Generally one phenol extraction one phenol/chloroform and one chloroform extraction 
was performed although the number of extractions did vary depending on the quality 
of the sample. Phenol extraction of DNA entailed adding one volume of water 
saturated phenol to the lysed nuclei or bacteria, mixing thoroughly, and separating the 
organic and aqueous phases by centrifugation. The aqueous phase was recovered and 
the extraction procedure repeated with one volume of phenol/chloroform (1:1). The 
final extraction was performed with chioroform/isoamyl alcohol (24:1) to remove 
residual traces of phenol from the aqueous phase. The DNA was then recovered by 
ethanol precipitation. 
Of DNA for library construction 
The solution of DNA from the lysed nuclei was gently extracted once with 0.5 
volumes of phenol and 0.5 volumes of chloroform and again with 1 volume of 
chloroform. Following the gentle but thorough mixing of the organic and aqueous 
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phases the were separated by centrifugation at room temperature. To prevent 
breakage of the DNA the organic phases were removed from the bottom of the tube 
using a pasteur pipette and the DNA transferred into a clean tube by gentle pouring. 
The DNA was then placed inside dialysis tubing and dialysed against 1 litre of TE 
buffer (10mM tris pH 7.4, 1mM EDTA) overnight. The next day the DNA was 
further dialysed against 3 litres of TE buffer overnight. The DNA was of high 
molecular weight but very dilute to concentrate the DNA it was dialysed four times, 
for two hours each dialysis, against lOOmd volumes of butan-2-ol. All dialysis was 
performed at 4°C with gentle stirring. 
2.10: Ethanol precipitation of nucleic acids 
DNA and RNA was recovered by precipitation with 2.5 volumes of 1000/0 
ethanol containing 0.3 volumes of NaAcetate pH 5. The ethanol mix and phenol 
extracted DNA/RNA sample were mixed, genomie DNA was spooled out using a glass 
rod and partially air dried before being dissolved in TE buffer (10mM tris pH 7.4, 
1mM EDTA pH 8). Plasmid DNA and RNA samples were incubated at -70 for 30 
minutes. This was then centrifuged and the resulting pellet of nucleic acids washed 
twice with 70% ethanol air dried and redisolved in TE buffer. Genomic DNA was 
stored at 4°C, plasmid DNA at -20°C and RNA at -70°C. 
2.11 : Spectophotometric analysis to determine concentration of DNA 
and RNA samples. 
Aliquots of 5-10 p1 of the sample nucleic acid were added to TE buffer to give 
a fmal volume of 1 ml. The optical density of the diluted DNA/RNA was then 
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determined using a spectrophotometer with a deuterium light source at 260 and 280 
urn. An optical density reading of 1 equals 50p.g DNA/nil; 40g RNA/ml. 
2.12 Restriction Endonuclease digestion of DNA 
Genomic DNA 
1 Op.g of DNA was digested in a volume of 200 j.d with 2 units of enzyme/pg of 
DNA according to the manufacturers directions. Digestion was allowed to proceed for 
at least 5 hours then the digested DNA was phenol/chloroform extracted and ethanol 
precipitated. The pellet was resuspended in 40 il of TE buffer. 0.2 volumes of 
loading dye (30% ficoll 400, 0.1% SDS, 40mM EDTA pH8, 1.2 mg/mi bromophenol 
blue) were added then the sample was heated to 65°C for 10 minutes before being 
loaded on an agarose gel. 
Plasmid /cosmid DNA 
Restriction digests of plasmid or phage DNA were carried out at a concentration of 
enzyme of less than lpgflOp.1 with the concentration of enzyme not exceeding 10% 
The incubation timed varied from 1 to 2 hours. Small aliquots of these digests were 
checked on agarose nmiigels for completeness of digestion. 
2.13 Agarose Gel Electrophoresis 
(a) Of DNA 
Digested genomic DNA was electrophoresed in 0.7 % agarose gels. Large 
(20cm x 20cm) gels were run at 30-40 volts overnight and small (10cm x 12cm) were 
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run at 20 volts overnight. Digested plasmid DNA of small recombinant clones 
(AATB, TAB subclones) were electrophoresed in 0.8-1% agarose gels at 50-70 volts 
for 30 minutes to several hours depending on the resolution required. Digests of the 
cosmid clones were electrophoresed in 0.396 agarose gels and run at a maximum of 30 
volts at 4°C (to prevent the gel melting) until the fragments were sufficiently well 
resolved (usually 8 hours or overnight). All agarose gels used for DNA electrophoresis 
were made from and run in buffer containing 40mM tris acetate, 2.5mM EDTA/Na 
pH7. 7 and 0. 5p.g/ml of ethidium bromide. 
(b) Of RNA 
1 Oj.tg equivalents of RNA samples were electrophoresed in denaturing agarose 
gels (1.5% agarose, 2.2M formaldehyde, 10mM MOPS (3-N-morphoIino)- 
propanesulphonic acid) pH 7). 200 of sample buffer (50% formamide, 2.2M 
formaldehyde, 0.5mM EDTAINa, 10mM Sodium phosphate pH 8) was added to each 
RNA sample, on ice, immediately after heating the sample at 65°C for 10 minutes. 
The gel was run in lx MOPS at 25 volts overnight 
2.14 A c,ylamide gel Electrophoresis 
(a) Denaturing sequencing gel 
Sequencing reaction were electrophoresed in 0.8% denaturing acrylamide gels 
(31.5g Urea, 7.5 ml of 10xTBE pH 8.8, 11.25 ml of 40% acrylamide,Bis solution 
(supplied by Bio-Rad), 25 ml of distilled deionised water, 4001d of 10% APS 
(ammonium persulfate), 40.d TEMED). The gels were cast using 4mm spacers and 
run on a Bio-Rad vertical sequencing gel apparatus. The running buffer was 1 x TBE 
and the gel run at 50 watts for 4 to 6 hours. Once the run was finished the sequencing 
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gels were fixed in 10% acetic acid for 20 minutes, then transferred onto Whatmann 
3MM paper and dried at 80°C under vacuum on a gel drying apparatus. 
(b) SDS PAGE 
SDS polyacrylamide gel electrophoresis was used to analyse the protein 
composition of the milk samples of the transgenic mice. The resolving gel was a 10% 
acrylamide gel (16.2 ml dH20, 10 ml 1.5M Tris-HCl pH8.8, 400.d 10% SDS, 13.3 ml 
30% AcrylamidefBis, lOOpi 10% APS, 201ii TEMED). The gel was poured, overlaid 
with distilled water and left to polymerise overnight. The next morning the water was 
removed and a 4% stacking gel (6.1 ml dH20, 2.5 ml 0. 5M Tris-HCl pH 6.8, 1.3 ml 
30% acrylamide/Bis, 500 10% APS, 5p1 TEMED) poured on top of the polymerised 
resolving gel. A comb was then inserted into the gel and left in-situ until the stacking 
gel was sufficiently well polymerised and wells were formed (approximately 1 hour). 
Once the gel was polymerised the wells were washed and then filled with running 
buffer (15g Tris base, 72g glycine, 5g SDS made up to 5 litres with dH20). Samples 
were run in the stacking gel for 45 minutes at 26mA and in the resolving gel for a 
further 3.5 hours at 36 mA in tris-glycine running buffer. Once the run was complete 
The gels were stained and fixed (20m1 100% trichloroacetic acid, 74ml acetic acid, 
500m1 Methanol, 0.4g coomassie blue, made up to 1 litre with dH20) overnight. The 
next morning the gels were washed several times with destain (70m1 acetic acid, 230m1 
ethanol made up to 1 litre with dH20) to remove the excess coomassie stain. 
2.15: Western blotting 
Following electrophoresis of the milk samples in a 10% denaturing acrylamide 
gel the proteins were transferred to a nitro-cellulose membrane by electroblotting. The 
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current was 0.8 mAIcm2 the anode buffer was 0.3M Tris, 20% methanol in distilled 
water pH 10.4 and the cathode buffer was 25mM Tris, 40mM hexanoic acid and 20% 
methanol in distilled water pH 9.4). Following electroblotling the nitro-cellulose filter 
was immersed in a 50/o(w/v) solution of skimmed milk in PBS. Human a1AT was 
identified on the immunoblot filters by incubating the filter with goat anti-c 1AT serum 
(1;200dilution of serum in lOmis skimmed milk at 37 °C for 2 hours), followed by 
incubation of the filter with anti-sheep/goat IgG serum conjugated to horseradish 
peroxidase. The filter was given four 30 minute washes in 20 ml of skimmed milk 
solution after each incubation. Finally the filter was developed in 4-Chloro-1-napthol 
and H202.(4m1 4-Chloro-1-napthol at 3mg/mi, imi lMTris-HCI p11 7.5, 19m1 dH20, 
500 3% 11202) 
2.16: Transfer of nucleic acids onto a solid support 
(a) Southern blotting 
Before transfer of DNA to Hybond N nylon membrane (Amersham) the DNA 
was depurinated by immersion in 0.25M HCI for 2x 15 minutes. The DNA was then 
denatured by immersion in 1.5M NaCl, 0.5M NaOH for 40 minutes changing the 
solution after 20 minutes. The gel was then neutralised using a 0. SM solution of Tris-
HC1 pH 7.4 containing 1.5M NaCl. The gel was gently shaken in all solutions to aid 
diffusion of the solutions throughout the gel. The gel was then rinsed in 2x SSC (20 x 
SSC is 175.3g NaCl, 88.2g tn-sodium citrate to a final volume of 1 litre NaOH or HC1 
used as appropriate to bring the solution to pH 7). The DNA was then transferred by 
Southern blotting (Southern, 1975, Manniatis, 1982). The bottom reservoir contained 
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10 x SSC. The gel was inverted and laid on top of the 3MM wick from the bottom 
reservoir. The filter was then placed on top of the gel followed by 31\/M paper soaked 
in 2 x SSC. Finally a layer of paper towels were placed on top of the gel to draw the 
solution through the gel and transfer the DNA onto the Nylon membrane. Transfer 
was allowed to proceed overnight. After removal of the filter from the apparatus it 
was rinsed in 6 x SSC and then partially dried. The DNA was then fixed to the nylon 
membranes using UV-irradiation (wavelength 302 nm) using a pre-calibrated 
stratalinker. 
(b) Northern blotting 
RNA gels do not need to be treated before blotting. The gels were rinsed in 1 
x SSC and blotted onto Hybond N membrane as described above. 
2.17 Ge/purification of DNA 
A number of methods were used for the recovery of DNA from agarose gels. 
(a) Spin-X columns 
Small fragments to be used as DNA probes were recovered by cutting the band 
out of the gel (generally 0.8% agarose) and placing in the upper chamber of a spin-X 
column. The column was then placed at -70°C for 30 minutes to freeze the gel and 
thus fractionate the agarose matrix. The tube was then removed from the freezer the 
gel allowed to thaw, and then spun at high speed in an Eppendorf microfuge. The 
agarose is retained in the upper chamber, which was discarded and the buffer and 
much of the DNA was at the bottom of the tube. To precipitate the DNA 0.3 volumes 
of NaAcetate pH 5 were added to the solution followed by two volumes of 1000 'o' 
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ethanol. The tube and contents were then incubated at -70°C for 30 minutes. 
Following this the tube was then spun at high speed in a microfuge for 15 minutes at 
4°C. The supernatant was removed and the DNA pellet washed twice in 70% ethanol 
before air drying. Finally the pellet was dissolved in an appropriate volume of TE 
buffer (generally 50jil) depending on the size of the pellet. 
Electrophoresis into 15% PEG 
Some larger fragments for subcloning were isolated using this method (e.g. 
Eco RV fragment of Clone 9). The fragment run in an ethidium bromide stained gel 
was visualised by illumination with low intensity LTV light. A piece of the gel (of 
similar shape and size to the migrating band) immediately in front of the band was 
removed using a sterile scalpel. This trough was then filled with a solution of 15% 
polyethyleneglycol (PEG) in TE. The gel was then replaced into the electrophoresis 
tank which now contains only enough buffer to be level with the top of the gel but not 
submerge it. electrophoresis was allowed to proceed again for ten minutes to run the 
DNA into the trough. The PEG was removed and the gel illuminated with LTV light to 
check the band has been removed. DNA removed in this way was used directly in 
ligation reactions. 
f3-Agarase 
Fragments used in the construction of the secondary transgene were isolated 
using this method. The fragments were run in a 1% LMP agarose gel containing 
0. 5p.g/ml ethidium bromide. Once resolved the piece of gel containing the fragment 
was removed. Two volumes of lx agarase buffer were added to the gel slice and this 
was left to diffuse for 2 x 30 minutes. The buffer was then removed by aspiration and 
the gel slice melted at 65°C once melted the gel slice was incubated at 37°C and 
allowed to cool to this temperature. (3-agarase (1 unit per lOOjil of gel) was then 
added to the melted gel slice and digestion allowed to proceed for one hour at 37°C. 
Once digestion was complete the tube was cooled on ice for 15 minutes and then spun 
at high speed in an eppendoif microfuge. Any undigested agarose formed a pellet in 
the bottom of the eppendorf tube. The supernatant containing the DNA was removed, 
phenol/chloroform extracted and finally ethanol precipitated. 
2.18 Radioactive labelling of DNA 
Probes were radiolabeled according to the random priming labelling method 
devised by Feinberg and Vogelstein, (1983). Either Amersham's or Boehringer 
Mannheim's random prime labelling kits were used according to the manufacturers 
directions. Generally 25ng of DNA were labelled. Incorporation of the radioactive 
label was checked by counting a 1i.l aliquot dropped onto a glass fibre filter which was 
then washed with 5% trichloroactetic acid and recounted. Incorporation as determined 
by Cherenkov counting was routinely in excess of 1 x 109 dpm!p.g DNA. 
219 Hybridisation 
All hybridisations were performed in phosphate buffer (0.5M sodium 
phosphate pH 7.2, 7% SDS, 1mM EDTA1Na) according to Church and Gilbert, 
(1984). All filters were pre-hybridised in buffer for 1 hour before addition of the 
radiolabelled probe. The probe was denatured by the addition of 0.25 volumes of 
Oj 
freshly made NaOH 5 minutes before addition to the hybridisation chamber. All 
hybridisations were performed at 65°C in a perspex hybridisation chamber or in 
hybridisation bottles. Filters were washed at 65°C in 40mM sodium phosphate, 1% 
SDS or 0.1-0.2 x SSC, 0.1% SDS. All washes were high stringency. 
220: construction of a Cosmid Library of AA TB 46.2 
Preparation of vector DNA 
20g of SuperCosi vector (Evans et al., 1989) was digested with Xba 
restriction endonuclease in a total volume of 2001il in standard buffer conditions. The 
digested vector was then subject to phenol/chloroform extraction, ethanol precipitation 
and the pellet resuspended in 20tl distilled, deionised water giving a final 
concentration of 1 j.tg/pi. The digested vector was then treated with calf intestinal 
alkaline phosphatase (CEP). Following this treatment the protein was extracted using 
phenol/chiorofonu and ethanol precipitated. The pellet was resuspended in 20p1 of 
TE buffer. Finally the vector was digested with Barn Hi restriction endonuclease 
followed by phenol/chloroform and chloroform extraction and ethanol precipitation. 
the pellet was resuspended in 201 of TE buffer. 
Nde II partial digestion of the AATB 46.2 chromosomal DNA 
Nde II is an isoschizomer of Sau 3A and generates ends compatible with 
ligation into the Barn Hi cloning site of the cosmid vector. A series of test partial 
digests were performed on liver and DNA isolated by the methods described in 
sections 2.7 and 2.9(b) of this chapter. Digestion using 0.5 units of Nde II was 
allowed to proceed for 5 to 45 minutes. The test digestion reactions were stopped by 
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removal of an aliquot from a l0Od reaction and adding 10xl of loading dye. The time 
point samples were run on a 0.3% agarose gel with DNA size markers. The bulk of 
the digested DNA migrated with an apparent size of 50 kb after a 30 minute digestion. 
Two large scale digestion of 250p.g of DNA was then performed using conditions 
determined from the test digest (total reaction volume 550p1). The digest was stopped 
by the addition of 9d of 0. 5M EDTA, pH8.0. 
c) Size selection of digested genomic DNA 
The entire DNA digest was loaded on a 100%-40% sucrose gradient. The 
gradient was spun at 25000rpm in an SW28 Rotor in a Beckman ultracentrifuge for 16 
hours at 21'C. 1 ml fractions were obtained by piercing the bottom of the 
polypropylene tube with a needle and allowing the solution to drip into Eppendorf 
tubes placed underneath it. Aliquots of the fractions were run on a 0.4 % agarose gel. 
All fractions containing DNA of an apparent size of 30-50 kb were pooled and ethanol 
precipitated. A total of i.5p.g of genomic DNA was obtained from this procedure. 
The isolated DNA was then CIP treated for 60 minutes at 37°C followed by phenol 
extraction, chloroform extraction and ethanol precipitation. 	The pellet was 
resuspended in 100 of TE buffer giving a final concentration of 0.05p.g/il. 
(c) Ligation of DNA and packaging of the cosmid library 
The ligation reaction contains 0. 5p.g of Nde II digested DNA, 0.2 ug of Xba 
1/Barn Hi digested cosmid vector, 2gl of 10mM ATP and 6.8p.l  of distilled-deionised 
water. The ligation reaction was incubated at 14°C overnight. Packaging of the DNA 
was performed using Stratagene's (Jigapack Gold II in vitro phage packaging extracts 
S 
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according to the manufacturers directions. Only 4d of ligation reaction were added to 
the extracts and incubation of the extracts and ligated DNA was allowed to proceed for 
2 hours at 22 °C. 
(e) Plating of the Cosmid Library 
Screening of the cosmid library involves the fixing of DNA from the colonies to a 
hybridisation membrane. The colonies of the library were grown on hybond N 
gridded filters [20 000 colonies per filter (132mm diameter)]. The filters were placed 
on top of LB plates containing 50ig/ml of ampidillin. The colonies were spread on the 
filter by dropping the recombinant bacteria onto the centre of the filter and shaking at 
high speed (Luckman R100 rotatest shaker, speed 10) for several minutes until the 
solution is close to the edge of the filter. To prevent excessive growth of the colonies 
the filters were incubated overnight at 30°C. 
) Replica Plating of the Cosmid Library 
The filters were replica plated on identical hybond N filters. Two replicas were 
made of each filter. The library filters were placed on sterile 3MM paper (autoclaved 
between sheets of glass in a dry autoclave for several hours). All manipulation of the 
filters were performed with sterile forceps which were ethanol flamed after each use. 
A hybond filter was then placed on top of the library filter, covered with another sheet 
of sterile 3MM and a heavy stack of glass plates placed on top for 30 seconds. The 
filters were marked using a needle and ink so they could be orientated following 
hybridisation. The replica filters were placed on 140mm LB amp plates and grown for 
5 hours before treatment of the filter to fix the cosmid DNA to the Hybond 
membrane. The original filters were placed on fresh LB amp plates and grown for 5 
hours at 37°C to allow the colonies to recover. Following incubation the master plates 
were stored at 4°C and regularly placed on fresh LB amp plates. The replica filters 
were prepared for hybridisation by placing it colony side up for 30 seconds in the 
surface of Whatmann 3MM paper soaked with 0.5M NaOH, then another sheet of 
Whatmann paper soaked with 1M Tris-HCI, pH 7.6 for 30 seconds. Following this 
the filters were immersed in 1M Tris-HCI, pH 7.6, 1.5M NaC1 and the bacterial debris 
removed by gently rubbing the filter with a gloved hand. The filters were air dried till 
they were almost thy then the DNA was fixed to the filter by exposure to UV light 
(wavelength 302nm) in a pre-calibrated stratalinker. Finally the filters were immersed 
quickly in chloroform to remove any remaining bacterial debris washed in 1M Tris-
HCI, 1.5M NaC1 dried and wrapped in saran ready for hybridisation. 
2.21 Phage Cloning of the Secondary transgene 
(a) Preparation of the lambda DASH II vector 
51ig of Lambda DASH II undigested vector (Stratagene) was digested with Not 
I restriction endonuclease in a total volume of 50il. The digest was allowed to 
proceed for two hours. The phage DNA was then extracted once with 
phenolIchloroform and once with chloroform. An equal volume of 4M NI-LOAc 
(ammonium acetate) was added to the aqueous phase followed by 2.5 volumes of 
ethanol. The DNA was then pelleted by spinning at high speed in an Eppendorf 
microfuge. The pellet was washed twice in 70% ethanol air dried and dissolved in 
501d of TE buffer. 
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Preparation of the insert 
The insert was prepared form the 15 .2 kb Not I fragments of clones 8 and 9. The 
Not I fragments were gel purified and then digested with Srf I. The fragments 
containing the murine DNA and part AATB transgene were gel purified and ligated 
together in the presence of Not I restriction digest to suicide ligations that occurred 
between the Not I ends of the two fragments. Analysis of the ligation reaction on 
agarose an agarose gel demonstrated the presence of several products of ligation. Only 
the large 19.9 kb fragment was gel purified for ligation into the lambda DASH II 
vector. 
Ligation of phage vector and secondary transgene 
The ligation reaction contained 0.5.d of ligase buffer (Boehringer Mamthiem), 0. 5tg 
of Digested lambda DASH, 0. 75j.tg of insert DNA and 2.5 units of T4 DNA ligase. 
The reaction was incubated at 4°C overnight. For efficient packaging it is 
recommended that the ligation reaction be carried out at DNA concentrations in excess 
of 0.2 pg/j.d. In this instance the DNA concentration per microlitre is 0.25p.g. 
Packaging of ligation reaction 
The recombinant phage was packaged using Gigapack II Gold in-vitro lambda 
packaging extracts (Stratagene). The packaging procedure was carried out following 
the manufacturers directions. 41xl of the ligation reaction was added to the extracts. 
the incubation was allowed to proceed for 2 hours. Finally 500pl of SM buffer was 
added to the packaging extract. 
Plating the phage clones 
The host cell strain was XL1-Blue MRA (P2). A culture of host cells were grown in 
LB medium containing 0.2% maltose and 10mM Magnesium sulphate at 37°C for 5 
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hours with shaking. The culture was then spun for 10 minutes at 2000 rpm. The cells 
were then gently resuspended in 10mM MgSO4 The cells were then diluted to an 
0D600 of 0.5 with sterile 10mM MgSO4. 600i.l of cells were infected with a range of 
volumes of the packaged ligation reaction. (lOOi.ii, 501.d, lOgi and ljii). The phage 
were incubated with the cells for 15 minutes at 37°C with gentle shaking to allow the 
phage to attach to the cells. The phage were grown on NZY bacterial plates (see 
media, section 2.. The infected cells were added to 3ml of top agar (NZY broth and 
0.7% (w/v) agarose) at 48 °C mixed gently then poured onto the plates. The plates 
were placed at 37 °C overnight. A total of 35 plaques were obtained each was 
screened for the presence of 5' and 3' AATB sequences. All but one of the clones 
hybridised with both probes. Two phage clones were picked for large scale 
preparation of the phage. 
(f) Large scale preparation of Lambda phage 
To obtain enough phage DNA in order to excise the cloned DNA insert a large bulk 
culture was processed (Blattner et al., 1977). 2 x 	phage were absorbed to 32 ml of 
XL 1-Blue MRA cells which had been concentrated into 0,2 volumes of 10mM 
MgSO4. The absorption was left at 37 °C for 20 minutes before being added to 
500m1s of prewarmed NZY. This was shaken at 37 °C until lysis occurred, after 
which 5 ml of chloroform was added, shaking continued for 30 minutes before 3mg of 
RNase and 3mg of DNase were added per flask. The flask was left to sit at room 
temperature for 40 minutes before being cleared of debris by centrifuging at 10 000 
rpm for 10 minutes in a Sorval GSA rotor. 10% PEGww and 1M NaCl were added to 
the phage containing supernatant, dissolved and left at 4°C overnight. The precipitated 
phage were pelleted by centrifugation at 10 000rpm for 15 minutes at 4°C in a Sorval 
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GSA rotor. The phage pellet was dissolved in 8 ml of phage buffer, residual debris 
was extracted by vigorous shaking with an equal volume of chloroform and clearing by 
brief centrifugation at 3 000rpm for 2 minutes. The top phase was removed and 
overlaid on a CsCI step gradient (consisting of 1.5 ml 56% CsC1 at the bottom of the 
tube, 1.5 ml of 45% CsC1 on top of this and 2.5 ml of 31% CsCI on top of this) The 
step gradients were centrifuged in an Beckman SW 28 rotor at 23 000rpm and 4°C for 
2 hours 15 minutes with zero deceleration. The phage heads band between the 45% 
and 56% CsCI layers and are visible as a slight bluish coloration. The band was 
removed through a wide bore needle and dialysed against two changes of 50m1\4 Iris- 
HCI pH7.9, 10mM MgCl2, 10mM NaCl. To isolate the phage DNA the dialysed 
phage heads were extracted twice with phenol/chloroform and twice with chloroform 
and ethanol precipitated 
2.22 : Erase a Base deletions of 3' murine DNA 
The Erase-a-Base systems designed for the rapid construction of plasmid clones 
containing progressive unidirectional deletions in any inserted DNA. The system is 
based on the procedure developed by Henikoff (1984). Exonuclease III is used to 
specifically digest insert DNA from a 5' protruding or blunt end restriction site. The 
adjacent sequencing primer binding site is protected from digestion by a 4 base 3' 
overhang restriction site. Exonuclease ifi removes a single strand of the DNA starting 
from the 5' overhang. The reaction proceeds at a steady rate. The reaction is stopped 
by placing aliquots in Si nuclease buffer which has a low pH and contains zinc 
cations, both of which inhibit further exonuclease activity. The Si nuclease removes 
the single stranded tail produced by exonuclease ifi and results in blunt ends at either 
end of the clone. These are then ligated and transformations performed so the vector 
containing the reduced insert can be obtained in sufficient quantities for sequencing 
reactions to be performed. 
Using this method nested deletions were made in the 3' murine flanking DNA 
that was subcloned in bluescript phagemid vector using the Not 1 and Hind ifi sites in 
the multiple cloning site. In all 23 kb of the murine DNA was sequenced using this 
method (see Chapter 5). The subclone was digested with CIa I and Kpn I. CIa I 
(which cuts nearest the insert) generates a 5' overhang and digestion with this enzymes 
makes the DNA 5' of the restriction site susceptible to Exonuclease ifi digestion. 
Whereas digestion with Kpn I (which cuts nearest the priming site) generates a 
resistant 3' overhang. The Kpn I site is adjacent to the T7 and M13 priming sites of 
the vector and the Cia I site is immediately 3' of the insert. The remainder of the 
procedure was carried out as per the manufacturers directions 
2.23 Sequencing 
Sequencing of double stranded recombinant clones was performed using a USB 
sequencing kit.. The DNA template was denatured by the addition of 2j.d of 
denaturing mix ( 300p,i of SM NaOH, 2p.l of 0.5M EDTA 200j.tl dH20) to a total 
volume of 20.ml incubated on ice for 15 minutes. The solution was then neutralised by 
the addition 11 0il of neutralising mix (8p.l 1M Tris-HCI pH 4.5, 3j.IJ 3M NaAc pH 
5.2, 100Jd 100% ethanol). Following this addition the tube is spun at high speed in a 
microfuge and the pellet of denatured DNA resuspended in 6p1 of dH20 and 2p.l 
Sequenase buffer and 1il of primer (concentration O,SjM). This is heated to 65°C 
for 2 minutes and then the reaction is allowed to cool slowly so the template and 
primer anneal From this stage onwards the sequencing reactions are essentially the 
same as that devised by Sanger et al., (1977). [35S]dATP-x-S was used as the 
radioactive label. The kit was used according to the manufacturers directions 
2.24: Generation of Transgenic Mice 
Transgenic mice were generated by the injection of gel purified insert DNA of TAB 
and TA plasmids (at a concentration of 1.5 ng'jal) into pronuclear mouse eggs, 
obtained from superovulated C5713L16 x CBA Fl females after mating with Fl males. 
Injected eggs were cultured overnight, cleaved embryos were transferred into the 
oviducts pseudopregnant MF1 recipients (Simons et al., 1987). 
2.25: Tail screening by PCR 
Screening G0  offspring generated from pronuclear injected eggs, for transgenic mice 
was done using tail DNA. Approximately 1-1.5cm of mouse tail was removed and 
placed in 1.5m1 of digestion buffer (0.3M NaAcetate, 10mM Tris-HCI pH 7.9, 1mM 
EDTA, 1% SDS with 200 &g/ml proteinase K) at 37°C overnight, with shaking. The 
next day the digested sample is vortexed to dissaggregate debris. Proteins and other 
unwanted matter were removed by phenol/chloroform extraction. of 7500 of the 
residue. 25p.l of 3M NaAcetate were added to the extracted aqueous phase followed 
by 1 volume of isopropanol. The mixture was mixed well and left at room 
temperature for 10 minutes for the DNA precipitate to form. The DNA was pdlleted 
by spinning briefly at high speed in. an Eppendorf microfuge. The pellet was washed 
twice in 70% ethanol air dried and resuspended in 250d of TE buffer. 
PCR reactions were then performed with 1d of the DNA. One 0 of DNA 
form each animal was placed in a 500p1 Eppendorf tube under 50p1 of mineral oil. 
The DNA was denatured by heating for ten minutes at 95°C for 10 minutes on a PCR 
block.. 501.d of PCR sample mix was then added to each tube (51.d 10 x PCR buffer, 
8gl of NTP mix, 51tl of DMSO, 0. 51il of transgene primer mix, 0. 5p1 control primer 
mix (HPRT) dH2O to a final volume of 50j&l mix plus 0.25 jil of Taq polymerase for 
each tube). The samples were then subject to 30 cycles of 91.5°C for 30 seconds then 
60°C for 5 minutes. Once the program was complete aliquots of the reactions were 
analysed on 2% agarose gels. 
Control primers amplify a 332 bp segment of the HPRT gene. The BLG primers 
amplify a 246 bp segment of the 5' end of the BLG gene. The generation of the 
smaller PCR product is diagnostic of the presence of the AATB transgene. 
2.26 Analysis of Milk Samples 
(a) Radial immunodiffusion 
Milk samples were obtained from all animals on the 11th day of lactation 
following oxytocin administration. The milk samples were defatted by dilution the 
milk 1/5 with sterile distilled water, vortexing the samples briefly, and re-suspending 
the casein pellet gently in the lower aqueous phase. The aqueous phase was then 
gently removed from the bottom of the Eppendorf tube and the milk fat left behind. 
for loading on the partigen plates the samples were further diluted 1/4, 1/20 and 1/100 
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giving final dilutions of 1/20, 1/100 and 1/500. Samples that did not give a measurable 
precipitate at these dilutions were loaded at the 1/5 strength. 200 of the diluted milk 
samples were loaded in the wells of human c 1-antitiypsin LC-Partigen plates (Behring 
diagnostics). These plates were left at room temperature for 5 days to develop. The 
precipitin rings formed by each sample were measured. The concentration of the 
hAAT in the milk samples were determined from a calibration curve obtained from 
standards loaded on the same plate. Southern blotting was performed on mice that 
were PCR positive to verify the result. 
for SDS PAGE 
The samples for SDS PAGE were also diluted 1/5 and defatted. Aliquots of 
defatted milk were further diluted 1/5 in sample buffer (6.4 ml distilled H20, 2 ml 
0.5M Tris HC1 pH 6.8. 2g glycerol, 3.2 ml 10% SDS, 0.8 ml 2-mercaptoethanol, 2 ml 
0.05% bromophenol blue) giving a final dilution of 1/25. The diluted samples were 
boiled for four minutes and then returned to the pre-boiling volume by the addition of 
sterile distilled water. 5.il of the treated sample was loaded per lane in a further 30j.d 
of sample buffer. 
2.27 Hybridisation of Dried Agarose Gels (Iinblots) 
The approach is to hybridise radiolabelled probes directly to nucleic acids 
trapped within dried gels or "unblots" (Shinnick et al., 1975; Purello and Balazs 1983; 
Tsao et a! 1983; Wallace and Miyada 1987). The method works well with 
oligonucleotide probes giving an at least five fold higher signal intensity than transfers 
(Wallace and Miyada 1987). Since probes generated by random priming of purified 
DNA fragments are longer their accessibility to the DNA molecules trapped in the gel 
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presents a problem; hybridisation of unbiots with such probes give rise to unacceptably 
high background hybridisation (Schinnick et at, 1975). This problem can be 
overcome by chemically fragmenting the random primed probes (using HC1) before 
hybridising them with the unbiot (Stoye J.P. personal communication). The advantage 
of the unbiot over conventional Southern blotting is that the result can be obtained in 
less time and the sensitivity is greater (single copy junction fragments visible after a 
few hours exposure to X-ray film). However stripping the unblot is more difficult than 
stripping the signal form Southern blots and thus the number of hybridisations that can 
be performed on each unbiot is limited relative to a nylon filter obtained by Southern 
blotting. The protocols used for probe preparation drying and hybridisation of the gels 
are given below. 
Chemical fragmentation of the Probe 
Probes were labelled as detailed in section 2.18. The probe was purified by 
increasing the probe volume to 100 .tl loading the entire volume to a 1 ml G50 
sepliadex column equilibrated with TE buffer and then spinning the column at 1.6 g 
for 4 minutes in a Sorval HB4 swing out rotor. One .ig of sheared salmon sperm 
DNA was added to the resultant purified probe and adjusted to 0.1M HC1 by the 
addition of one tenth volume of 1M HCI. This was incubated at 37°C for 40 minutes 
followed then by the addition of a half volume of 1M Tris HCI pH7. 5. The probe was 
denatured by boiling for ten minutes and was then incubated on ice for five minutes 
before being added to the hybridisation chamber. 
Drying of Agarose Gel 
Following FIGE (field inversion gel electrophoresis) the 0.7% agarose gel 
(Sigma) was immersed in 0.5M NaOH, 1. 5M NaCI for 30 minutes (solution changed 
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after 15 minutes). It was then rinsed thoroughly in distilled water and neutralised by 
immersion in 0.5M Tris-HCI, 1.5M NaCl with gentle shaking for 30 minutes at room 
temperature (solution changed after 15 minutes). The gel was then placed on two 
sheets of Whatmann 3A/EM and the other side covered with plastic wrap. It was then 
placed paper side down on a gel drier and dried at room temperature under vacuum 
for 30 minutes until nearly flat. The heater of the gel drier was then turned to 60°C 
and the gel dried for a further 20-30 minutes until it is the thickness of X-ray film; care 
should be taken not to overdry the gel to the thickness of plastic wrap. At this point 
the gel was marked by punching holes in two corners of the gel using a Pasteur pipette. 
The gel will never fully rehydrate and can be removed from the paper backing by 
wetting the unblot and paper and placing it on plastic to which it adheres to preferably 
and then removing the Whatmann 
(c) Hybridisation of the unbiot 
The gel was placed in a perspex hybridisation box with lOOmis of 5x SSPE (lx 
SSPE contains 150mM NaCl, 10mM NaH2PO4, 1mM EDTA with pH adjusted to 7.4 
with NaOH) and 0.1°/o SDS at 55°C. The denatured probe was then added to the box 
and hybridisation carried out overnight at 55°C. Following hybridisation the unbiot 
was washed four times (5 minutes each) in hybridisation buffer at room temperature, 
then a further twice (30 minutes each) in O.1xSSC, 0.l%SDS at 55°C. The gel was 
then exposed to AGFA Curix X-ray film at -70°C with Du-Pont intensifying screens. 
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CHAPTER 3 RESTRICTION ENZYME ANALYSIS OF HIGH 
EXPRESSING AATB LOCI 
31 INTRODUCTION 
3. 1.1 The Apparent Position Effect Of AATB 35 
As discussed in the Introduction to this thesis, the promoter region of the ovine 
BLG gene has been shown to drive efficient expression of BLG protein in the 
mammary gland of transgenic mice (Simons et al., 1987). In these experiments BLG 
was shown to have the expected profile of expression throughout pregnancy and 
lactation. A subsequent study of BLG expression in transgenic mice demonstrated the 
expression of BLG in transgenic mice was position independent and copy number 
dependent (Whitelaw et al., 1992). 
The work in this thesis further examines the expression of a hybrid transgene, 
AATB, that encodes an important biomedical protein, a1-antitrypsin This transgene 
comprises the ovine BLG promoter linked to a minigene encoding human a1  
antitrypsin (hAAT) (Archibald et al., 1990). The protein coding regions of the AATB 
transgene are that of the Ml variant of the hAAT gene (Ciliberto et al., 1985). The 
hAAT sequences included within the transgene are 6.3 kb in size. Intron 1 has been 
removed but all other introns are present. Also included in the AATB transgene were 
1.3 kb of 3' untranslated sequences of the human AAT gene. 
Two studies had been performed previously in mice with the AATB transgene. 
Unlike the ovine BLG transgene, the hybrid transgene was not expressed in a position 
independent and copy number dependent fashion. In the first study (Archibald et al., 
1990) six of the thirteen lines generated did not detectably express the transgene. The 
lower limit of detection in this study was 0.5 ig/ml. Three lines expressed the 
Me 
transgene in the range of 0.5 mg/mI to 1 mg/nil. But only one line, AATB 35, gave a 
particularly good expression level of 7 mg/ml. The expression of hAAT in the milk of 
AATB transgenic mice did not correlate with the transgene copy number 
Similar results were obtained in the second study using the same AATB 
transgene (Carver et al., 1993). In the second study all of the eleven female founder 
mice expressed the protein in their milk. Again, the levels of expression, were on the 
whole, very low. Only three of the eleven founder mice expressed at levels greater 
than 0.2 mg/mi, and only two of the three gave particularly good levels of expression. 
AATB 46.2 was reported to give 8mg/mi and AATB 45.5, 12.5 mg/ml of hAAT in 
their milk. The levels of expression obtained from transgenic mice in this study also 
did not correlate with transgene copy number. 
AATB 35 appeared to harbour a low transgene copy number. The unusually 
high expression of hAAT in line AATB 35, relative to the other lines harbouring the 
construct, could have been the result of either a mutation occurring within the 
transgene sequences, or a direct consequence of the nature of the murine genomic 
sequences into which the transgene had inserted (Al-Shawi et al., 1990)). Position 
effects have been widely mentioned in the literature (see introduction to this thesis). 
The term is generally used to explain unexpected patterns of expression (in terms of 
tissue specificity or levels) obtained in transgenic animals. A positive position effect 
was considered to be a likely explanation for the unusually high levels of expression of 
hAAT in line AATB 35 and AATB 46.2. The aim of this work was to study this 
position effect. 
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3.1.2 The Proposed Approach 
AATB 35 was reported to carry a single copy of the AATB transgene 
(Archibald et al., 1990). The AATB transgene was 10.6 kb in size. Thus, the single 
transgene locus of line AATB 35 could have been accommodated easily in a cosmid 
vector (insert size 32-42 kb). A number of clones harbouring the transgene locus 
ought to have been detected by screening a cosmid library of the line. The clones 
would have varied only in the amount of both 5' and 3' flanking DNA present in the 
insert. Each of the clones would then have been used to generate secondary transgenic 
animals. Comparison of the hAAT expression in the secondary transgenic lines with 
the expression in the original AATB transgenic mice (Archibald et al., 1990 & Carver 
et al., 1993) would have demonstrated if the presence of the murine flanking DNA 
from AATB 35 gave improved expression of hAAT in transgenic mice. Thus 
comparison of hAAT expression between the secondary transgenic lines, harbouring 
different clones, could have been an approach to define the position of sequences that 
mediate the positive position effect. A diagrammatic representation of the approach is 
given in figure 3.1 
Secondary transgenic animals could also have been generated by re-
introduction of the cloned AATB transgene with minimal flanking DNA. This would 
have demonstrated if the high expression of AATB 35 was due to mutation of the 
transgene sequences (Al Shawi et a! 1990). 
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FiA'ure 3.1 Proposed Approach for study of position effect in line AATB 35 
The diagram represents the proposed approach for the study of the position effect in 
line AATB 35. Section (a) is a representation of the reported single copy transgene 
locus ofAATB 35 (Archibald et al., 1990). It shows the single AATB transgene and 
the flanking murine, chromosomal DNA. Section (b) represents a number of clones 
isolated from a cosmid library of line AATB 35. The clones differ  in the amount of 5' 
and 3' flanking chromosomal DNA present in the cloned insert. Section (c) 
represents the loci of the secondary transgenic animals, (n) represents the number of 
transgenes present in the locus. This would va,yJbr each line. Comparison of I'L4AT 
expression in the secondary transgenic mice with that of the primary AATB mice 
generated by Archibald et. al. and Carver et all would have demonstrated whether 
the murine sequences had any positive effect on both the level and frequency of 
expression ofAATB. 
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Figure 3.2: Original copy number estimate of line AATB 35 
The figure shows the results of the original screen of the AATB lines by Southern blot 
analysis (courtesy ofAlan Archibald). Each of the lanes contain 10 ug of mouse tail 
DIVA. The probe is the entire AATB construct including the p-Folly Ill-I vector 
(digested with Barn HI). The copy number of all trcinsgenic founder mice was 
estimated by comparing the intensity of the bands on the autoradiograph with that of 
one copy and ten copy equivalent plasmid controls. Barn Hl generated two internal 
fragments from AATB of 6.3 kb and 1.8 kb. Fragments of this size are generated by 
Barn HI digestion of AATB 35. The intensity of these fragments is low and was 
comparable with that of the single copy plasm id control. suggesting AATB 35 had a 
low copy number locus. However the presence of a 2.5 kb Barn HI band from AATB 
35 intimates that AA TB 35 may not actually be single copy. A 2.5 kb Barn HI 
fragment is not an internal fragment ofAATB, but would be generated from an AATB 

























Figure 3.3: Probes Used In Genomic mapping Of Transgenic Mice 
The AATB transgene has three Barn ff1 sites. Digestion of AA TB gives two internal 
fragments one 1.8 kb in size (probe (a)) and a larger fragment of 6.3 kb (probe (b)). 
These fragments were gel purified and used as probes in the estimation of copy 
number and the genomic mapping of the transgenic mice. AATB also had two Hind 
III restriction sites generating an internal 2.8 kbfragrnent (probe c) that was used to 
identzjj which of the junction fragments contained 3' AATB sequences (figure 3.121). 
A fourth probe (probe d) generated by Barn HI / Hind III double digestion was used 
to probe the unbiot (figure 3.11). 
102 
AATB 
Nofl Barn HI Hind III 
Barn HI 










6.3 kb Barn Hi 
3.5 kb Barn HI Hind liT'  
 
28 kb Hind III 
3.2 ESTIMA TING THE COPY NUMBER OF AATB 35 
3.2.1 Copy Number Estimation Of AATB 35 By Comparison With Plasmid 
Controls 
A more detailed analysis of the AATB 35 locus was carried out before starting the 
experiments. It had previously been reported that AATB 35 harboured a single copy 
of the AATB transgene (Archibald et.aL, 1990). The result was obtained by 
comparing the intensity of internal fragments of the transgene, on Southern Blots, with 
1 copy and 10 copy plasmid controls (Figure 3.2). This method of estimating 
transgene copy number is standard practice, but does need to be interpreted with a 
certain amount of caution, as significant errors can be made using this technique. 
Since a single copy or very low copy locus was crucial for the planned 
approach of this work it was important to establish definitively the copy number of the 
locus. The copy number estimation was repeated employing the same method used 
previously. The results are shown in Figure 3.4. 
It is quite clear from this Southern blot that the locus of AATB 35 has multiple 
copies of the transgene. Comparison of the internal fragment with the 5 copy plasmid 
control would indicate that the transgene copy number of the locus is considerably in 
excess of five copies and certainly not one as reported (Archibald et al., 1990). As 
previously emphasised this method of copy number estimation is susceptible to a 
number of errors. The accuracy of this method relies on three factors; firstly; accurate 
determination of DNA concentration, secondly; accurate serial dilution of the plasmid 
controls and thirdly; accurate pipetting of generally viscous genomic DNA. Thus this 
method of determining transgene copy number is not entirely reliable. Nevertheless 
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FiRure 3.4: Determination Of AATB 35 Copy Number By Comparison With 
Plasmid Control Autoradiograph of copy number control experiment 
The figure shows a repeat of the copy number estimate of line AATB 35 using 
plasmid copy number controls. All the lanes contain 10 zig of mouse genomic DNA 
preparedfrom liver. The plasmid copy number controls were loaded in 10 pg of non 
transgenic mouse DNA. The lane labelled AATB(]) contained 10 pg of genomic 
DNA of a female third generation mouse AA TB 35.11.60. The lane labeliedMTB(2) 
contained 10 pg of genomic DNA of male third generation mouse AATB 35.8.11. 
The control lane contains 10 pg of liver DNA from a non transgenic mouse. DNA in 
all lanes was restricted with Barn HI endonuclease. Barn HI generates two internal 
fragments from AATB a 6.3 kb fragment from the human AAT sequences and a 1.8 kb 
fragment from the ovine BLG sequences. The probe used in this instance was probe 
(h) Figure 3.3. The Southern blot was laid down with X-ray film for four days at - 
70'C with intensifying screens. The copy number of both AATB 35 mice was similar 
and appeared to be well in excess of 5 copies. 
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the disparity of the results is larger than expected and, was not easily explained by 
simple technical error.  
The animals analysed in the Southern blot in figure 3.4 are third generation, 
whereas the original copy number determination was performed on the founder AATB 
35. It is conceivable that this animal may have been a somatic mosaic. If this were so 
then the copy number of the animal would be an underestimate since only a 
percentage of the cells would harbour the transgene array. However the frequency of 
transmission of the transgene to the offspring was close to fifty percent (data not 
shown). This implied that the animal was not germline mosaic but does not eliminate 
the possibility of somatic mosaicism. 
Another possibility is that the locus of AATB 35 had undergone expansion 
over the generations. This is unlikely as both third generation animals analysed in 
figure 3.4 were obtained from different offspring of the AATB 35 founder. It is 
unlikely that expansion of the locus would occur similarly in two independent 
transgemc mice. Moreover, if this were so then a concomitant change in the level of 
expression of hAAT would be expected. The level of human AAT in the milk of a 
third generation animal of line AATB 35 was measured on the 11th day of lactation by 
radial inimunodiffusion, and found to be equivalent to the level determined in the Gi 
animals assayed previously (Archibald et al., 1990). The founder AATB 35 was male 
and thus no milk sample was analysed at Go. It is likely that AATB 35 was somatic 
mosaic but in the absence of DNA from AATB 35 this could not be proved. 
The original strategy for this project had been to clone the entire AATB locus 
from this line into a cosmid vector (see figure 3.1). As the AATB transgene is 10.6 kb 
in size this would only have been possible if the locus harboured three or less copies of 
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the AATB transgene. This would, nevertheless, considerably diminish the amount of 
flanking chromosomal DNA within the inserts of the cosmid clones. Since the murine 
sequences mediating the effect might have been some distance from the transgene 
locus this had an important bearing on the suitability of the planned approach for the 
study of this line. To be absolutely sure of these results another method was employed 
to accurately establish the transgene copy number of line AATB 35. 
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Figure 3.5: Comparison Of Third Generation Mouse of AATB 35 With Go Mice 
Of Other AATB Transgenic Lines 
The figure shows the results of a Southern blot of DATA of various AATB transgenic 
mice. Each lane contains 10 ug of genomic DNA digested with Eco RV restriction 
endonuclease. The DATA from AATB 17, 26, 65 and 69 were the tail DATA from the 
original screening of the AATB lines generated by Archibald et al. this lab. The DATA 
ofAA TB 35 is from a thi rd generation transgenic mouse and is liver DNA. All of the 
lines on the Southern blot generated a 10.6 kb band This is evidence that these 
AATB lines harbour a head to tail array of the AATB transgene. The relative 
intensities of these bands gave an indication of the relative copy numbers of the lines. 
The published copy number for each line is given below each lane. Qualitatively the 
results of this blot support the published copy number for the all of the lines except 
AATB 35. 
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3.2.2 Copy Number Estimation Of AATB 35 By Junction Fragment Comparisons 
It was apparent from the previous result that the locus of AATB 35 contained 
an array of transgenes. In order to gain further information about the array, liver DNA 
from AATB 35 was restricted with Eco RV, an enzyme which cuts at a unique site 
within the AATB transgene. This analysis confirmed both the orientation of the 
transgenes within the array and allowed a more accurate determination of their 
number. Head to head and tail to tail orientations would have given fragments of a 
defined length for each enzyme: such fragments (13.2 kb for head to head, and 8 kb 
for tail to tail, upon digestion with Eco RV) were not detected. Complex loci which 
have other non transgene DNA present, or transgenes harbouring deletions, would 
produce bands of sizes which were not predicted from the known restriction map of 
AATB, in addition to two junction fragments. The generation of only three bands 
upon Eco RV digestion of the genomic DNA (figure 3.6) demonstrated that the 
transgene array of AATB 35 had a simple head to tail arrangement. The only internal 
fragment from the array was a 10.6 kb AATB repeat length fragment. This indicates 
that all the transgenes within the array were orientated in head to tail fashion. The 
other two fragments of 9 kb and 6.5 kb were assumed to be the 
transgene/chromosomal junction fragments. The intensity of the three fragments were 
compared by densitometry of the autoradiographs. Figure 3.7 shows the densitometry 
of the 9kb junction fragment and the 10.6 kb junction fragment. 
Junction fragments are usually single copy. Using a probe which spans the 
restriction site and comparing the intensity of the internal array fragments to the 
junction fragment in each lane gave a clearer indication of the copy number of the 
locus than using plasmid copy number controls. 
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Figure 3.6: Autoradiograph Of Eco RV Digested Genoniic DNA of Line AATB 
35 
All the lanes contain 10 ug of liver DNA from AATB 35.8.1], digested with Ecu RV 
The numbers above the lanes are the time (in hours) digestion was allowed to 
proceed, o/n= overnight digestion with extra enzyme added. The time course of 
digestion was performed to ensure that the fragments being compared on the 
Southern blot were indeed the junction fragments and the internal AATB fragment 
from the array: as opposed to fragments generated by either partial digestion of the 
DNA, or star activity of the enzyme. The digested DNA was electrophoresed in a 
0. 7% agarose gel. The gel was Southern blotted onto hybond N membrane and 
hybridised with probe (b,), Figure 3.3. Only three fragments were generated. One 
intense AATB repeat length fragment and two less intense junction fragments (sizes 
given in kb on the left). The intensity of the two junction fragments was similar 
Each junction fragment is present in only one copy per genome and thus comparison 
of the signal from the junction fragments with that of the repeat length fragment gave 
an indication of the number of transgenes present within the array (see figure 3.7). 
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Fqure 3.7: Densitometry Of The Autoradiograph Shown In Figure 3.6 
The intensity of the three Eco RV fragments (figure  3.6) was compared by 
densitometry. All lanes were scanned using a Shimadzu densitometer. The intensity 
of both junction fragments were found to be very similar but the background was 
always greater for the larger junction fragment which was closest to the repeat length 
band. The background of the repeat length band and the larger junction fragment 
was similar: this allowed an accurate comparison of the two fragments. The figure 
shows the densitometry result of the larger junction fragment and the repeat length 
fragment of lane 4, figure 3.6. The ratio of the intensities is one to ten. This result 
cannot be considered absolutely quantitative because of the non linear response ofX-
ray film. Nevertheless is does show that the locus of AA TB 35 will not fit within a 
single cosmid vector. 
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The densitometry (figure 3.7) confirms the result from the plasmid copy 
control experiment. The ratio between the junction fragment and the internal fragment 
is one to ten. This method of estimating transgene copy number is not exact and a 
number of points need to be taken into consideration. Firstly nothing is known about 
the nature of the junction fragments and thus of the proportion of AATB sequences 
within those fragments capable of hybridising to the probe. The assumption was made 
that the probe sequences 5' of the Eco RV site were also present in the 5' junction 
fragment and similarly the probe sequences 3' of the Eco RV site were also present in 
the 3' junction fragment. The Eco RV restriction site is not quite in the centre of the 
probe sequences. The significance of this would appear to be minimal as analysis of 
the two junction fragment bands by densitometry shows the intensity of the bands is 
not significantly different (data not shown). However the internal fragment hybridises 
with the entire probe whereas the junction fragments only hybridise with hail of the 
probe sequences Finally the response of X-ray fthn is only linear over a very limited 
range of signals, for this reason the weak signal from the junction fragment may be 
under represented relative to the intense signal of the internal fragment and vice versa. 
The Southern blot shown in Figure 3.5 suggests that the copy number of AATB 35 
may be considerably more than eleven (suggested by the densitometry result). Figure 
3.5 shows the autoradiograph of a Southern blot of a number of AATB lines digested 
with Eco RV. Although the junction fragments are not clear for any of the lines on this 
blot. it is clear that all the AATB lines analysed on this blot gave rise to an AATB 
repeat length fragment on digestion with Eco RV. This demonstrated the presence of a 
head to tail transgene array in all of these lines. A copy number standard was not 
loaded on the Southern in figure 3.5. Nevertheless the figure provides qualitative 
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support for the published copy numbers of the AATB lines analysed (other than 
AATB 35). This supports the assertion that the underestimation of the AATB 35 copy 
number was not the result of an error in the plasmid copy number controls but was the 
result of somatic mosaicisin of the founder. 
Taking all of these factors into account the fact remains that the copy number 
of AATB 35 was in excess of what had been expected and posed a real problem for 
the planned approach for studying position effects with this line. A locus of this size 
could not conceivably be accommodated within either a cosmid or even a P1 vector. 
In addition it had been thought that the 7mg/mi expression of MAT in line AATB 35 
was driven from one single copy of the AATB transgene. The analysis of the copy 
number outlined in this chapter shows that the transgene copy number is probably in 
excess of eleven copies. This means that the expression per copy of the transgene is at 
best 0.64 mg/mI. 
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Figure 3.8: Comparison of AATB 46.2 With AATB 35 
The figure shows an autoradiograph of a Southern blot ofAATB 35 andAATB 46.2 
liver DATA probed with probe (a) figure 3.3. C= control (non transgenic liver DNA), 
one copy equivalent plasm id control (p-Poly-III-I-AATB digested with Not 1), 35= 
AATB 35 liver DNA (10 pg, 46.2= AATB 46.2 liver DNA (10 pg), 1= internal AATB 
fragment, ff= chrornosomali'transgene junction fragment, r= AATB repeat length. 
Comparison of the 1.8kb internal Barn HI fragment of AATB 35 and AATB 46.2 
demonstrated that the copy number of AATB 46.2 was less than that of AATB 35. 
The generation of a repeat length fragment with EcoRVandNhe I demonstrated that 
both AATB 35 and AATB 46.2 harbour a head to tail array of' transgenes. 
Comparison of the intensity of the repeat length band generated by the two lines 
supports the data of the internal fragment: indicating the copy number ofAATB 46.2 
was lower than that of AATB 35. However comparison of the Eco R V junction 
fragment ofAATB 46.2 with the repeat length fragment suggested that more than one 
repeat length fragment was generated by Eco RV digestion of AATB 46.2. The 
information from this blot indicated that the copy number of AA TB 46.2 was at least 
three but probably more. 
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3.3 ESTIMATION OF THE COPY NUMBER OFAATB 46.2 
3.3.1 The Apparent Position Effect In AATB 46.2 
Only two stable lines of AATB transgenic animals were generated which 
expressed the human protein at relatively high levels. The other stable high expressing 
line was generated in the second study (Carver et al., 1993). The line AATB 46.2 
generated at Pharmaceutical Proteins Limited (now PPL Therapeutics) had very 
similar characteristics to AATB 35. It expressed human a1-AT at a comparable level 
(6-8 mg/nil) and the locus was also reported to be low copy. The high expression level 
of the human protein in the milk of lactating females had been maintained through 
several generations. if the copy number of this line was significantly lower than that of 
AATB 35 this line would be more amenable for the study of position effects using the 
previously outlined approach. Thus the copy number of AATB 46.2 was also 
investigated further. 
3.3.2 Copy Number Comparison of AATB 35 with AATB 46.2 
The first criterion was to compare the copy number of the AATB 46.2 with 
that of AATB 35. Liver DNA of one mouse from each line was compared using 
Southern blot analysis. The result of this analysis is given in figure 3.8. Barn HI 
generates two internal fragments of the AATB transgene. Comparison of the intensity 
of the Barn HI internal fragments from the two lines demonstrates the copy number of 
AATB 46.2 is lower than that of AATB 35. Therefore it was worth proceeding with a 
more in depth investigation of the copy number of this line as it was likely to be more 
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suitable for the study. However the enzymes Eco RV and Nhe I generated a 10.6 kb 
fragment that indicated the presence of a head to tail array of transgenes within the 
locus of both lines. The intensity of the repeat length fragment of AATB 46.2 was less 
than that of AATB 35 consistent with the copy number of AATB 46.2 being lower 
than that of AATB 35. However junction fragments liberated from the loci by these 
enzymes were visible in all lanes. The intensity of the junction fragments (assumed to 
be the intensity of a single copy fragment) was less than that of the internal 10.6 kb 
band generated from both lines. Densitometric analysis of this Southern blot (data not 
shown) demonstrates that the transgene copy number of AATB 46.2 is at least three. 
A copy number of greater than three prohibits the cloning of the entire AATB 
transgene locus in a single cosmid vector. It was, therefore, important to more 
accurately determine the copy number of AATB 46.2. The approach taken in order to 
circumvent the non-linear response of X-ray film was to perform a dilution blot 
analysis. 
3.3.3 Copy Number Estimation Of AATB 46.2 By Dilution Blot Analysis Of 
AATB 46.2 
To obtain a quantitative result from the type of analysis done in figures 3.6 and 
3.7 it was essential that both signals strong and weak were still within the linear range 
of X-ray film. The rationale of the dilution blot is to dilute the 10.6 kb internal 
fragment produced from the array till the signal from this, equates with that of the 
junction fragments, when hybridised with the same probe. The comparison in this 
case is like with like (weak signals with weak signals) so the effect of the non linear 
response of the film is circumvented. 
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The dilution factor required to bring the internal fragment to the same intensity 
as the junction fragment will give an estimated copy number of the array and hence of 
the line (which is the dilution factor plus 1). The dilution blot analysis is shown in 
figure 3.9. For the intensity of the repeat length fragment to match that of the junction 
fragment requires between a, one  in four, and, one in eight, dilution. Thus the repeat 
length fragment appeared to contain the equivalent of six copies of the transgene. 
Hence the total number of copies of the transgene in AATB 46.2 was approximately 
seven. Although the copy number of AATB 46.2 was less than that off AATB 35, the 
locus was still too large to be accommodated in a single cosmid clone. 
There were only two AATB lines from the previous studies that were stable 
and gave high levels of hAAT expression. From the more careful blotting analysis in 
this study neither of these lines were shown to harbour the very low transgene copy 
number loci anticipated, on the basis of previous experimental results. 
The lowest copy locus AATB 46.2 could conceivably be cloned in a P1 vector. 
This would allow the entire transgene array plus some of its flanking regions to be 
cloned. Unfortunately inserts in P1 vectors are frequently unstable. The insert in this 
instance would contain regular repeating units of AATB and it was considered 
technically unwise to use this approach. The locus of both lines could easily be 
accommodated within a YAC but such vectors harbour very large inserts and this 
would be a very non informative way of regenerating the position effect. 
Nevertheless the murine genomic DNA flanking the transgene arrays in both 
lines were apparently permissive for high levels of expression of human a1-AT. The 
nature of these sequences and their role in promoting the high levels of transgene 
expression was, therefore, still of considerable interest. 
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Figure 3.9 Estimation Of Copy Number Of AATB 46.2 By Dilution Blot 
Analysis 
The figure shows a Southern blot of an AATB 46.2 dilution gel. Each of the lanes 
contain 10 pg of DNA, digested with Eco R V The probe was probe b figure 3.3 The 
numbers above each lane gives the dilution factor of the transgenic DNA. The lanes 
vary only in the ratio of AATB 46.2 DNA and non transgenic mouse DNA present. 
The first lane contained 10 pg of liver DNA from a mouse of line AATB 46.2. The 
next lane contained a 1:1 ratio of non transgenic liver DNA and AATB 46.2 liver 
DNA (5pg of each). The third lane contains a 1:3 ratio of transgenic to non 
transgenic DATA. The fourth lane contains a 1:7 ratio of transgenic to non 
transgenic DNA and the fifth lane contains a 1:15 ratio. The final lane contains only 
non transgenic DNA. The dilution of the transgenic DNA reduces the intensity of the 
repeat length band in accordance with the dilution factor. Comparing across the 
lanes, the intensity of the single copy junction band (in the lane containing the 
undiluted transgenic DNA) with the diluted repeat length band allows the number of 
transgenes liberated from the array by Eco RV to be estimated. The intensity of the 
junction fragments lies between that of the repeat length band diluted 1/4 and 1/8. 
This suggests that approximately six AATB repeat length fragments were liberated 







3.4 THE ALTERNATIVE APPROACH 
3.4.1 Constructing A Secondary Transgene From Cosmid Clones Harbouring 
The AATB 46.2 Flanking DNA 
The locus of all the lines of AATB analysed appeared to harbour a head to tail 
array (Figure 3.5). It was thus concluded that the concatameric arrangement of 
trangenes within the array of AATB 35 or AATB 46.2 was not responsible for the high 
expression of the hybrid transgene in these lines. The approach decided upon was to 
proceed with the cosmid vector cloning of the locus (see figure 3.10). The proposal 
was to construct a cosmid library from liver DNA of an AATB 46.2 transgenic mouse, 
screen the library for clones that contained the transgene and isolate from these clones 
those that contained flanking genomic DNA. These flanking genomic sequences 
would be used to construct a secondary transgene comprising just one single copy of 
the AATB transgene, plus the chromosomal DNA from both the 5' and 3' ends of the 
locus. 
The approach was not as neat as the initial proposal in which the locus itself 
remains unchanged and a number of clones containing varying amounts of genomic 
flanking DNA both 5' and 3' were likely to be isolated. It would be impossible to 
regenerate the position effect per se using this approach since the locus would be 
dramatically altered. Nevertheless, a study of the chromosomal flanking sequences 
and their role in the high level expression of either line was still possible. AATB 46.2 
was the line of choice for the study since it had the lowest transgene copy number thus 
minimising as much as possible the possibility of recombination occurring between 
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direct repeats harboured within the cosmid inserts and maximising the chances of 
cloning both the 5' and the 3' flanking sequences. 
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Figure 3.10: The Alternative Approach 
The figure is a diagrammatic representation of the planed approach for the study of 
the position effect in AATB 46.2. (a) Represents the locus ofAA TB 46.2, ('nj) is the 
number of transgenes within the array. (b) represents clones of the 5' and 3' end of 
the loci which harbour significant amounts offlanking murine DATA. (c) represents 
the secondary transgene construct made from the isolated clones and one intact copy 
of the AA TB transgene. 
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3.5 THE RESTRICTION MAP OF THE LOCUS OF AATB 46.2 
A map of the locus of AATB 46.2 was required before the locus could be 
cloned from a cosmid library of the line. A number of enzymes were identified which 
cut either uniquely or infrequently within the AATB transgene (see figure.4.3). 
Restriction of AATB 46.2 genomic DNA with such enzymes followed by Southern 
blotting and hybridisation with 5' and 3' probes allowed the generation of a map of the 
locus. 
It has previously been established that the locus harbours a simple array of 
transgenes oriented in head to tail fashion. This array generates intense internal 
fragments on Southern blot analysis. All weaker fragments detected were assumed to 
be the junction fragments of the locus. Southern blot analysis of Barn HI digested 
AATB 46.2 DNA detected only one junction fragment because of the probes used 
(figure 3.12). likewise only one Hind ifi junction fragment was detected (figure 3.11). 
Two junction fragments were detected upon digestion with Eco RV and Nhe I (figures 
3.11 and 3.12). Sufficient information was available from these blots to confirm the 
structure of clones harbouring genomic DNA from the AATB 46.2 locus. The 
genomic map of the AATB locus is given in figure 3.13. 
The figure gives a restriction enzyme map of the AATB 46.2 locus. The locus 
has six copies of the transgene within the array. The two transgenes abutting the 
Chromosomal DNA are represented as entire copies. But the extent of transgene 
damage (if any) at the 5' end of the array is not clear from this analysis. A 10.6 kb 
junction fragment can be detected from the locus with the 6.5 kb Barn Ill probe. This 
demonstrates that the Barn HI restriction site that is normally present at the very 3' end 
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of the AATB transgene is missing in one of the transgenes. The single copy fragment 
is 10.6 kb, this is marginally larger than expected (8.9 kb) if the missing restriction site 
is from a transgene within the array. Thus the damage has occurred to the transgene 
abutting the host chromosomal sequences at the 3' end of the locus. This suggests that 
this transgene has sustained some damage either before, or during integration into the 
genome. No 3' Hind ifi junction fragment is detected with the same probe which 
suggests the Hind ifi site situated 150 bp from the 3' end of the AATB transgene is 
still present on the damaged transgene. 
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Figure 3. 11 : Detection Of Junction Fragments 
The figure shows an unbiot of variously digested AA TB 462 liver DATA probed with 
probe b, figure 3.3. The DNA was digested with the enzymes indicated. The gel was 
a 1% IMP agarose gel. The digested DNA was loaded on the gel and subjected to 
field inversion gel electrophoresis (FIGE). Each lane contained 10 pg of digested 
DATA. The gel treated with HCI followed by NaOH and finally iris HCI p11 7.4. It 
was then dried and hybridised directly with the probe. The AATB fragment 
generated by enzymes Sal I, Not I and Pvu I would appear to be too large to have 
entered the gel under the conditions used (see materials and methods). Enzymes Bgl 
II and Sca 1 generate one single large fragment. The actual size of the fragment 
could not be determined as fragments greater than 30 kb were not resolved 
Enzymes Nhe I and Eco R V generate the repeat length fragment ( r ) and two other 
faint fragments which are believed to be the chromosomal/transgene junction 
fragments 	Hind III generates the 7.8 kbfrag,nents expected fro m an AA TB head 
to tail array and a less intense fragment which is believed to be the junction 
fragment. The lane labelled I copy contains a one copy equivalent plasmid control 
which is P-PollyJI1-1-AATB digested with Not I (i.e. a one copy equivalent of the 
injected transgene. The lane labelled Barn HI (human) contains 10 pg of human 
mammary tumour DNA digested with Barn HI. 
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Figure 3.12 Identification of 5' Hybridising And 3' Hybridising Junction 
Fragments 
The figure shows the results of a Southern blot analysis to detect which of the 
junction fragments hybridised with a 5' AA TB probe (a, figure 3.3) and which with 
the 3' AATB probe (d, figure 3.3). r= AA TB repeat length fragment (10.6 kb), i 
internal AA TB fragment and jf= chromosomal/transgene junction fragment. Each of 
the lanes contained 10 jig of liver DNA digested with either Barn Hi, Ecu R V or Nhe 
1. For each enzyme the first lane is the result of hybridisation of the filter with probe 
a. The blot was exposed to X-ray film for 48 hours, at -70 ° C with intensifying 
screens. The second lane is the result of hybridising the same filter with probe c. in 
this instance the blot filter was exposed to X-ray film Jbr 72 hours, at -70 ° C with 








Figure 3.13: Estimated restriction Map Of Locus Of AATB 46.2 
The figure shows a restriction map of the locus of AATB 46.2 as determined by 
southern blot analysis (detailed earlier in this chapter). The number of copies of the 
transgene is approximately seven (see figure 3.9). Fragments, that appeared to be 
the junction fragments, were identified using afour restriction endonucleases and 5' 
and 3' AA TB probes (see figures 3.11 and 3.12). These junction fragments are 
represented in the figure by thick lines, the size (in kb) of the junction fragment is 
given above each. The 3 'junction fragments were detected with a 2.8 kb probe from 
the 3' end of AATB (probe dfigure 3.3). No 3' [find III junction fragment was 
detected (data not shown,) that suggested that the 3' most Hind III site of AA TB was 
present and thus the majority of the AATB transgene at the 3' end of the transgene 
array. However the detection of a Barn HI junction fragment with this probe 
suggested that the Barn HI site situated 20 bp from the 3' end of AA TB was missing 
from the transgene at the 3 end of the array. The probe used to detect the 5' 
junction fragments was an internal fragment that did not span the 5' most AATB 
sequences (probe afigure 3.3) and thus was not as informative about the amount of 
transgene present at the 5' end of the transgene array. 
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SUMMARY 
Two lines of mice harbouring the AATB transgene were found to express the 
transgene at unusually high levels in the milk of transgenic mice. The BLG promoter 
has been used to drive the expression of biomedical proteins in the mammary gland of 
Eransgenic animals. Unfortunately the expression levels of heterologous transgenes 
driven by the BLG promoter are unpredictable and more often than not disappointing. 
The aim of this work is to investigate the role of the surrounding murine chromosomal 
sequences in the high level expression of the transgene in one of the lines. 
The proposal was to clone the entire locus in a cosmid vector and generate 
from the clones a number of transgenic lines with a new secondary construct which is 
the AATB transgene from the high expressing line along with significant amounts of 
the flanking murine DNA. Crucial to this approach was the presence of a single or 
very low copy transgene locus within one of the lines. 
It has been demonstrated in this Chapter that neither of the high expressing 
lines possesses a locus of sufficiently low copy number to make the planned approach 
feasible. An in depth investigation of the transgene copy number in both lines has 
been performed. 
The higher than expected transgene copy number ruled out the original 
proposal as a method of investigating the position effect of either line AATB 35 or 
AATB 46.2. An alternative approach to study the position effect in AATB 46.2 was 
designed. This involves constructing and screening a cosmid library from line AATB 
46.2. Clones isolated which harboured the 5' and 3' murine flanking DNA can then 
be used to construct a secondary transgene to investigate the role of the murine 
chromosomal DNA, surrounding the locus. 
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CHAPTER 4: CLONING AND CHARACTERISATION OF THE 
AATB 46.2 LOCUS 
4.1 INTRODUCTION 
4.1.1 Construction of the Cosmid Library 
A cosmid library was constructed in Stratagene's Super-cos vector (Evans et 
al. 1989) (see Figure 4.1). This vector is capable of accommodating 32 to 42 kb of 
insert DNA. The vector carries a neomycin (neo) resistance marker and an SV40 
promoter for neomycin gene expression in eukaiyotic cells. It has T3 and T7 
promoters to make RNA probes from the insert that can, for example, be used for 
cosmid walking. The vector also has two cos sites to allow efficient cloning of non 
size selected DNA. However, it was found that the DNA had to be size selected to 
establish the library in this instance. 
The genomic DNA was prepared from high molecular weight liver DNA of a 
transgenic mouse of line AATB 46.2 (Carver et al., 1993), (see Materials and 
Methods for details of library construction). The DNA was partially digested with 
Nde II (an isoschizomer of Sau 3A), size selected on a sucrose gradient and 
dephosphorylated before ligation into the Barn HI cloning site of the Super-Cos-One 
vector. The bacterial strain infected with the packaged cosmid vector was E. coli 
NM554. This strain harbours a RecA mutation rendering it recombination deficient. 
It also harbours mutations affecting the E. co/i restriction system (mcrA and rncrB) 
which prevent the cutting of methylated genomic DNA cloned within the cosmid 
vector. 
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4.1.2 Screening The Cosmid Library 
A library of approximately 8 x 105  clones was obtained. It had been calculated 
that 2.2 x 105  would need to be screened for a reasonable probability of cloning the 
locus. This figure was calculated using the equation bellow. (Glover, DNA Cloning, 
Vol. I, 1985,pl3) 
N =j( 
hi(1-cIy) 	- - 
N = number of colonies required to be screened 
P = an arbitrary probability of finding a particular sequence of DNA 
x = the insert size 
y = genome size 
The arbitrary probability used was 95 % (see Glover, DNA Cloning, Vol. 1, 1985, 
p13). The murine genome is approximately 3 x 106  kb and the average insert size was 
assumed for the purposes of the calculation to be 40 kb. 
The library was titered and the colonies plated at approximately 2 x 104  per 
filter of 15 cm diameter. A total of 4 x 10' colonies were screened to maximise the 
chances of cloning the murine flanking DNA of the AATB 46.2 locus. 
The library was screened using only the BLG sequences of the AATB transgene 
(probe (b), Figure 4.2). This was to prevent the detection of cosmid clones harbouring 
the mouse, endogenous AAT gene which may have cross hybridised with a probe 
containing 1IAAT sequences. Multigenic clones were obtained on the primary screen. 
Seven were obtained on the secondary screen. Analysis of these seven clones by 
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Southern Blotting demonstrated that only four clones genuinely harboured AATB 
sequences. Table 4.1 shows the clones obtained at each stage of the screening 
process. 
Table 4.1 : Number of positive clones obtained on each screen 
Clones Primary screen Secondary screen Southern blot 
1 + + 
2 + + 
3 + 
4 + + same as5 
5 + + + 
6 - + 
7 + 
8 + + + 
9 + + + 
10 ± + + 
4.1.3 Restriction Mapping Of The Cosinid Clones 
The DNA of all clones obtained on the secondary screening of the library was 
digested with a number of restriction enzymes. The restriction patterns of these clones 
were compared with the genomic map of the AATB locus (see chapter 3, Figure 
3.13). Three of the clones appeared to be isolated as a result of false hybridisation to 
the probe. The restriction map of these clones displayed no relationship to the genomic 
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map of the AATB locus, and no positive signals were obtained from the Southern 
blots hybridised with AATB probes. 
Two clones (5 and 10) gave a simple restriction pattern entirely consistent with 
being internal to the transgene array (Figures 4.4 - 4.9). All of the insert, in both of 
these clones, was of AATB origin. These clones had given the strongest signals on the 
primary screening and this was consistent with several copies of AATB being present 
in the insert. Two other clones (8 and 9) gave restriction fragments expected of the 
AATB transgene. These clones also gave restriction fragments consistent with the 
junction fragments of the genomic maps, and were thus likely to contain the mouse 
chromosomal DNA flanking the transgene array. The detailed restriction enzyme 
analysis of these four clones is presented in the following sections. 
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Fifure 4.1 Super-Cos-One Vector 
The Super-Cos-One vector is 7937 bp in size (Evans et aL, 1989). In packaging 
1080 bp are lost between the cos sites resulting in afinal vector size of 6857 bp, after 
infection of E. Co/i NM554. The positions of some of the restriction sites, of 












(90) J\\\ 	Not 1 
Hind ill 	 Xbal 	7 \__EcoRl 
10)
(3370)  (I 170)'\
(31 
Multiple cloning site 
	 Neomycin resistance gene 
Ampicillin resistance gene 
	— SV40 promoter 
Origin of replication 	 lambda cos sites 
FiRure 4.2 	AATB Probes Used For Sereenini! The Library And 
Characterisation Of The Clones 
The figure shows the probes used for the screening of the library and the 
characterisation of the clones which are detailed in this Chapter. It shows a 
diagrammatic representation of the AATB transgene and the position of the enzymes 
used to generate the probes. Probe (a) is the entire AATB transgene which was 
removed from its vector sequences with restriction endonuclease Not I. Probe (b,) 
was generated by digesting AATB with Not I and Smal, it contains almost all of the 
ovine BLG sequences present in the AATB transgene, and was used to screen the 
cosmid library. Probe (c) is generated by digesting AATB with Eco RI and Not I. 
This double digest generates two small fragments of 615 bp and 555bp which co-
migrate in agarose gel electrophoresis. Thus the probe consists of two fragments 
which together span more than 1 kb of the 5' end of AA TB. Probe (c) was used to 
characterise the clones isolated from the library. Probe (d) is the 2.8 kb Hind III 
fragment from the 3' end of the AATB transgene. Probe (d) was also used to 
characterise the clones isolated from the library. All of the probes were purified by 
electrophoresis in 0.7 % agarose gels (see Chapter 2, Materials and methods for 
details of probe purification) 
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FiRure 4.3 .Restriction Sites In The AA TB Transifene 
A number of restriction enzymes were used in the mapping of the AATB 46.2 genomic 
locus and in the characterisation of the positive clones obtained from the library 
screen. The figure shows the position, within the AA TB transgene, of the restriction 
sites, of enzymes used in the mapping studies,. The number of recognition sites for 
each enzyme is given. Sma I cuts twice in AA TB but the sites are only 58 base pairs 
apart and can thus, for the purpose of rough mapping of the cosmid clones be 
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4.2 RESTRICTION ANALYSIS OF CLONES ISOLA TED FROM THE 
LIBRARY 
4.2 1 Restriction Analysis Of Clone 5 
The restriction analysis of Clone 5 is detailed in Figures 4.4 and 4.5. Figure 
4.4 shows the restriction fragments generated by digestion of clone 5 with various 
restriction enzymes. The gel shown in the figure is a 0.3 % agarose gel. The use of 
low percentage gels was essential to allow the resolution of the large fragments 
generated from clone 5 by a number of the enzymes used. Figure 4.5 shows an 
autoradiograph of the Southern blot of the gel, following hybridisation of the filter 
with the entire transgene probe (probe (a), figure 4.2). figure 4.6 is a diagrammatic 
representation of the restriction map of clone 5 deduced from the information in the 
agarose gel and Southern blot, in conjunction with the known restriction maps of the 
AATB transgene and the Super-Cos-One vector. 
In all eight restriction enzymes were used for the restriction analysis of clone 5. 
Cia I, Bgi II, Not L Eco RI, Sal I, Nhe I, Eco RV and Sma I. Figure 4.1 shows the 
position of the restriction sites of Cia I, Bgl II and Sma i in the cosmid vector. Figure 
4.3 gives the position of the Not I, Eco RI, Sal I, Nhe I Eco RV and Sma I sites in the 
AATB transgene. In this section the information obtained from each digest is 
considered in turn. The Southern blot of the gel in figure 4.4 was only probed with 
the entire transgene probe. Hybridisation with this probe alone was sufficient to 
establish that the insert of Clone 5 harboured only AATB sequences. 
Cia I was chosen for the analysis of the cosmid clones because it cuts at a 
unique site at position 90 in the cosmid vector (see figure 4.1). There was no Cia I 
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restriction site present in the AATB transgene (fill sequence of AATB courtesy of 
Mike Dalrymple, PPL Therapeutics Ltd.). The enzyme generated only one large 
fragment on digestion of clone 5 (figure 4.4) demonstrating the presence of a large 
insert in the cosmid vector. The fragment hybridised with the AATB probe showing 
that the insert harboured AATB sequences. 
Bgl II was chosen because it also cut at a unique site within the cosmid vector 
(see figure 4.1) and did not cut within AATB. This enzyme was a key enzyme in the 
mapping of the clones. It had a six base pair recognition site and would thus be 
expected to cut several times within a cosmid insert of greater than thirty-two kb. 
Digestion of clone 5 with Bgl II generated a single large fragment. The enzyme merely 
linearised the clone indicating that the large insert present in this clone had no Bgl II 
restriction site. As with the fragment generated by CIa I digestion this fragment 
hybridises with the AATB transgene probe (figure 4.5, Bgl if). 
Digestion of clone 5 with Not I was more informative. The cosmid vector had 
two Not I sites situated 5' and 3' of the cloning site (see figure 4.1). Thus Not I was 
used to liberate the insert from the cosmid vector. This enzyme has an eight base pair 
recognition site that consists only of G and C bases. Cleavage by this enzyme is 
inhibited by methylation at cytosine bases. DNA isolated from eukaryotes is partially 
methylated and thus the enzyme cuts infrequently in eukaryotic, genoniic DNA 
(average fragment size greater than 400 kb, (Brown. and Bird,. 1986). Not I was the 
enzyme used to isolate the AATB transgene from the p Poly ffl-I vector prior to pro-
nuclear injection of the transgene. Thus the injected AATB transgene had 
complementary, GC rich, four base pair, 5' overhang at either end. There is no 
internal Not I site in the AATB transgene. Digestion of clone 5 with this enzyme 
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generated four fragments (figure 4.4, Not 1). One of the fragments was 6.8 kb, the 
expected size of the cosmid vector. This was the only one of the four fragments that 
did not hybridise with the AATB probe (figure 4.5 Not I) (it was assumed that this 
fragment was the cosmid vector but this has not been proven by hybridising the filter 
with a cosmid probe). The entire insert hybridises with the AATB probe indicating 
that the insert is of AATB origin. Not I also generated a 10.6 kb fragment. This was 
the size of the injected AATB transgene. The fragment hybridised with the AATB 
transgene probe and was assumed to be individual transgenes generated from the 
transgene array. The fragment is more intense than the other fragments in the lane. 
This suggests that there is more than one intact transgene within the insert of clone 5. 
The generation of this fragment demonstrated that the Not I sites have been 
regenerated in the transgene array. The other two fragments generated by Not I were 
9.4 kb and 4.8 kb in size. These fragments are situated at the 5' and 3' end of the 
insert respectively (See figure 4.6, Not I and later section on Sma I digest) and were 
the result of Nde II digestion of AATB transgenes present in the array. 
Digestion of Clone 5 with Eco RI was consistent with the Not I digestion of the 
clone. Like Not I, Eco RI liberated the insert from the cosmid vector (see figure 4.1). 
A 6.8 kb fragment was generated from clone 5 by digestion with this enzyme (figure 
4.4, Eco RI). This fragment was the same size and intensity as the 6.8 kb fragment 
liberated by Not I digestion of the clone (compare Not I digest with Eco RI digest 
figure 4.4, fragments labelled (C)). This fragment did not hybridise with the AATB 
transgene probe (Figure 4.5, Eco RI) and was assumed to be the cosmid vector. Eco 
RI cuts twice within AATB. At position 611 and 1169 (see figure 4.3). Digestion of 
AATB with this enzyme liberated a 558 bp internal fragment. A head to tail array of 
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transgenes would have been expected to generate a 10055 bp fragment and the small 
internal fragment previously mentioned. Fragments of this size were visible on the gel 
shown in figure 4.4. Both of these fragments also hybridised with the AATB 
probe.(figure 4.5, Eco RI). One other fragment is generated from Clone 5 by this 
enzyme. The fragment is 3.6 kb and hybridises with the AATB probe. This size of 
this fragment was consistent with Eco RI digestion of the 4.8 kb truncated transgene 
present at the 3' end of the insert (see figure 4.6, Not I and Eco RI). 
Enzymes Sal I, Nhe I and Eco RV all cut once within the AATB transgene 
(see figure 4.3) and not at all in the cosmid vector. Each of these enzymes generated 
only two fragments on digestion of clone 5. Each generated an AATB repeat length 
fragment of 10.6 kb that hybridised with the AATB transgene probe (figure 4.4 Sal I, 
Nhe I and Eco RV and figure 4.5 Sal I, Nhe I and Eco RV). Each of the enzymes 
would have been expected to generate such a fragment from a head to tail AATB 
array. The second fragment is 21.5 kb. This fragment (generated by each of these 
enzymes) incorporates the cosmid vector and the remainder of the insert following 
removal of the AATB repeat length fragments. The repeat length fragments and the 
21.5 kb fragments generated by Sal I and Nhe I are of equal intensity (Eco RV has 
demonstrated star activity and was not suitable for this analysis). This suggested that 
the two fragments contained equal masses of DNA. Since the larger fragment was 
two times bigger than the repeat length fragment this indicated that two repeat length 
fragments must have been generated from clone 5 by digestion with Sal I and Nhe I. 
In conjunction with the information generated by the Not I digest this suggests that the 
insert of clone 5 harbours two intact copies of the AATB transgene and two truncated 
copies of 9.4 kb and 4.8 kb. This gives a total insert size of 35.5 kb. This was within 
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the range expected for a cosmid vector insert (minimum insert 32 kb, maximum insert 
42.kb).. The vector could not in fact have accommodated three intact transgenes and 
the two truncated transgenes as this would have been outwith the maximum insert size. 
Similarly one intact transgene and the truncated transgenes would have been below the 
expected insert size for the cosmid vector 
Sma I was the only enzyme used in the analysis of clone 5 that cut within the 
vector (see figure 4.1) and within AATB (see figure 4.3). Sma I cuts twice in AATB 
(at position 4115 and 4173) but the restriction sites are only 58 bp apart. For the 
purpose of the rough mapping of the cosmid clones this enzyme was considered to cut 
once within AATB. Digestion of clone 5 with other enzymes detailed in this section 
had demonstrated that the insert of clone 5 was an integral part of the AATB 
transgene array of line AATB 46.2 (see figure 3.13, Chapter 3). As Sma I cut within 
the insert and the vector digestion of the clone with this enzyme allowed the 
orientation of the cosmid and the insert to be ascertained. The enzyme generated 3 
fragments. The AATB repeat length fragment and two fragments of 6.6 kb and 3.9 
kb. The 3.9 kb fragment did not hybridise with the AATB transgene probe suggesting 
it was of cosmid origin. The other two fragments hybridised with the transgene probe 
indicating that they contained AATB sequences. The 6.6 kb fragment gave a weak 
signal, because only 2.9 kb of the fragment is of AATB origin and the remaining 
sequences are derived from cosmid (see figure 4.6). 
The restriction map of clone 5 is shown in figure 4.6. Digestion with Not I 
demonstrated that the insert contained an integral part of the AATB 46.2 transgene 
array. The results of digestion with Eco RV, Nhe I and Sal I demonstrated the 
transgenes in the insert were oriented head to tail (as expected from the genomic 
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mapping, Chapter 3). These enzymes also confirmed the presence of two intact 
copies of AATB within the insert in addition to the two truncated copies identified by 
Not I digestion. 
The insert size is 35.5 kb and incorporates 3 transgene /transgene junctions. 
The injected transgene possessed Not I complementary ends. The Not I site has been 
faithfully regenerated at all three transgene/transgene junctions present in the clone. 
The aim of the cloning was to isolate the murine sequences flanking the AATB 
46.2 transgene array. As it was clear from the preliminary mapping studies that clone 
5 had only AATB sequences within the insert, no further analysis was performed on 
this clone. 
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Figure 4.4: Ethidium Stained afarose ye! of Clone 5 Restriction Difesls 
The figure shows a 0.3% agarose gel stained with ethidium bromide. Mraoul 
molecular weight markers. The clone was digested with Clal, BglII, Not I, Eco RI, 
Sal I, Nhe 1, Eco R V, and Sma I. Not I liberates the insert from the cosmid vector as 
does Eco RI. A 6.8 kb fragment (the expected size of the packaged cosmid vector) is 
generated by both of these enzymes. Not L  Sal I, Me I, Eco R V, and Sma I all 
generate a 10.6 kb fragment. This is the repeat length of the AATB transgene. The 
generation of this fragment with these enzymes indicates the presence of a head to 
tail array of transgenes within the insert. (see text for details). The generation of this 
fragment with Not I indicates that the Not I restriction site has been regenerated 
between all of the transgenes present in the insert of this clone. Cla I and Bgl II cut 
once in the cosmid vector and not at all in the AATB transgene. These enzymes 
linearise the cosmic!, generating one single large fragment which co-migrates with 
the 48 kb molecular weight marker. Restriction of Clone 5 with Sma generates only 
three fragments, one is 10.6 kb (AATB repeat length). Sma I cuts within the vector 
(see Figure 4.1) and within the AA TB transgene (see figure 4.3) thus restriction of 
the clone with this enzyme allows the orientation of the vector with respect to the 
insert to be ascertained. Fragments marked (C) are fragments which do not 




Fure 4. 5: Autoradioeraph of Southern Blot Of Gel In Figure 4.4 
The figure shows the autoradiograph of a Southern blot of the gel shown in figure 
4.4. The blot was probed with the entire AA TB transgene (probe (a), figure 4.2) and 
then exposed to X-ray film for 18 hours, at -70 C, with intensifying screens. The 
majority of fragments seen on the stained gel in figure 4.4 hybridise with the 
transgene probe. Only the 6.8 kb fragments generated by Not 1 and Eco RI and the 
3.9 kb Sma I fragment do not hybridise (see fragments marked C in figure 4.4). In 
each case the size of the fragment is that predicted for the cosmid vector. All 
fragments generated from the insert of clone 5 hybridise with the AATB transgene, 
indicating that the entire insert is ofAATB origin. 
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Fi,zure 4.6: Restriction Map Of Clone 5 
The insert of clone 5 harbours part of the transgene array ofAA TB 46.2. The insert 
has two intact transgenes and two truncated transgenes of 9.4 and 4.8 kb (see Not 1 
digest, figure 4.4 and 4.5). The Not I site has been regenerated at all three 
transgene/transgene junctions present in the insert. The 4.8 kb transgene contains 
the 5' end of AA TB. This is ascertained by the generation of a 3.6 kb fragment on 
digestion of clone 5 with Ecu RI (figure 4.4). All the transgenes in the insert are 
oriented head to tail (demonstrated by the generation of the AATB repeat length by 
enzymes Nhe I, Sal I and Eco R V, that cut only once in AA TB). This orientation was 
expected from the results of the genomic mapping studies detailed in Chapter 3. 
Digestion with Sma I demonstrates that the 9.4 kb part transgene is at the 5' end of 
the insert (with respect to the 5' 3' orientation of AATB) and the 4.8 kb part 
transgene is present at the 3' end of the insert. The three fragments which do not 
hybridise with the AATB transgene probe (probe (a) figure 4.2) are labelled (c). 
These fragments are assumed to be cosmid. 
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4.2.2 Restriction Analysis Of Clone 10 
Clone 10 was mapped using ten different restriction enzymes : CIa I, Bgl II, 
Not I, Sal I, Eco RV, Sfi I, Nhe I Eco RI, Hind ifi and Sma I. The positions at which 
these enzymes cut the cosmid vector and AATB are shown in figures 4.1 and 4.3 
respectively. The fragments resulting from digestion of clone 10 with each of the 
enzymes listed were separated on an 0.3% agarose gel run in TAE buffer with 0.5 
pg/mi ethidium bromide (shown in figure 4.7). The gel was Southern blotted and the 
filter hybridised sequentially with two AATB probes ; one from the 5' end of the 
AATB transgene (probe (c), figure 4.2) and one from the 3' end of the AATB 
transgene (probe (d), figure 4.2). The use of the two probes enabled more 
information to be extracted from the blots than is possible with the single AATB probe 
used to characterise clone 5 (see section 4.2.1). 
Cia I cuts at position 90 in the cosmid vector (figure 4.1) and has no 
recognition site in AATB. Restriction of clone 10 with this enzyme gave a single large 
fragment that migrated with the 48 kb molecular weight marker (see figure 4.7, Cia I). 
The fragment hybridised with both 3' and 5' AATB probes. (figure 4.8 A, CIa I and 
figure 4.8 B, CIa I). This indicated the presence of a large insert that harboured 
AATB sequences. 
Bgl II similarly lincarised the clone generating a single large fragment (figure 
4.7, Bgl II). This fragment also hybridised with both AATB probes. As with clone 5 
the insert of clone 10 appeared to have no Bgl II restriction site. This enzyme would 
normally have been expected to cut several times in a cloned insert of this size. The 
160 
paucity of Bgl II restriction sites in the insert was entirely consistent with the insert 
harbouring only AATB sequences, as the AATB transgene contained no Bgl II site. 
The Not I restriction digest generated four fragments (figure 4.7, Not I). The 
cosmid vector had two Not I sites; one either side of the cloning site (see figure 4.1). 
Thus this enzyme liberated the insert from the vector. As expected a 6.8 kb band was 
present in the Not I lane of figure 4.7 (fragment labelled (c)). This fragment did not 
hybridise with any of the AATB probes, and it was therefore presumed that this 
fragment was the vector. The Not I digest produced three fragments from the insert. 
Not I restriction sites would not be expected to occur at such a high frequency in 
genomic DNA. Restriction of clone 10 with this enzyme generated a 10.6 kb 
fragment which hybridised with both 5' and 3' AATB probes. 10.6 kb was the size of 
the injected AATB transgene. The generation of this fragment and the presence of so 
many Not I sites in the insert was suggestive of the insert harbouring an AATB array. 
The generation of single 10.6 kb transgenes from the cloned array with Not I 
demonstrated the faithful regeneration of the Not I site between individual AATB 
transgenes present in the array confirming the analysis of Clone 5 (see previous 
section). 
The intensity of the 10.6 kb fragment was greater than that of the 6.8 kb 
cosmid fragment. The differential in the intensity of the two fragments was not 
commensurate with their difference in size. This suggested that more than one entire 
transgene was liberated from the cosmid insert. The other two fragments generated by 
Not I are relatively small and are only faintly visible on the gel (figure 4.7, Not I). 
These fragments are 2.8 kb and 3.2 kb in size. The 3.2 kb fragment hybridises with 
the 3' AATB probe (probe (d), figure 4.2) but does not appear to hybridise with the 5' 
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AATB probe (probe (c), figure 4.2). The 2.8 kb fragment appears not to hybridise 
with either probe. Information from other restriction digests of this clone however 
suggests that this fragment is the 5' end of a truncated AATB transgene (see next 
section on Sal I digest). 
Sal I was chosen for the analysis because it cuts at a unique site in the AATB 
transgene (see figure 4.3). The restriction site was 25 bp from the 5' Not I site of the 
AATB transgene. There was no Sal I site in the cosmid vector. Digestion of clone 10 
with this enzyme generated only two fragments; an AATB repeat length fragment and 
a 12.8 kb fragment. The repeat length fragment hybridises with both AATB probes 
which shows it was the AATB transgene. The fragment was as intense as the 10.6 kb 
fragment generated by Not I and more intense than the 12.8 kb fragment in the same 
lane (figure 4.7, Sal I). This suggested that the enzyme liberated more than one 
AATB transgene from the army. The 12.8 kb fragment was the remainder of clone 10 
following the removal of the intact AATB transgenes. The Not I digest generated two 
small fragments of 2.8 kb and 3.2 kb. The size of the larger Sal I fragment was 
consistent with being the cosmid vector (6.8 kb) plus these two fragments. The 12.8 
kb fragment hybridised with both the 5' and 3' AATB probes. The 3.2 kb Not I 
fragment hybridised with the 3' AATB probe so the hybridisation of the larger Sal I 
fragment with the 5' AATB probe suggested that the 2.8 kb Not I fragment was in fact 
the 5' end of an AATB transgene. The results of the Sal I digest in combination with 
those of the Not I digest revealed the entire insert was of AATB origin. Thus like 
clone 5, clone 10 harboured an insert that was an integral part of the AATB transgene 
array. 
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Like Sal I, restriction enzymes Eco RV and Nhe I cut at a unique site in 
AATB and not at all in the packaged cosmid vector. These enzymes also generated 
only two fragments; an AATB repeat length fragment and a larger fragment of greater 
than 20 kb. Both of the fragments hybridised with both AATB probes (figure 4.2 (c) 
and (d)). The importance of these enzymes in the mapping of the clones is that they 
demonstrated, by the generation of an AATB repeat length fragment, that the 
transgenes in the insert were orientated head-to-tail. Enzyme Eco RV appeared to 
exhibit some star activity (see faint bands in Eco RV lane, figure 4.7 and figure 4.8 B) 
but the two fragments generated by Nhe I appeared to contain equal masses of DNA. 
Since the larger fragment was approximately 23 kb (just over twice the size of the 
repeat length fragment) Nhe I must have liberated two AATB transgene fragments 
from the insert. Digestion of clone 10 with Not I showed the part transgenes present 
in the insert to be 3.2 and 2.8 kb. In the light of this Nhe I could only have generated 
two AATB fragments from the insert, if the insert contained three whole copies of 
AATB (see figure 4.9). Three intact transgenes and two truncated transgenes of 2.8 
kb and 3.2 kb gave a total insert size of 37.8 kb. This was within the expected range 
for an insert in the Super-Cos One vector (32 kb - 42 kb). 
Sfi I and Hind ifi cut more than once in the AATB transgene (see figure 4.3) 
giving internal AATB fragments of defined length. Both enzymes also cut once in the 
cosmid vector (Figure 4.1). Sfi I cuts AATB four times. One site is Thp from the 5' 
Not I site, the second at position 3578, the third at position 9872 and the fourth at 
position 10602 only eight base pairs from the Not I site at the 3' end of the transgene 
(see figure 4.3). The enzyme thus generates AATB internal fragments of 6.2 kb and 
3.6 kb and 800 bp. Four fragments were visible in the Sfi I lane of figure 4.6. Two of 
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the fragments were more intense than the other two (see fragments labelled (i) in Sfl 
I, figure 4.6). These intense fragments were the correct size to be the internal AATB 
fragments. This data is consistent with there being more than one AATB transgene 
within the clone 10 insert. The 800 bp fragment is not seen because fragments of less 
than 1.8 kb were run off the bottom of the gel. The other two fragments are 5.1 kb 
and 6.9 kb. The former fragment hybridised with the 5' AATB probe (probe (c) 
figure 4.2) whereas the latter hybridised with the 3' AATB probe (probe (d) figure 
4.2). The size and hybridisation pattern of these fragments in conjunction with the 
data from the Not I digest allowed the orientation of the vector and insert to be 
established (see figure 4.8) 
Hind ifi cuts twice within AATB (see figure 4.3). This enzyme generates one 
internal AATB fragment of 2.8 kb from a single AATB transgene, and generates an 
additional 7.8 kb internal AATB fragment from a head to tail AATB array. Fragments 
of 2.8 kb and 7.8 kb were generated by digestion of clone 10 with Hind ifi (see 
fragments labelled (i), Hind 111, figure 4.7). The 7.8 kb fragment was more intense 
than other fragments in the lane; suggesting that the insert of clone 10 contained a 
head-to-tail array of several AATB transgenes. The 2.8 kb fragment was the smallest 
of the fragments liberated from clone 10 by Hind ifi. If the stoichiometry of the 
fragments in this lane had been one to one, this fragment should have been the least 
intense; however, this fragment was more intense than either the 5.2 kb fragment or 
the 4.5 kb fragment consistent with the fragment being an internal AATB fragment 
from a multicopy AATB array. 
The 5.2 kb Hind ifi fragment hybridised with the 5' AATB probe. It was not 
confirmed that this fragment contained cosmid sequences but the size was consistent 
164 
with this being the 3' most truncated transgene (detected by Not I digestion) and 2.3 
kb of cosmid vector incorporating the T7 priming site (see figure 4.9). The 4.5 kb 
fragment was assumed to be the remaining cosmid sequences (including the T3 
priming site) from the Hind ifi site in the cosmid vector to the first Hind ifi site at the 
5' end of the insert (see figure 4.9). This fragment does not hybridise with any of the 
AATB probes (figure 4.7 A and figure 4.7 B). This is consistent with the fragment 
comprising mainly cosmid sequences and only 0.4 kb of AATB sequences outwith 
those used as AATB probes used in this analysis (see figure 4.9, Hind Ell). 
Sufficient information was obtained from the gel in figure 4.6 and the 
Southern blots shown in figure 4.7 to establish that the insert of clone 10 like that of 
clone 5 was an integral part of the transgene array of AATB 46.2. The insert of clone 
10 was shown to contain no Bgl II site. This would be expected of clones containing 
part of the transgene array, since AATB does not contain a Bgl II site. Not I digest of 
the clone demonstrated that the insert contained more than one intact transgenes and 
that the Not I site had been regenerated at all four transgene/transgene junctions 
contained within this insert (see also analysis of clone 5,section 4.2.1). The Not I 
restriction digest also demonstrated that two part transgenes were present in the array. 
The results of the Sal I, Eco RV, Nhe I, Hind ifi and Sma I digests demonstrate that 
the transgene copies are arranged in a head-to-tail fashion; a result consistent with the 
genomic mapping studies of AATB 46.2 detailed in Chapter 3. The Nhe I digest in 
particular demonstrated that the insert of clone 10 must contain three whole copies of 
the transgene in addition to the two truncated transgenes. The fragments generated 
from digestion with Sfl I and Hind ill (which cut within AATB and the cosmid) 
demonstrated that the truncated transgenes were present at either end of the insert 
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abutting the cosmid vector. The insert obviously contains no murine DNA and was 
not further investigated in this work. 
Figure 4.7: Ethidium StainedAEarose Gel Of Clone 10 Restriction diRests 
Clone 10 was digested with a number of restriction enzymes. The resultant 
fragments were separated by electrophoresis in a 0.3% agarose gel run in TAE 
buffer containing ethidium bromide at 0.5 jig/mi. M= raoul molecular weight 
markers (Appligene). Clone 10 was digested with CIa], Bgl H, Not I, Sal I, Eco R V 
Sfi I, Nhe I, Eco RI Hind III and Sma I. C/a I and Bgl II enzymes each cut at a 
single site within the cosmid vector, digestion with either of these enzymes generates 
one single linear fragment. This indicates that the large insert contains no 
recognition site for these enzymes. Bgl II would be expected to cut several times in 
an insert of this size. The lack of Bgl II sites in the insert is consistent with the insert 
being entirely ofAA TB origin. Not I, Sal I, Eco R V, Nhe I and Sma I all generate a 
10.6 kb fragment. This is the AATB repeat length and the generation of this 
fragment with these enzymes is indicative of an head to tail AA4TB array being 
present within the insert. Not I and Eco RI both liberate the insert from the cosmid 
vector c= the 6.8 kb fragment liberated by these enzymes that is assumed to be the 
cosmid vector. Enzymes Sf1 I and Hind Ill cut more than once within the AATB 
transgene (see figure 4.3), i= the internal AA TB fragments generated by digestion of 
clone 10 with these enzymes. The intensity of the internal fragments is greater than 
all other fragments generated by these enzymes indicating the presence of several 






Figure 4.8: Autoradiojzraph OfSouthern Blot Of Gel In Figure 4.7 
 
The gel in figure 4.7 was Southern blotted on hybond N membrane (Amersham) and 
hybridised with a probe from the 5' end ofAATB (probe (c), figure 4.2). The filter 
was exposed to X-ray film, for two days, at room temperature, with intensifying 
screens. The linearised clones hybridise with this probe as do the AATB repeat 
length fragments. Only two of the Hind III fragments hybridised with this probe: the 
7.8 kb internal fragment ((z) figure 4.7) and the 5.25 kbfragment. Only two of the SJI 
I fragments also hybridised with this probe: the 6.3 kb internal fragment ((i) figure 
4.7) and the 5.1 kb fragment. The filter was then stripped and laid down with X-ray 
film to ensure removal of the signal, before being reprobed 
 
The gel in figure 4.6 was Southern blotted on hybond N membrane (Amersham) and 
hybridised with a probe from the 3' end ofAATB (probe (d), figure 4.2). The filter 
was then exposed to X-ray film, for 1 hour, at -70'C, with intensifying screens. The 
linearised clones also hybridise with this probe as do the AA TB repeat length 
fragments. Only one Hind Ilifragment hybridises with this probe, this was expected 
since the Hind III internal fragment is the probe used. Two Sfl Ifragments hybridise 




Fijiure 4.9: Restñction Map Of Clone 10 
The insert of clone 10 harbours part of the transgene array of A4 TB 46.2. The 
insert has three intact transgenes and two part transgenes of 3.2 kb and 2.8 kb (see 
Not I digest, figure 4.7). The Not I site has been regenerated at all four 
transgene/transgene junctions present in the insert. Digestion of the clone with Eco 
R V, Nhe I and Sal I liberated a 10.6 kb AA TB repeat length fragment demonstrating 
the head to tail orientation of the transgenes in the insert. The 3.2 kb truncated 
transgene is at the 5' end of the insert (with respect to the 5' 3' orientation ofAA TB) 
and is the 3' end of an AATB transgene. The 2.8 kbfragment  is located at the 3' end 
of the insert and is the 5' end of an AATB transgene. Thus at least 5 of the 
transgenes present in the array ofAATB 46.2 are orientated in a head-to-tail manner 
(the copy number ofAATB 46.2 is 7, see Chapter 3). Both Not I and Eco RI generate 
a 6.8 kb fragment that did not hybridise with AA TB probes. This fragment is believed 
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4.2.3 Restriction Analysis Of Clone 9 
The restriction analysis of clone 9 was carried out in a manner similar to that 
described for clone 10 (section 4.2.2). The same ten restriction enzymes were used: 
Clal, Bglll, Not 1, Sal JEcoRV, Sf1, NheI, EcoRl, Hind ffl and Smal. The 
analysis of clone 9 was performed more rigorously than that of clone 10, or clone 5, 
because it harboured DNA that was not of AATB origin. Four probes were used in 
the restriction characterisation of clone 9: The entire transgene (probe (a), figure 4.2), 
a probe from the 5' end of the AATB transgene (probe (c), figure 4.2), a probe from 
the 3' end of AATB (probe (d), figure 4.2), and the entire cosmid (figure 4.1). The 
analysis demonstrated that the insert of clone 9 spanned the chromosomal/transgene 
junction at the 5' end of the AATB 46.2 array. The insert of clone 9 contained 4.6 kb 
of murine DNA. The remaining insert was three AATB transgenes arranged head to 
tail (see figure 4.14). 
Restriction of clone 9 with Cia I generated a single fragment. The fragment 
co-migrates with the 48 kb molecular weight marker and, hybridised with all four 
probes (a,c and d, figure 4.2, and cosmid). That result demonstrated that the clone 
contained a large insert which contained AATB sequences from both ends of the 
AATB transgene. 
Restriction of Clone 9 with Bgl If generated two fragments (figure 4.10, Bgl 
II). Since one Bgl II site was known to be present in the cosmid vector, the second 
Bgl II site, required to generate the two fragments from the circular clone, must have 
been within the insert. AATB contains no Bgl II site therefor the insert contained 
DNA that was not of AATB origin. The larger of the two fragments (figure 4. 10, Bgl 
II) hybridised with all AATB probes used in the analysis (figure 4.11 A and B: and 
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figure 4.13 A) and with the cosmid probe (figure 4.13 B). The 7.3 kb Bgl If 
fragment did not hybridise with any AATB probes including the entire transgene 
(Figures 4.11 A and B, and figure 4.13 A). It did, however, hybridise with the cosmid 
probe (figure 4.13 B). This fragment contains some of the cosmid vector sequences 
and some of the non hybridising DNA from the insert. 
Digestion of clone 9 with Not generated only three fragments (figure 4. 10, Not 
I and figure 4.12). Not I sites were present at either side of the cloning site in the 
Super-Cos -One vector and enabled the separation of the insert from the vector (figure 
4.1). One of the three fragments generated was 6.8 kb in size (the expected size of the 
cosmid vector) and hybridised with the cosmid probe (Figure 4.13 B). The other two 
fragments were generated from the insert. One was the same size as the injected 
AATB transgene (10.6 kb). The other fragment was larger, migrating a little slower 
than the 14.9 kb molecular weight marker. Both fragments hybridised with 5' and 3' 
AATB probes (figure 4.11 A and B) but not with cosmid (figure 4.13 B). The 
generation of the 10.6 kb fragment which was more intense relative to other fragments 
in the lane (figure 4. 10, Not I) suggested the presence of more than one copy of the 
AATB transgene within the insert. As in the clones described earlier in this chapter 
the Not I site is regenerated at all transgene/transgene junctions cloned in the insert. 
The 15 2 kb fragment contains the 5' most AATB transgene of the AATB 
46.2 array and the murine DNA which harbours the Bgl II site. Double digestion of 
clone 9 with Not I and Bgl II reduces the 15.2 kb Not I fragment to 11.7 kb (compare 
Not I digest of clone 9 (N 9) with Not I/Bgl II digest of clone 9 (NB 9), figure 4.12): 
giving a fragment of 3.5 kb which did not hybridise with AATB or cosmid probes (see 
fragment marked with arrow in Not J/Bgl II digest of clone 9 (NB 9) in figure 4.12). 
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The double digest of clone 9 with Not J!Bgl II also liberates two cosmid hybridising 
fragments of 4.2 and 2.6 kb (figure 4.12, NB 9). The generation of these fragments 
was predicted from the known restriction sites of these enzymes in the packaged 
cosmid vector. 
Restriction enzymes Eco RV and Nhe I cut only once in AATB (figure 4.3) 
and not at all in the packaged cosmid vector. Both of these enzymes generate the 
AATB repeat length fragment from clone 9. In each case the repeat length fragment is 
more intense than other bands, of similar size, in the same lane. This result 
demonstrates the transgenes present in the insert are arranged in a head to tail manner. 
The clones described earlier in this chapter (clone 5, section 4.2.1 and clone 10, 
section 4.2.2) contained only AATB sequences within their inserts, and generated only 
two fragments when digested with either Eco RV or Nhe I. In contrast clone 9 
generated three fragments on digestion with either Eco RV or Nhe I (see figure 4.10). 
The smaller fragments produced by each enzyme (see fragments labelled (a) and (b) 
figure 4.10) did not hybridise with the 3' AATB probe but did hybridise with the 5' 
AATB probe. The size of these fragments (7.3 kb for Eco RV and 9 kb for Nhe I) 
was entirely compatible with that of the 5' hybridising junction fragments identified for 
these enzymes in the genomic mapping studies (see Chapter 3). This suggests the non 
hybridising DNA of the clone 9 insert was murine DNA flanking the AATB 46.2 
transgene locus. 
Hind ifi also produced a fragment of a size that correlated with the 5' Hind ifi 
junction fragment: as determined from the AATB 46.2 genomic mapping studies (see 
fragment labelled (c), figure 4.10). The 11.4 kb fragment hybridised with the 5' 
AATB probe but not with the 3' AATB probe (figure 4.11 A and B respectively). 
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Hind ifi also generated the predicted 7.8 kb and 2.8 kb internal fragments from the 
AATB array present in the insert. These fragments were more intense than the other 
fragments. This was consistent with the data from other digests that indicated the 
presence of more than one transgene in the insert. Neither of the remaining two 
fragments, generated by digestion of the clone with Hind ffl, hybridised with the 5' or 
3' AATB probes, and were thus assumed to be cosmid. The size of these fragments 
was consistent with the orientation of the cosmid and vector deduced from the the Sfi I 
digest. 
Digestion of Clone 9 with Sfi I also generated fragments whose size (6.2 kb, 
3.6 kb and 800 bp), probe specificity, and hybridisation intensity was that expected for 
the internal AATB fragments generated by this enzyme. The other two fragments 
generated by Sfi I digestion (3 kb and 9 kb ) did not hybridise with the AATB probes. 
The 9 kb fragment contained both cosmid and murine sequences from the Sfi I site in 
the cosmid vector to beyond the T3 primer site, and the entire 4.6 kb of murine DNA 
present in the insert. AATB has an Sfi I site at both ends of the transgene (figure 4.3). 
The generation of this fragment from this clone indicated that the transgene abutting 
the junction at the 5' end of the AATB 46.2 locus was either intact or very nearly 
intact, since the 5' Sfi I site of AATB includes the last four bases of the Not I site. The 
nature of the transgene end was demonstrated later by sequencing across the transgene 
chromosomal junction of the cloned insert (see Chapter 5). The generation of the 3kb 
fragment indicated that the 3' most Sfi I site of AATB (see figure 4.3) was not present 
in the 3' most transgene of the insert of clone 9. 
Digestion of clone 9 with Sal I generated only two fragments. As with the 
other enzymes which cut once in AATB, Sal I generated an AATB repeat length 
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fragment. The second fragment was greater than 20 kb. Both fragments hybridise 
with the 5' and 3' AATB probes. The intensity of the two Sal I fragments on the 
agarose gel appears to be the same (figure 4.10). This indicates the fragments are 
present in equal mass. Since the larger fragment is twice the size of the repeat length 
fragment, Sal I must liberate two transgenes from the insert. The intensity of the 
larger band on the autoradiographs of the Southern blot, probed with either 5' or 3' 
AATB probes, was approximately half that of the repeat length band (see figure 14.11 
A and B). This agrees with the larger band having the same amount of DNA but only 
half the amount of hybridising sequences as the repeat length band. The intensity of 
the repeat length fragment both on the agarose gel and on the autoradiographs was the 
same as the repeat length fragments generated by Not I, Eco RV, and Nbc I, 
suggesting all of these enzymes liberate two transgene copies from the insert. 
Therefore the insert harboured three transgenes and the murine flanking DNA. The 
total insert size was 36.4 kb which is within the expected range for a Super-Cos -One 
insert (32-42 kb). 
In summary Clone 9 appears to contain the 5' chromosomal/transgene junction 
from the AATB 46.2 locus. Bgl II (which does not cut AATB) cuts within the insert 
and the cosmid generating a 7.3 kb fragment which does not hybridise with AATB 
probes. A double digest of the clone with Bgl II and Not I liberates a 3.5 kb fragment 
that does not hybridise with either AATB or cosniid probes. Thus the insert of the 
clone harbours DNA of non AATB origin. 
The generation of fragments with Eco RV, Nhe I, and Hind Ill which are 
similar in size to the 5' hybridising junction fragments, determined for these enzymes 
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in the genomic mapping studies (Chapter 3), suggests that the non hybridising DNA is 
the murine DNA flanking the AATB 46.2 locus. 
The intensity of the AATB repeat length fragment generated by Sal I is similar 
to that of the larger fragment generated by this enzyme. The differential in size of 
fragments suggests that the repeat length fragment must contain the equivalent of two 
copies of the transgene to be present in equal mass. In conjunction with similar 
information determined from other restriction digests of the clone this shows the 
presence of three transgenes in the insert, in addition to the 4.6 kb of murine DNA. 
Not I restriction of the insert demonstrated that the Not I restriction site has been 
regenerated at both transgene/transgene junctions present in the insert of clone 9. The 
results of the Sfi I and Sal I restriction digests also suggest that the 5' most transgene at 
the chromosomal transgene junction has sustained little or no damage prior to 
integration into the mouse genome. 
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Fifure 4.10.• Ethidium StwnedARarose Gel Of Clone 9 Restriction Di,- k
The  gel is a 0.3 % agarose gel stained with ethidiuni bromide at 0.5 jig/mi. The 
enzymes used for each digestion are given above each lane. M= raoul molecular 
weight marker (Appligene) The size of the markers is given in kb on the left. L= the 
linearised clone. R= the AA TB repeat length fragment generated by enzymes Not I, 
Sal I, Eco R V, Nhe I and Sma I. a= the 5' Eco R Vjunction fragment, b= the 5 'N/ic 
1 junction fragment and c= the 5' Hind III junction fragment. The intensity of the 
repeat length fragment is greater than that of other fragments (Sal I lane excepted: 
see text for details) indicating the presence of more than I AA TB transgene in the 
insert. The generation of fragments a, b and c by Eco RV N/ie I and Hind III 
respectively: that are the expected size of the 5 'junction fragments (as determined in 
the genomic mapping studies), suggested this clone harboured the 5 
chromosomal/transgene junction ofAA TB 46.2. 
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Fiuiure 4.H:  Autoradiojjirraphs of SOW 	Blot of Gd in Fijiure 4.10 
A. 
The agarose gel in figure 4.10 was Southern blotted onto Hybond N nylon membrane 
(Amersham). The filter was then hybridised with a 5 'AATB probe (probe (c), figure 
4.2). The autoradiograph was produced by exposing the filter to X-rayfilm, for two 
hours, at -70° C, with intensifying screens. The 7 kb Bgl II fragment does not 
hybridise with this probe. The linearised clone (Cla I) does as did the repeat length 
fragments generated by Not I, Sal I, Eco RV, N/ic I and Sma I. The suspected 
junction fragments a, b and c all hybridise with this probe: consistent with them 
being the 5' junction fragments of AATB 46.2. The filter was then stripped and 
exposed to X-ray film to ensure removal of the signal, before being reprobed. 
This is an autoradiograph of the filter in figure 4.11 A. The filter was in this 
instance hybridised with the 3' AATB probe (probe (d), figure 4.2). The filter was 
exposed to X-ray film, for 1.5 hours, at room temperature, with intensifying screens. 
The linearised clone (Cia I) also hybridised with this probe. This suggested the 
presence of entire AATB transgenes in the insert. The repeat length fragments 
generated by Not I, Sal I, Eco R V, N/ic I and Sma 1 also hybridised with this probe in 
addition to the 5 'probe (fIgure 4.11A). This demonstrated that the 10.6 kb fragment 
present in many of the lanes was the AATB transgene. The suspected 5' junction 
fragments a, b and c (figure 4.10) did not hybridise with this probe. 
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FiRure 4.12. Ethidium StaznedA2arose Gel of Double DiJ!ests of Clones 8 and 9 
The figure shows a 0.3% agarose gel stained with ethidium bromide 0.5 jig/mi. M 
raoul molecular weight markers, (sizes given in kb on the right). The gel shows 
similar digests of clone 8 (8) and clone 9 (9) run in adjacent lanes. The clones were 
digested with Not I, (N); Bgl H, (B); and Eco R V. (E) and doubly digested with Not 
I/Bgl II, (NB); Not 1/Eco R V (NE); and Bgl Il/Eco R V This gel was Southern 
blotted and hybridised with transgene and cosmid probes. The results of the 
hybridisations are shown in figure 4.13. Fragments which did not hybridise with 
either of the probes are indicated with an arrow. These fragments were believed to 
be murine in origin and be the flanking DNA from the AA TB 46.2 locus. 
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FiRure 4.13: Autoradiojraphs of Southern Blot ofAJ!arose Gel in FiRure 4.12 
FU 
Is the autoradiograph of a Southern blot of the gel shown in figure 4.12: probed with 
the entire AATB transgene (probe (a), figure 4.2). The numbers between the two 
autoradiographs are the size of the raoui molecular weight markers in kb (see figure 
4.12). Clone 8 (8) and clone 9 (9) were similarly digested and run in adjacent lanes. 
N = Not I, B= Bgl II, E= Eco R V NB= Not I/Bgl II double digest, ME= Not 1/Eco R V 
double digest and BE= Bgl Il/Eco R V double digest. The filter was stripped and 
exposed to X-ray film to ensure removal of the signal, before being reprobed 
Wi] 
Is the autoradiograph of a Southern blot of the gel shown in figure 4.12: probed with 
all of the cosmid sequences. The sizes of the raoul molecular weight markers are 
shown on the left (see figure 4.12). Clone 8 (8) and clone 9 (9) were similarly 
digested and run in adjacent lanes. N= Not I, B= Bgl II, E= Eco R V, NB= Not I/Bgl 
Ii double digest, NE= Not 1/Eco R V double digest, BE= Bgl Il/Eco R V double digest. 
Comparison of Clone 8 and Clone 9 showed important differences between the 
clones. Digestion of clone 9 with Not I generated only one single 6.8 kb fragment 
that hybridised with cosmid sequences, whereas, clone 8 generated two fragments 
that hybridised with the cosmid clone. one of 6.8 kb and another of 4.8 kb. Not I 
would be expected to generate only one 6.8 kb fragment that hybridises with cosmid 
as this enzyme liberates the insert from the vector. All of the fragments generated by 
Bgl II hybridise cosmid only the large fragment hybridises with AATB. Not I/Bgl II 
double digest of clone 8 generates Sfragments visible on the gel (figure  4.12). Two 
hybridise with cosmid and another two hybridise with AATB. The remaining 
fragment does not hybridise with either probe indicating that it is murine in origin. 
An additional fragment of approximately 750 bp hybridised with the cosmid probe 
but not with AATB. Not I/Bgl II digestion of Clone 9 generated five fragments. two 
hybridised with AATB and two others hybridised with cosmid. The remaining 
fragment did not hybridise with either probe and was believed to be murine in origin. 
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FiRure 4.14.• Restriction Map of Clone 9 
The clone contains part of the AATB transgene array of AATB 46.2 and 4.6 kb of 
murine flanking DNA. Double digests with Not 1/ Bgl II and Not 1/ Eco R V generated 
fragments that did not hybridise with either AATB of cosmid suggesting that they 
were murine in origin. Fragments generated by Eco R V, Nhe 1 and Hind III are the 
correct size to be the 5' hybridising junction fragments detected in the genomic 
mapping studies (see Chapter 3 and figure 4.22). These fragments hybridise only 
with the 5 'AA TB probe and are represented in the figure by thick lines. The insert 
spans three transgene/transgene junctions and the Not I restriction site is 
regenerated at all three. Digestion of the clone with Eco R V, Nhe I and Sal I 
generated a 10.6kb AATB repeat length fragment, demonstrating that the transgenes 
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4.2.4 Restriction Analysis Of Clone 8 
The restriction analysis of clone 8 was carried out as for clone 9. Ten enzymes 
were used in the restriction mapping: Cia I, Bgl II, Not I, Sal I, Eco RV, Sfi I, Nhe I, 
Eco RI, Hind ifi and Sma I. A total of four probes were used in the analysis: three 
AATB probes (a, c and d, figure 4.2) and the cosmid probe (the entire cosmid 
sequences, figure 4.1). The insert of clone 8 was found to contain sequences that did 
not hybridise with the cosmid or AATB probes. The generation of these fragments 
suggested the presence of murine genomic DNA in the insert. Moreover, Eco RV and 
Nhe I generated fragments that were the expected size of the 3' AATB 46.2 junction 
fragments (identified in the genomic mapping studies) that hybridised only with 3' 
AATB sequences. Thus clone 8 appeared to harbour the 3' AATB 46.2 
chromosomal/transgene junction. 
The initial plasmid preparation of clone 8 gave low yields of DNA relative to 
all other clones from which DNA was prepared (see table 4.1): suggesting there was 
some problem with this clone. This preparation of the clone 8 showed very faint 
bands of 4.8 kb and 2.4 kb in samples of uncut cosmid run on an 0.3% agarose gel 
(data not shown) and in Cia I digested clone 8 (figure 4.15). However later plasmid 
preparations contained large amounts of the small contaminating entity (figure 4.16, all 
lanes). The contaminant would appear to be supercoiled as two bands are visible in 
uncut cosmid samples and upon digestion with Cia I, Sal I, Eco RV and Nhe I (Sal I, 
Eco RV and Nhe I do not cut within the cosmid vector). However upon digestion 
with Bgl II, Not I, Eco RI and Sma I a single 4.8 kb band is generated. All of the 
aforementioned enzymes that apparently linearise this contaminant cut within the 
cosmid vector. 
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Analysis of clone 8 demonstrated the presence of an additional part-cosmid of 
4.8 kb that was an integral part of the clone. The contaminant present in the DNA 
preparation of clone 8 was also 4.8 kb. This was suggestive of recombination 
occurring within the clone. The 'recombining out' of the 4.8 kb fragment from clone 
8 would have been expected to give two products: (a) a recombinant that contains the 
AATB sequences, murine DNA and only a 6.85 kb cosmid vector and; (b) a small part 
cosmid vector of 4.8 kb. A fragment that was likely to be the larger of the two 
products of recombination (clone 8 minus the 4.8 kb cosmid) was visible on agarose 
gels following electrophoresis of CIa I digested DNA (see figure 4.16). The intensity 
of this fragments in the ethidium stained gel was very weak suggesting only very low 
levels of this recombinant were present. 
It would appear that the plasmid preparation contained three separate cosmids, 
two of which had arisen as a result of recombination of the original clone . The 
original clone contains the AATB sequences, murine sequences and the two cosmids 
(one complete 6.8 kb and one truncated 4.8 kb). The low concentration of the large 
recombinant would suggest that recombination occurs at a low frequency. The large 
excess of the smaller recombinant is probably due to its replicative advantage over the 
other two clones since it is approximately one tenth of their size. 
The remainder of this section deals with the restriction mapping of clone 8. All 
mapping studies outlined in this section were performed on the first DNA preparation 
of clone 8 that contained only minimal amounts of the recombined molecules. 
Digestion of clone 8 with Cia I linearises it (figure 4.17, Cia I). The linearised 
clone was large and hybridises with AATB probes (Figure 4.18 A and B). This 
indicated that the clone had a large insert harbouring AATB sequences. 
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Digestion of clone 8 with Bgl II generated three fragments: one large fragment 
of greater than 30 kb and two smaller fragments of 6.3 kb and 4.8 kb. Super-Cos One 
has one Bgl II site (see figure 4.1). The generation of three fragments with this 
enzyme indicated the presence of two further BgI II sites within the clone. The AATB 
transgene has no Bgl II sites so the clone 8 insert contained DNA that was not of 
AATB origin. All three fragments hybridised with the cosmid probe (figure 4.13 b). 
Only the largest of the three fragments hybridised with the AATB probe (figure 4.13 
a). It was at first surprising that all three fragments generated hybridised with the 
cosmid. The intensity of the 6.8 kb and the 4.8 kb fragment was similar suggesting a 
molar ratio of one to one. This indicates that the 4.8 kb fragment was generated from 
digestion of clone 8 rather than being present as a separate entity. 
Not I digestion of clone 8 generated five fragments: the fragments were 15.2 
kb, 10.6 kb, 6.8 kb 6.3 kb and 4.8 kb. Three of the fragments generated hybridised 
with the 3' AATB probe (probe (d), figure 4.2). These were the 15.2 kb, 10.6 kb and 
6.2 kb fragments. Two of these three fragments also hybridised with the 5' AATB 
probe (probe (c), figure 4.2). The fact that the 6.3 kb fragment did not hybridise with 
probe d suggested that the fragment was the 3' end of a truncated AATB transgene 
(see figure 4.20). The 10.6 kb fragment hybridised with both AATB probes and was 
the size of the original injected AATB transgene. Its generation from the clone 8 
insert by Not I suggested that this transgene was part of an array and, that the Not I 
site had been regenerated between it and adjacent transgenes (see also analysis of 
clones 5,10 and 9). The intensity of this fragment relative to the 15.2 kb fragment 
demonstrated that only one single 10.6 kb transgene was liberated from the insert. 
The 15 2 kb fragment contained both 3' and 5' AATB sequences and thus contained 
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most if not all of the AATB transgene. None of the AATB hybridising fragments 
hybridised with the cosmid probe. The results of Not J!BgI IT double digests suggest 
that the 15.2 kb fragment also contained murine DNA (see later this section). 
Not I liberates the insert from the cosmid vector. The predicted size of the 
cosmid vector is 6.8 kb. As expected the 6.8 kb Not I fragment hybridised with the 
cosmid probe. In addition the 4.8 kb fragment also hybridised with the cosmid probe. 
This was most unexpected and suggested that this clone was not as straightforward as 
the others (clones 5, 10 and 9) that generated only the expected single 6.8 kb cosmid 
hybridising band upon Not I digestion. 
A Not J!Bgl II double digest was performed on clone 8 (figure 4.12). Three 
fragments were found to hybridise with the cosmid probe (figure 4.13 b). Two of the 
fragments (4.2 kb and 2.6 kb) were expected too, as these were the predicted cosmid 
fragments, based on the known restriction map of Super-Cos-One. The third 
fragment was not expected. It was only 750 base pairs and, because of its small size, 
had not been visible on the ethidium bromide stained gel. No such small cosmid 
hybridising fragment was detected on single Bgl II or Not I digests. Close examination 
of the small fragments generated by Not I and Bgl II on 1% agarose gels found no 
small fragments were generated by Not I digestion, but three small fragments were 
generated upon digestion of clone 8 with Bgl II (see figure 4.19 A). These fragments 
did not hybridise with either AATB or cosmid probes indicating they were probably 
murine in origin. These fragments were later sequenced (see chapter 5). A fourth 
small fragment was generated on double digests (see figure 4.19 B) that hybridised 
with the cosmid probe only. This fragment was cloned and the ends were sequenced. 
It spanned the T3 site from one cosmid vector leading into the sequences of another 
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cosmid at position 3130. Thus the truncated vector was adjacent to the intact vector 
in clone 8 and contained all the sequences from 180 bp 5' of the Sfl I site (see figure 
4.1) to the cloning site beyond the T7 promoter sequence. This is 4.8 kb: the size of 
the extra cosmid hybridising fragment in the Not I digests and, moreover, the size of 
the contaminating recombinant fragment. The truncated cosmid had lost the T7 
promoter site the lambda cos site and the SV40 promoter but retained the cosmid 
origin of replication and the ampicillin resistance gene. Thus clone 8 contained two 
bacterial origins of replication. 
In addition to the three small Bgl II fragments (see figure 4.19 A) Not JIBgL II 
double digestion of Clone 8 generated another fragment which did not hybridise with 
any of the probes used in the analysis. This fragment was 3.6 kb in size and was 
generated by Bgl II digestion of the 15.3 kb Not I fragment (see figure 4.12). The 
small Bgl II fragments total approximately 1 kb of DNA. The total amount of mouse 
genomic DNA in clone 8 is at least 4.6 kb. 
Eco RV was used to map the AATB 46.2 genomic locus (see Chapter 3). This 
enzyme generated two junction fragments from AATB 46.2: one 5' hybridising 
fragment of 7.3 kb (isolated in clone 9, see previous section), and one 3' hybridising 
fragment of 5.6 kb. Eco RV digestion of clone 8 generated a fragment, that 
hybridised with the 3' AATB probe but not the 5' probe, that was 5.6 kb (see band 
labelled (a), figure 4.18 B). The presence of murine DNA in clone 8 was shown by 
Not JfBgl II digests of clone 8. The generation of the 5.6 kb fragment upon digestion 
with Eco RV was good evidence that the murine DNA was the flanking murine DNA 
of the AATB 46.2 locus. 
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Further corroborative evidence that clone 8 spanned the 3' 
chromosomal/transgene junction was obtained from the Nhe I digest. This enzyme 
generated a 6.3 kb junction fragment from the AATB 46.2 genomic locus (see chapter 
3). Digestion of clone 8 with Nhe I also generated a 6.3 kb fragment that hybridised 
only with the 3' AATB probe (see fragment labelled (b), figure 4.18 B). Nhe I also 
generated a 2 kb fragment that did not hybridise with either AATB or cosmid probes. 
The murine DNA in clone 8 appears to be the AATB 46.2, 3' chromosomalltransgene 
junction. The murine DNA incorporated in clone 8 contained two Nhe I sites. 
Both Eco RV and Nhe I generate an AATB repeat length fragment. The 
intensity of the fragment generated by these two enzymes is greater than the intensity 
of the 10.6 kb fragment generated by Not land Sail (see figure 4.17). More than one 
AATB repeat length was liberated from clone 8 by Nhe I and Eco RV. The 6.2 kb 
truncated transgene shown to be present by Not I digest contains both the Eco RV and 
Nhe I restriction sites in AATB (see figure 4.3). From the Not I data two other 
transgenes were shown to be present. The generation of two 10.6 kb fragments from 
the insert of clone 8 demonstrates that the three transgenes are arranged head to tail. 
Both Nhe I and Eco RV also generate another fragment in addition to the 
aforementioned fragments. In each case this was larger than the other two fragments 
and comprised the remainder of the clone following the removal of the two AATB 
repeat length fragments and the junction fragments. These fragments are 17.6 kb for 
Eco RV and 14.8 kb for Nhe I (figure 4.15, and 4.17). Fragments of this size could 
only have been generated, from clone 8, by these enzymes, if the 4.8 kb Not I 
fragment was an integral part of the clone. Neither of these large fragments hybridised 
with the 5' and 3'AATB probes (probes (c) and (d) respectively, figure 4.2). 
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However the 17.6 kb Eco RV fragment was shown to hybridise with the entire 
AATB transgene (figure 4.13 a) and the cosmid probe (figure 4.13 b). The 17.6 kb 
Eco RV fragment therefor did contain AATB transgene sequences, but not the 5' 
most or 3' most sequences. 
In summary clone 8 appears to span the 3' chromosomal/transgene junction 
from the AATB 46.2 locus. It contains at least 4.6 kb of murine genomic DNA. Not 
I digest of clone 8 generates a 15.3 kb fragment that contains the 3' most transgene of 
the array and the murine DNA. Another intact transgene was present that was 
liberated by Not I digestion. This indicated that the Not I site was regenerated between 
the transgenes (figure 4.20). The generation of two AATB repeat length fragments 
from the insert by Eco RV and Nhe I (both of which cut only once within AATB) 
showed that the transgenes present in the array were all orientated head to tail (figure 
4.20). 
Clone 8 also contained an extra part cosmid which had not been anticipated. 
Yields of DNA from clone 8 were always inferior to preparation of other clones 
suggesting that the presence of either the murine DNA or more likely the additional 
cosmid sequences were causing some problem. The extra cosmid sequences 
'recombined out' of the clone readily resulting in a small plasmid being the most 
abundant species in DNA preparations from the clone (see figure 4.1 B). The 
recombination of the clone is not entirely surprising since the presence of the 
additional cosmid sequences constitute a direct repeat. Homologous recombination 
between these direct repeats would be expected to result in the excision of the 
intervening DNA (Lewin, Genes ifi, (1987), p598). 
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FiRure 4. IS: Restriction Di2esls of Clone 8 (First DNA Preparation) 
The figure shows a 0.3% agarose gel stained with ethidium bromide following the 
electrophoresis of various restriction digests of clone 8 (first preparation of cosmid 
DNA from this clone). M= raoul molecular weight markers, the size of the markers, 
in kb, are given on the right. The clone is linearised with Cia I, the linearised clone 
is indicated with an arrow. Many of the digests give rise to a 10.6 Ith fragment, 
which is the AA TB repeat length: these fragments are also indicated with an arrow. 
The small white arrows indicate the small contaminating fragments seen in this first 
preparation of DNA from this clone. The concentration of DNA in these fragments is 
considerably less than any other fragment on the gel even the 2 5 kb Eco RI fragment 
and the 2 kb Mw I fragment. These fragments are barely visible in samples of uncut 
clone 8 on agarose gels. This in combination with their low concentration suggests 




FiRure 4.16: Restriction Digests of Clone 8 (Second DNA preparation) 
The figure shows a 0.3% agarose gel stained with ethidium bromide following the 
electrophoresis of various restriction digests of clone 8 (second preparation of 
cosmid DNA from  this clone). M= raoul molecular weight markers, the size of the 
markers, in kb, are given on the right. The clone is linearised with Cia I, the 
linearised clone is indicated with an arrow. Many of the digests give rise to a 10.6 
kb fragment, which is the AA TB repeat length: these fragments are also indicated 
with an arrow. The small white arrows indicate the small contaminating fragments 
seen in this second preparation of DNA from this clone. The concentration of DNA 
in these fragments is considerably more than any other fragment on the gel. These 
fragments are the same size as the faint contaminating bands seen in the first 
preparation of DNA from this clone (see figure 4.15). Enzymes Cia I, Sal I, Eco R V 
and Nhe I appear not to cut within the contaminating cosmid, as two bands are 
visible in these lanes (s = supercoiled, o= open circle). Enzymes Not I, Bgl II, Eco RI 




Fijiure 4.17: Ethidium StainedARarose Gel of Clone 8 Restriction Dijiests 
The gel is a 0.3% agarose gel stained with ethidium bromide at 0.5 pg/mi. The 
enzymes used for each digest are given above each lane. M= raoul molecular weight 
marker (Appligene). The size of the markers is given in kb on the left. L= the 
linearised clone. R = the AA TB repeat length fragment generated by enzymes Not 1, 
Sal I, Eco R V Nhe I and Sma I. a= the 3' Eco R Vjunction fragment and b= the 3' 
Nhe I junction fragment. These fragments are the same size as the 3' hybridising 
Eco R V and Nhe I junction fragments determined in the genomic mapping studies. 
This suggests that the insert of clone 8 spans the 3 'transgene/chromosomal junction 








Fieure 4.18: Autoradio -raphs of Southern Not of Gel in FiRure 4.17 
 
The agarose gel in figure 4.17 was Southern blotted onto hybond N nylon membrane 
(Amersham). The filter was hybridised with a 5' AA TB probe (probe (c), figure 4.2). 
The autoradiograph was produced by exposing the filter to X-ray film, for 16 hours, 
at room temperature with intensit'ing screens. The filter was stripped and exposed 
to X-ray jilm to ensure removal of the signal, before being reprobed. 
 
This is an autoradiograph of the filter in figure 4.18A. The filter in this instance 
was /wbridised with the 3' AATB probe (probe (d), figure 4.2). The filter was 
exposed to X-ray film for 48 hours, at room temperature with intensifying screens. 
Digestion of clone 8 with enzymes Eco R V and Nhe I generated fragments which 
were of the size expected of the 3' hybridising junction fragments (determined in the 
genomic mapping studies,). Both of these fragments hybridised with the 3' probe but 
not with the 5' probe. This data further supports the contention that this clone 
harbours the 3 chromosomal/transgene junction ofAATB 46.2. Ecu RI generates a 2 
kb fragment and Nhe I generates a 1.6 kb fragment (see figure 4 15) that did not 
hybridise with either AA TB probe used in this analysis. This suggested the clone 
contained murine DNA. 
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FkUTe 4.19: Analysis of the Small BRIHfraJ!ments 
The figure shows a 1% agarose gel stained with ethidium bromide at 0.5 pg/mi. 
The sample is clone 8 digested with Bgl II. The gel demonstrates that the non AATB 
DNA present in the clone contains a cluster of Bgl II sites. digestion of the clone with 
this enzyme generates three small fragments (a, b and c) that do not hybridise with 
either AA TB or cosmic! probes (see figures 4.13 A and B) 
The figure shows a 1% agarose gel stained with ethidium bromide at 0.5 pg/mi. 
The sample is clone 8 digested with both Not I and Bgl II. Double digestion 
generates the same three fragments (a, b and c) visualised on Bgl II digestion and 
one additional small fragment (d). This fragment hybridises with cosmic! probe (see 
figure 4.13 B, NB digest of clone 8). This fragment was sub-cloned and sequenced 
and shown to be part of the SuperCos I vector (see figure 4.20, insert). Sequencing 
of the fragment demonstrated that a second truncated cosmid vector is also present 
in clone 8 and abuts the intact cosmid vector. 
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FiRure 4.20. Restriction Map of Clone 8 
The figure shows the restriction map of clone 8 determined from the data presented 
in this section. The clone harbours one truncated copy of AA TB that is 6.3 kb in size 
and is located at the5' end of the insert abutting the vector, an intact copy of AA TB 
that is liberated from the insert by Not I, and the transgene/chromosome junction at 
the 3' end. The junction fragment  liberated by Not I is 15.2 kb in size and hybridises 
with both 5 'and 3 'AATB probes (probes (c) and (d), figure 4.2) which indicated that 
the fragment contained most of the AATB sequences. Hind III digestion of the clone 
indicates that the Hind III site 120 bp from the 3' end of AI4TB is present at the 
junction demonstrating the transgene at the junction is almost complete. The 
junction fragments generated by Eco RV, Nhe I digests and Eco RI digests are 
indicated using thick lines. Clone 8 also contains a duplication of 4.8 kb of the 
cosmid sequences. The intact 6.8 kb cosmid and the 4.8 kb cosmid abut each other 
and the Not I/Bgl II fragment that was sequenced is shown in the insert. 
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4.3 Comparison Of Clones With Genomic DNA 
The transgene array/chromosomal junctions for both the 5' and 3' ends of the 
AATB 46.2 locus were successfully isolated from the library screen. The amount of 
mouse chromosomal DNA was approximately 4.7 kb in clone 8 and 4 6 kb in clone 9. 
The larger Not I fragments from both clones 8 and 9 spanned the 
chromosomal/transgene junction. These fragments hybridised to both 5' and 3' 
AATB probes. This indicated the transgenes at both the 5' and 3' ends of the array 
contained much of the 3 'most and 5 'most AATB sequences. 
To demonstrate that the junctions were indeed cloned without rearrangement. 
Genomic DNA of AATB 46.2 and the clone inserts have been compared by Southern 
blotting. Control mouse DNA laced with single copy equivalents of Clone 8 or Clone 
9 was digested with restriction enzymes Eco RI and Eco RV and subject to 
electrophoresis adjacent to similarly digested AATB 46.2 genomic DNA. The size of 
the 5' and 3' hybridising fragments of the clones and genomic DNA are thus 
compared directly. Autoradiographs of the Southern blot (figure 4.21) probed with 5' 
and 3' AATB probes confirms the clones do indeed span the junction fragments of 
both ends of the AATB 46.2 locus. No major rearrangements of the locus have 
occurred during the cloning procedure. 
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Fifure 4.21 Direct Comparison of Clones 8 and 9 WIth Genomic DNA of AA TB 
46.2 
The figure shows an autoradiograph of genomic DNA run along side control DNA 
laced with one copy equivalents of the cosmid clones 8 and 9. Two enzymes were 
usedfor this analysis Eco R V and Eco RI. 
A 
Is probed with a probe from  the Pend ofAATB (probe c, figure 4.2). All three lanes 
show the expected intense signal of the internal AA TB fragments from the array (10.6 
kb for Eco R V and 10.1 kb for Eco Ri). Clone 8 shows no junction fragment signal 
on hybridisation with this probe. The signal from the junction fragments is indicated 
by if The signal from Clone 9 and genomic DNA are identical demonstrating that 
clone 9 harbours the 5' transgene/chromosomal junction ofAA TB 46.2. This result 
shows that no rearrangement of the locus has occurred during cloning of the locus. 
Uhl 
Is the same blot as in figure A probed with 3' AA TB sequences (probe (d), figure 
4.2). All three lanes show the expected signal of the internal fragments of the A4 TB 
array. Clone 9 shows no other signal with this probe but clone 8 and the genomic 
DNA give identical signals from the junction fragments dfi demonstrating that clone 
8 harbours the 3' end of the AA TB 46.2 locus (the junction fragments appear to be of 
slightly different size this is because the DNA in lane 3 appears to have run 
anomolously and it is my belief these fragments are indeed the same size). The result 













Figure 4.22: Comparison of Genomic Map With Maps of Clones 5,8,9 and 10 
The figure shows the restriction map of the genomic locus compared with that qf the 
clones isolated from the cosmid library. The genomic map was obtained from the 
mapping studies detailed in Chapter 3. The genomic mapping studies indicate that 
AATB 46.2 harbours seven copies of AATB and thus contains six 
transgene/transgene junctions. The mapping of the clones is detailed in Chapter 4. 
Alignment of the clones with the genomic map indicate that clones 9,10 and 8 
together span the AATB locus except for a sew hundred base pairs. Since it is not 
possible to align clones 5 and 10 exactly it is not certain that the entire locus is 
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Discussion 
This chapter describes the successful isolation of cosmid clones harbouring the 
murine DNA flanking the AATB 46.2 transgene locus. Only one clone including the 
5' flanking DNA, and one containing the 3' flanking DNA were obtained. Both of the 
clones contain approximately 4.6 kb of murine DNA plus two intact copies and one 
part copy of the AATB transgene. 
Other clones were isolated which contained only DNA of AATB origin. These 
clones were internal to the array each contained at least three transgene/transgene 
junctions. It is likely that together the clones span the entire transgene locus of AATB 
46.2. Each clone harbouring the junction fragments of the locus spanned at least two 
transgene /transgene junctions. In every case the Not I site was present between the 
transgenes. The genomic mapping studies detailed in chapter 3 show clearly that the 
transgenes in the array are arranged in a head to tail manner. This has been confirmed 
by the cloning of the locus, detailed in this chapter. It has been widely demonstrated 
that transgenes present in an array are generally oriented head to tail. The paucity of 
head to head and tail to tail orientation of transgenes within transgene loci has lead to 
the proposal that transgene arrays do not form by simple end on ligation of the linear 
injected fragments, but rather by mechanisms involving homologous recombination. 
The loci of both AATB 35 and AATB 46.2 are no exception to the rule. All 
transgenes within the array of each line are oriented head to tail. Thus it seems 
unlikely that the Not I site is regenerated between the transgenes by simple end on 
ligation despite the fact that end on ligation would be expected to be very efficient in 
this instance because the enzyme generates a 5', GC rich., 4 base pair overhang. 
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Nevertheless the Not I restriction site is present at all transgene/transgene 
junctions within the array. This is suggestive of efficient ligation occurring between 
the Not I "sticky ends". Circularisation of linear input DNA has been shown to be 
efficient and accurate upon cytoplasmic injection into mammalian culture cells 
(Kopchick and Stacey, 1985). The Not I site could be re-established in the injected 
AATB transgene by circularisation of the injected fragment if this occurred before 
nibbling occurs at the transgene ends. Some studies have reported the regeneration of 
a restriction site between transgenes within an array (Pahuiter et al., 1982, Ninomiya et 
al., 1988, ) but this has never been demonstrated in a cloned transgene locus. A study 
performed by Hamada et al., (1993) investigated the nature of four transgene/ 
transgene junctions "nibbling" of the transgenes had occurred in all instances. The 
transgene in the Hamada study was blunt ended prior to injection. Ligation of blunt 
DNA fragments is believed to be less efficient than that of fragments with cohesive 
tennini and, thus blunt ended transgenes may be more susceptible to end damage than 
those having complementary ends. 
Kopchick and Stacey (1985) found that the nature of the ends of the linear 
fragments had a large beating on the fidelity of circularisation of cytoplasmically 
injected fragments . The difference between the Hamada study and this study 
demonstrate this is probably also true of pronuclear injection. It has been proposed 
that the head to tail transgene arrays are built up by homologous recombination 
between circular molecules or circular and linear molecules or circularly permuted 
molecules. The presence of an intact Not I site between each of the transgenes in the 
AATB 46.2 locus would suggest that all of the transgenes of the array have undergone 
efficient high fidelity circularisation prior to their inclusion in the array. 
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CHAPTER 5: THE CONSTRUCTION OF THE SECONDARY 
TRANSGENE 
5.1 Introduction 
The previous chapters outline the restriction mapping and cloning of the 
AATB 46.2 locus. The aim of this work was to investigate the role of the murine 
sequences flanking the transgene array, of this locus, in driving high level MAT 
expression in this line. Unfortunately the transgene array of the AATB 46.2 locus 
contained several more copies of the transgene than had been anticipated at the outset 
of this work (see chapter 3). It was therefore, not possible to clone the entire high 
expressing locus for generation of secondary transgenic mice. 
It was therefore proposed to construct a secondary transgene which harboured 
a single intact copy of AATB flanked by the cloned 5' and 3' flanking chromosomal 
DNA of AATB 46.2. Two cosmid clones (clone 8 and clone 9), each containing 
almost 5kb of the flanking murme DNA were obtained from the library screen (see 
Chapter 4). These clones were used to generate a secondary transgene comprising one 
copy of AATB flanked by these sequences (see figure 3.10). The construction of this 
transgene is detailed in this Chapter. 
5.2: The Pre-integration site of AA TB 46.2 has not been Characterised 
An attempt was made to establish the nature of the pre-integration site of the 
AATB 46.2 locus. It was hoped that Southern blotting would establish if the flanking 
5' and 3' flanking DNA of AATB 46.2 was contiguous or whether rearrangement of 
the genomic locus had occurred. 
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Similarly digested AATB 46.2 liver DNA and non transgenic control DNA 
were subject to agarose gel electrophoresis, Southern blotting and probing with 3' 
murine DNA from the AATB 46.2 locus. The result was a smear in all lanes (figure 
5.6). This type of result is diagnostic of the presence of repetitive sequences in the 
probe. Because of this, no information regarding the pre-integration site was obtained 
from this Southern. The experiment was not repeated with probes obtained from the 
5 'murine DNA, and it is not currently known if the locus is a result of straightforward 
insertion of a transgene array into the genome or if the chromosomal site of insertion 
has been rearranged. No integrated transgene locus that has been subject to detailed 
analysis has been demonstrated to be a straightforward insertion of a transgene array 
into the genome. Integration has always been associated with either simple deletions 
(Hainada et al., 1993) or other rearrangements (Palniitter et al., 1987). Since this locus 
appears to more straightforward than many analysed to date, mapping of the pre-
integration site of this locus may provide further information about the nature of 
transgene integration. 
53: Only Seven Bases are Missing At The 5' Chromosomal/Transgene 
Junction 
Restriction mapping of clone 8 and clone 9 indicated that the transgenes at 
both the 5' and 3' end of the transgene concatamer of line AATB 46.2 were almost 
complete. Sequencing was performed to determine more precisely the nature of the 
chromosomal/transgene junction of clone 9. A 7.8 kb Eco RV junction fragment, 
from the clone, was sub-cloned into bluescript phagemid (Stratagene). Using a primer 
to the 5'end of the AATB transgene (kindly provided by Anthony Thomlinson, PPL 
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Therapeutics Ltd.) the chromosomal/transgene junction was sequenced (see figure 
5.1). Sequencing demonstrated that the transgene abutting the chromosomal DNA 
was missing only seven base pairs (including the four base single stranded end 
generated by Not I digestion of P-Polly HI-I-AATB) (see figure 5.1). This small 
deletion was the only perceptible damage to the most 5' copy of AATB in the array. 
5.3.1: The Immediate 5' Flanking DNA is AT Rich 
The transgene concatamer had integrated next to a thirty base pair 
microsateite, comprising ten TAA trinucleotide repeats (see figure 5.2 A). A further 
145 bp of the munne DNA immediately 5' to the transgene array was sequenced and 
the entire region was found to be AT rich (80 % AT: see figure 5.2 B). Mammalian 
genomes are typically 40-60% AT (Lewin 1987) rich and an AT content of 80 % is 
unusually high. 
AT rich regions of chromosomes have been shown to bind the Nuclear Matrix. 
Though this region is AT rich it does not however contain motifs that have been 
identified in matrix attachment regions. Two regions have been highlighted in the 
immediate 5' flanking DNA (figure 5.2 A). Region (a) ATATAT is the same as a 
previously identifies nucleation site for base un-pairing that was identified to be 
important in the binding of a MAR binding proteins SAT Bi (Dickenson et al., 1992) 
and nucloelin (Dickenson et al., 1995). There are of course thousands of ATATAT 
motifs in the genome which but the presence of this nucleation site in such an AT rich 
environment may be significant. The other region is the microsatelite (AAT)10 this 
region may also have high base un-pairing potential. This is a property of some but 
not all AT rich sequences and has been proposed to be important in the regulation of 
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superheical strain of transcribed loci and therefor important in the regulation of gene 
transcription per se (Bode et al., 1992). 
A further 342 bp of murine DNA from clone 9 was also sequenced (figure 5.2 
B). This region was situated approximately 1 kb upstream of the 5' AATB transgene. 
Unlike the immediate 5' flanking DNA the sequence of this upstream region was not 
more than averagely AT rich. It does however contain an AT dinucleotide repeat of 
twenty base pairs long which is very likely to have high base un-pairing potential. 
Other than this no significant motifs were found in these sequences. A search of the 
EMBL database with the sequence of both of these regions, using the FASTA 
program, detected no significant homologies with other sequences in the database. 
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Figure 5.1: Sequencing Of The Transgene/Chromosomal Junction Of Clone 9 
The 7.8 kb Eco RVjunction fragment of clone 9 was sub-cloned into bluescript 
phagemid (Stratagene) and the junction (region A) was sequenced using a primer of 
the 5' AATB sequences (BLG amp 10: kindly donated by A. Thomlinson, PPL 
Therapeutics Ltd.). The 5' most transgene of the AATB 46.2 array is almost intact. 
Only seven bases are missing from the transgene end as it would have been on 
injection. These seven base pairs include the four base pair single stranded end of 
the transgene generated by Mot I digestion. The murine sequences immediately 5' of 
the transgene end are that of an AAT microsatelite that is 30 bp long. The regions 
underlined with heavy black lines are those sequenced. The sequence of these 
regions is given in figures 5.2 A and B 
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5' most AATB transgene of AATB 46.2 array (from clone 9) DNA of cl 
AAAT TAT TAT TAT TAT TAT TAT TATT AT TAT TACCGGAGCT CCCGGCCTAGACGACC 
GGCCGCCGGCCT CGAGGGCCGGATCTGCTGG 
CGGCCGGAGCTCCCGGCCTAGACGACC 
5' End of injected AATB transgene 
Figure 5.2 A: AT Rich Sequences Of The Immediate 5' Flanking DNA 
A total of 145 bp of murine flanking DATA were sequenced using the BLG amp 10 
primer. These sequences proved to be very AT rich. Highlighted in blue are regions 
(a) = an ATATAT element proposed to be a base un-pairing nucleation site 
(Dickenson et al., 1992) and (b) = 30 bp microsatelite composed of an AAT 
trinucleotide repeat. Dots are placed above A and T residues present in the 







aaatgaattaaaccaatatgtagaattat taaacatc 	gaacct 
Si---------+---------+---------+---------+---------+ 
tttacttaatttggttatacatcttacataatttqta 	cttgga 
ggtaattaaaactt 	 3 
101 +---------+---------+---------+-----_____ Ip 
coat taattttaaa 	 S 
AATB 
sequences 
Total Number Of Bases = 145 bp 
Total Number of A & T = 116 bp 
Percentage of A & I = 80 
Total Number of Bases = 115 
Total Number of A & T = 86 
Percentage of A & T = 75 
Figure 5.2 B: Sequence of 5' End of Eco RV Junction Fragment 
The Eco R Vjunction Fragment of clone 9 was sub-cloned into bluescript phagemid 
and the 5' end sequenced using theT3 and SK priming sites of bluescript. The 
sequence of this region (region (b), figure 5.1) is shown in the figure. The region 
highlighted in blue is a dinucleotide repeat (AT)10 such sequences are thought to 
have high base un-pairing potential and may have a role in gene transcription. 
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gaggcacaccggctaatgctgcagagtaagtct t tcttaagt ttagtat t 
51 
ctccgtgtgqccgattacgacgtctcattcaqaaagaat tcaaatcataa 
ttctcatggtct tctgtgtaatgtgctgtaccctgtgtccatt ttgtcc 
101 ---------+---------+---------+---------+---------+ 
aagag tacccagaagacaca t t acacgaca tgggacacagg taaaacagg 





cgaagcaaaggagtaggtaaaccctactataat tat tacggtcagagtat 
aacgatatggaat taacagtaaatgaataacaatatgtagaatgtat taa 
251 ---------+---------+---------+---------+---------+ 








5.4 Fifty Base Pairs of AA TB have been Deleted At the 3'junction of 
AATB 46.2 
Previous mapping studies on clone 8 had determined that the 3' most Hind ifi 
site of AATB was present in the transgene at the 3' end of the array. However they 
also demonstrated that the 3' most Barn HI site of AATB was missing from the last 
transgene in the array (see Chapter 3, Section 3.5). Clone 8, which harboured the 3' 
AATB 46.2 chromosomal/transgene junction was unstable however it was possible to 
sub-clone the 3' junction from the TAB clone. 
A Hind Ill/Not I fragment that spanned the junction was sub-cloned into 
bluescript phagemid (Stratagene). In order to find out more about the 3' munne 
sequences a major part of the subclone was sequenced using the Erase-a-Base system 
(Promega). This system allows nested deletions of the plasmid insert to be made so 
the insert can then be sequenced from one primer. This clone was sequenced using 
the M13-20 priming site of bluescript. In total 2.6 kb of the 3' flanking DNA was 
sequenced. Only one strand was sequenced. The sequencing demonstrated that only 
50 bp had been deleted from the 3' most transgene of the array (figure 5.3). 
In order to generate a functional secondary transgene, that could be 
compared with AATB, using the approach outlined in the following sections of this 
chapter, it was essential the 5 'most and 3 'most transgenes of AATB 46.2 were nearly 
complete. The TAB secondary transgene harbours a single AATB transgene that has 
seven bases missing at the 5' end and 50 bp missing at the 3' end. The lack of the 
terminal 50 bp of AATB in the secondary transgene was not considered to be 
important: as the missing 50 bp were in the 3' untranscribed region of hAAT 
approximately 2kb downstream of the polyadenylation signal of the MAT minigene. 
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5.4.1: The 3' Flanking Murine DNA of AATB 46.2 Contains Murine Repetitive 
Elements 
The regions sequenced are shown in figure 5.4. The sequences are given in 
figures 5.5 A, B and C. A search of the EMJ3L data base with these sequences 
detected three regions that displayed extensive homology with either B 1 or B2 murine 
repetitive elements (see figures 5.5 A and B). The presence of these sequences in the 
3' murine DNA was consistent with the findings of the pre-integration Southern 
(figure 5.6). Other than this no homologies with sequences in the database were 
found. 
The murine B  repetitive element is anAlu type element originally identified by 
its homology with the human Ala consensus sequence. The human Ala element is 
approximately 300 bp and there are an estimated 500 000 such elements dispersed 
throughout the haploid human genome, which have been calculated to be spaced about 
5 000 bp to 8 000 bp apart (for a review see Jelinek and Schmid, 1982). The human 
Ala repetitive elements are a family of elements which are non identical however they 
are sufficiently similar for a consensus sequence to have been derived. The nucleotide 
sequence of individual cloned Ala family members differ by an average of only 10% 
from the consensus sequence, and most of these differences appear to be randomly 
distributed throughout the 300 nucleotide sequence. It has been demonstrated that Alu 
family members are transcribed in vitro by RNA polymerase III yielding discrete low 
molecular weight RNA molecules, yet despite their high copy number seldom give rise 
to high levels of polymerase ifi transcribed RNAs in vivo. 
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Unlike the human Alu element the rodent B  repeat sequence is only 130 bp 
long but shows significant sequence similarity with the monomer unit of the human 
Alu element suggesting that the human and rodent repetitive elements have a common 
ancestry. At first it was thought that the BI murine repetitive elements were not 
transcribed, however, low level transcription of such elements has been detected and 
the level is elevated in certain undifferentiated embryonal carcinoma cells and SV40 
transformed cell lines (Carey and Singh, 1988). The level of transcription of these 
elements is low and,, although no studies of the chromatin structure of these elements 
have been published, it is thought that these elements are generally sequestered in 
transcriptionally inactive chromatin. The B 1 element in region B of the 3' flanking 
murine DNA ( figures 5.4 and 5.5 B) has an A rich sequence at one end and is flanked 
by 13 bp direct repeats. This is consistent with the proposed insertion of these 
elements into the genome by retroposition. 
Two regions of the 3' murine DNA showed homology with murine B2 
repetitive element family. The transgene array appears to have integrated into the 5' 
end of a B2 repetitive element. The second B2 element is 440 bp downstream of the 
first. Like the BI element this B2 element has an A rich region at one end and is 
flanked by 8 bp direct repeats (see figure 5.5 A). B2 elements have also been 
demonstrated to be transcribed by Polymerase Ill in vitro but these elements are 
almost entirely sequestered by chromatin proteins in quiescent cells. 	The 
transcriptional repression of these elements in vivo is thought to be mediated by 
bistone Hi. However it has been shown that they become partially unmasked in 
growing or SV40 transformed cells (Carey et al., 1986). As with the human Alu 
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family no definitive function has been determined for the B  and B2 repetitive 
elements. 
The 3' flanking DNA did contain numerous so called TG boxes. The TG box 
has been proposed to be a motif of a subset of matrix attachment regions (see 
Boulikas, 1993a and 1993b for a review). In addition the 3' flanking DNA contains 
GT dinucleotide repeats which have been proposed to have a propensity to form Z 
DNA under certain physiological conditions and have been proposed to have 
evolutionarily conserved chromosomal positions in Drosophila (Pardue et al., 1987). 
There was also a liberal amount of other microsateite repetitive DNA scattered 
throughout the sequenced regions. Only 2 kb of the 3' flanking DNA of clone 8 has 
not been sequenced. 
227 
Figure 5.3: Sequencing Of The 3' Transgene/Chromosomaj Junction Of Clone 8 
The 4.8 kb Hind IILNot I fragment of the secondary transgene was sub-cloned into 
bluescript. Sequencing of the 5' end of the fragment using the KS primer of the 
bluescript cloning vector allowed the sequencing of the 3' chromosomal/transgene 
junction ofAA TB 46.2. The figure  shows the sequence at the junction and compares 
this with the 3' end of the injected AATB transgene. 50 base pairs of AATB were 
missing from the AATB transgene at the 3' end of the AATB 46.2 transgene array. 
other than the 7 base pairs missing at the 5' end this was the only perceptible 
damage sustained by the AATB transgenes of the AATB 46.2 locus. This transgene 
was used to construct the secondary transgene, thus the AATB transgene in the 
secondary transgene (TAB) differs  from the AATB transgene of the Archibald and 
Carver studies in this respect. 
228 
Hind III 	 Not 1 
from bluescript primer i 
JUNCTION 
GATATGCJCCATCACCAAGCCCCCTAGGA GGAGAGATGGCTCTGTGGTGAJTGGTGCTUJCAC, 
END OF INJECTED AATh TRANSGENE  
CCAAGCCCCCTAGGA CACCAGACTGAGAGTCTGGACCTGGATCCGGCCCTCGAGGCCGGC 
GGT TCGGGGGAT CCTACTGTGGT CTGGACT CT CAGACTTCTGGACCTAGGCCGGGACT CC-GCCGCCGG 
murine genoniic sequences of clone 8 	 I 	I 3' end of AATB 46.2 transgene array 
Figure 5.4: Regions Of Clone 8 Murine DNA Sequenced 
The figure shows the regions of the murine DNA of clone 8 that were sequenced 
using the Erase-a-base system (Promega). Section (A) is 1462 bases long, section 
(B) is 994 bases long and section (C) is 201 bases long. The sequence of these 
sections and the regions of interest are shown in figures 5.5(A), (B) and (C). The 
position of restriction sites previously identified in the restriction mapping of the 
clones are shown. 
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P.c1 TT 	1i-,n RV P'n PT 
— 
4— 
(A) 	 (B) 
00 	 1 4.7 kb 
(C) 
3' end of AATB transgene 
J Murine genornic DNA from clone 8 
Regions of DNA sequenced 
Figure 5.5 (A): Sequence of Section (A) 
The figure shows the sequences of the murine chromosomal DNA of clone 8. Section 
(A) was 1462 bases long. Using the FASTA program these sequences were used to 
search for homology with sequences in the EMBL data base. The sequences 
underlined show considerable homology with mouse B2 repetitive elements. The 
second B2 element has an AT rich region at one end ('shown with tilde overlining) 
and is flanked by short direct repeats (indicated with by *). The regions overlined 
with dashed lines are GT dinucleotide repeats which have been proposed to be able 
to adopt Z DNA structure in cells under physiological conditions and proposed to 
have evolutionarily conserved chromosomal positions in Drosophila (Pardue et al., 
1987). The regions over/med with heavy lines are GT boxes (which have been 
proposed to he a in otf of a subset of matrix attachment regions. The positions of the 




AATB 	 qagaqatqgctctqtgqtgaatqqtqctttt.acacaq 
Sequences 	 -+ -+ -+— 
cc.t.ctctaccgaqac.accact taccacgaaaat.qt.qtc 
3 E2 
gtcctgpgt tcaat tctcagcaaccacatggtggctgatgctcact tctg 
caggactcaagt taagagtcgt tggtgtaccaccgactacgagtg.3agac 
gct tgta3gtatatatacagaaaaa9cattcatatataaaatacaggaat 
caacatccatatatat.gt.ct t t t. tcgt.aagt.atatat. t t. tatgtcct ta 




caagtactcggaaggcagagatcagatctcgagt tcaaggccagcct tat 
189 ---------+---------+---------+---------+---------+ 
gt tcatgagcct tccgtctctagtctagagctcaagt tccggtcggaata 
ctacagagt.ga9t t tcaggacat tcagggtccacagtgaaatc:c.tgtctc 
gat9tctcactcaaagt-cctgtaagtcccaggtgtcact ttaggacagag 
aaaaagacaaaaacaaaacaaaacaagat totat tgt tatgt t tat t tat 
tt t t tctgtt t ttgt tt tgt t ttgt tctaagataacaatacaaataaata 
t. t tat t t tat t t t. t t3tgtgct.at. t. tgcctgcat.ggatgcatgtgcacc 
aaataaaa taaaaaacacaccga t.aaacggac9tacctacgtacacg tgg 
acctgtgtgcctagtgtccagaaaatgccactggacatggagttatacat 
tggacacacggatcacaggtct t t tacggtgacctgtacctcaatatgta 
ggtggtgggaat taaacatgggccccctctctacaagagtaagcat t tta 
ccaccaccct taat t tgtacccgggggagagatgt tctcat tcgtaaaat 
tat tat ttttttagttt tat tt tat t tat ttatattaatacactgat 
489 ----- 	---------+---------+-----+--------~ 










gacqpgpaqtctttggtgt tctcccgtagtctaataat tcctacca 
pcactcggtggtacpcpaacg.ccpt taart tatct taacct tct 






tctctagcccagagagaaat t t tgagaaatagt t tgaggtacacaagatc 
689 ---------+---------+---------+---------+---------+ 
agagatcgggtctctct t taaaactctt tatcaaactccatgtgttctag 
t tgtctccacaaaacaaatgaaacatgaaaaat t tctgcacat t tagaaa 
739 -------------------+---------+---------+---------+ 
aacagaggtgt t ttgtt tact t tgtact t t ttaaagacgtgtaaatctt t 
ataat ttagnnnctgggtggtggtggtgcacatct t taat.cccagcactg 
789 ---------+---------+---------+---------+---------+ 
tat taaatcnnngacccaccaccaccacgtgtagaaat taggtcgtgac 














cgtatctcagtg9t tgagttatgaaa9cctggtcatgtaat tgt taat 
1039---------+---------+---------+---------+---------- 
gcatagagtccaccaactcaatactttcggacccagtacattaacaat ta 








t tactcgtgtgtgt9t. t tgtgt9tgtctgtatgtat.t'tgtacatggat. 
1189---------+---------+---------+---------+---------+ 
aatagcacacacacaaacacacacagacatacatacacaca tgtaccta 





cagatg tacacagacacacaacacacacaaatagacacacgg t t t.ctga 






cccctggccataaaacat t tat t 
143 
ggggaccggtat t t tgtaaataa 
Figure 5.5 (B): Sequence of Section (B) 
Further sequencing of the murine sequences present in clone 8. The position of the 
sequenced DNA is shown in figure 5.5. The region is almost 1 kb in length. A 
FASTA search of the FJVJBL data base with these sequences found only one region 
that displayed significant homology to any other sequences. That region has high 
homology with a mouse BI repetitive element. This repetitive element contains an A 
rich region (indicated by -) and is flanked by direct repeats (indicated by *). 
Overlined with dashed lines is a 38 bp CA perfect dinucleotide repeat (proposed to 
be capable of forming Z DNA under physiological conditions). Regions overlined 
with heavy dark lines are GT boxes. 
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(B) 
-b from b1uecript primer 
S 	tagaactgcaagggcgaccacatgacaaactctcaacct tatcagca t t 
1 ---------+---------+---------+---------+---------+ 
3 atcttgac'ttccccgctggtgtactgtttga9agttggaatagtcJJtaa 
cagtgata tcaat tacaagaatggagaactggagccgagca tggtggcgc 
Si---------+---------+---------+---------+---------+ 
gtcactatagt taatgt tot tacotot tgacctcggctcgtaccaccgcg 
Mk,7........  M E twi-E JR-3 ME- calamc-ruTa-0-4 7w-- -16  
tqagqccpgcctgtc tpcaaagtgggt tccagggcagccggggctpt. 
151 ---------+---------+---------+---------+---------+ 
actccggtcggaccacgatgt t tcpctcaagcrtccttcggtcccgatpt 




gaactgccat tgtctgctat tgttctctcaaatatatct taatccaatac 
251 ----------+---------+---------+---------+---------+ 
Ct tgacggtaacagacgataacaagagagt t tatatagaat taggt tatg 
tgggaagnatcataaaacaggcccct t t taatggat tactagaggcagat 
301 ---------+-------------------+---------+---------+ 
acccttcntagtattttgtccggggaaaattacctaatgatctccgtcta 
ataatatgagtgt t tgaaaraactgccaatgt taataaagagaagatccg 
351 ---------+---------+---------+---------+---------+ 
tat tatactcacaaact ttgttgacggttacaattatttctcttctaggc 
t tgtctacagtact t ttaatgataaggt tctgt tctaggacaaagtcaat 
401 ---------+---------+---------+---------+---------+ 
aacagatgtcatgaaaat tactat tccaagacaagatcctgt t tcagt ta 
tcctcat ttgatat tat tgtatccaccraaat tggaagcaatggaagt t 
aggagtaacactataataacataggtgggt t taacrt tcgt tacct tcaa 
tccatcaataaagaaat tcacty taatctgacgctt tctgctgtgatgta 
aggtagt.tat ttct. t. taagtgacat t.agactgcgaaagacgacactacat 





t tcaat tat t t t tat tatoct tagtggtggtggagggragtccataccct 
601 ---------+-------------------+---------+---------+ 
aagt taataaaaataataggaatcaccarcacctccctcaggtatggga. 
ggaat toot t tggaggtcaact tca tctcctcctactccgatcct tagg 
651 ---------+---------+---------+---------+---------+ 
cot taggaaacct.ccagt t.gaagtagagaggatgaggctaggaa toot 
at tgacct tagggototctcacgnnntggtgcacacaot t t taoaggt t t 
701 ---------+---------+---------+---------+---------+ 
taac t ggaat cccga ga gag t gcnnnarcaog t g t g t gaaaa t gt ccaaa 
gagcca tot tggcagcccaca ta tg t taactacaaagagggc tggaca ta 
751 ---------+---------+---------+---------+---------+ 
ct.cggtagaaccgtcgggtgtatacaat tgatgt t tctcccgacctgtat 





--------------------------------------------------------------------------------to tot cacacaoacacacaoaoacacacacacaoacacacacaooaoaaa 
agagagtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtggtgt t t -------------------------------------------------------------------------------- 
tgcattggtgttttgcatacatggtagactgtgtgaaagtggt 3' 
951 ---------+---------+---------+----------1----
acgtaaccaoaaaacgtatgtacoatctgaoacact t tcacca S 
851 
901 
Figure 5.5(C): SeQuence of Section (C) 
This region is the 3' most murine DNA of clone 8. A FASTA search of the EMBL 
data base with these sequences found no significant homologies with other sequences 







agacet tcagccaaccacaaaat tgacgactcggtagagaggtcagagg 
actgtcacct t t t tat t tat t tacat t t tgt tatatacatacataataca 
101 ---------+---------+---------+---------+---------+ 
tgacagtggaaaaataaataaatgtaaaacaatatatgtatgtat tatgt 
cacatacacatatatacatacatataactatcacct t taatgt tat tgcat 
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gtgtatgtgtatatatgtatgtatat tgatagtggaaat tacaataacgta 
from b1uecr±pt primer 
Figure 5.6: Probing Genomic DNA With Murine Sequences Of Clone 8 
The Southern blot shows genomic DATA of mouse of line AATB 46.2 (A) and a non 
transgenic sibling (C) digested with three different endonucleases. The Southern was 
probed with the 1.6kb Hind Ill/Eco R Vfragment of the murine sequences of Clone 8 
in order to obtain information about the pre-integration site of line AATB 46.2. The 
resultant smear obtained in all lanes with this probe demonstrated the presence of 
repetitive DATA in the probe sequences. Subsequent sequencing of this fragment 
demonstrated the presence of mouse repetitive elements within the probe sequences 






5.42 Rationale For Use of a Phage Vector to Construct the Secondary Transgene 
Constructing the secondary transgene in plasmids proved to be impossible 
because of the inherent instability of cosmid clone 8. Restriction mapping and 
sequencing of part of this clone demonstrated the clone harboured two origins of 
replication and two ampidilhin resistance genes both originating from the cosmid 
vector. The clone recombined to produce a small cosmid fragment which was 
considerably more abundant in DNA preparations than the original clone itself (see 
Chapter 4, Section 4.2.4). Numerous attempts to sub-clone fragments from clone 8 
using plasmids failed. 
This was the only clone isolated from the cosmid library that harboured the 3' 
flanking murine DNA of AATB 46.2. if the secondary transgene was to contain the 
3' murine sequences they had to be recovered from this clone. To circumvent the 
difficulties experienced using plasmids, a phage vector was employed to construct the 
secondary transgene. 
The secondary transgene encompassing the 4.6 kb 5' murine DNA, AATB 
(10.6 kb) and the 4.7 kb 3' murine flanking DNA, is 19.9 kb in size. This is within 
the size limit for the insert of many phage vectors, whereas, the size of the 
recombinant that caused the difficulty in the plasmid sub-cloning experiments was 4.6 
kb, and thus too small to be packaged (once ligated into a phage vector). Therefor 
using a phage vector allowed positive selection for the secondary transgene on the 
basis of size. Details of the construction and cloning of the secondary transgene are 
given in the next section. 
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Figure 5.7(A); The Large Not I Fragments From Clone 8 and 9 Are Suitable For 
Constructing The Secondary Transgene 
Both clone 8 and clone 9 liberate fragments of approximately 15.2 kb on Not I 
digestion. The figure shows clones 8 and 9 and in particular the position of the Srf I 
and Not I restriction sites. (F1) = The Mot I fragment spanning the 5' AATB 46.2 
chromosomal/transgene junction. It includes all the 5' cloned murine DNA of the 
locus (4.6 kb,) and an intact AATB transgene. (F2) = The Not I fragment spanning 
the 3' AATB 46.2 chromosomal/transgene junction. It contains all of the 3' cloned 
murine DNA of the AA TB 46.2 locus (4.7 kb) and most of the AA TB sequences (see 
chapter 4, analysis of clone 8). Each of the 15.2 kb Not I fragments harbours only 
one Srf I restriction site situated in the 3' end of the ovine BLG sequences of AA TB. 
Fragments F] and F2 were isolated by gel electrophoresis in 0.3% agarose gels and 
used in the construction of the secondary TAB transgene. 
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15.2 kb 	 Not 1 Not 1 SrI 1 Not 1 SrI 1 	Not 1 
5 k 
	 15.2 kb 
Cosmid 	 I I human AAT sequences 
BLG sequences I1l  mouse genomic DNA 
Figure 5.7 (B) Joining The Two Not I Srf I Fragments Gives An AATB 
Transgene Flanked By The Chromosomal DNA Of AATB 46.2 
The Not I fragments shown in Figure 5.7 (A) were digested with Srf I and the 8.8 kb 
fragment from clone 9 and the 11 kbfragment from clone 8 were gel purified. The 
yield from each round of digestion and gel purification was low so this procedure 
was performed several times and the purfled fragments pooled. The two fragments 
were ligated in the presence of Not I restriction enzyme: to reverse the favourable 
ligation of the Not I complementary ends. The ligation product (19.9 kb) was 
separatedfrom the input fragments (8.8 kb and 11 kb) and less abundant products of 
the ligation reaction (17.6 kb and 22 kb) by gel electrophoresis in 0.3% agarose gels, 
purified and then ligated into the Not I sites of the lambda DASH II phage vector 
(Stratagene :figure 5.7 Q. 
246 










8.0 kb '\condary 	
11 kb  
Figure 5.7 (C): The Lambda DASH II Phage Cloning Vector 
The figure is a diagrammatic representation of the Lambda DASHIIphage cloning 
vector (Stratagene). The vector accommodates an insert of 9kb to 23 kb. The Not I 
sites of the vector (shown in red) were used to ligate the insert into the vector. This 
removes the T3 and T7 promoters of the vector. The T3 and T7 promoters from the 
Super-cos-one vector are part of the secondary transgene (see figure 5.7 (B)). 
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5.43 Construction of the Secondary Transgene 
Chromosomal DNA flanking the AATB 46.2 locus was cloned in two separate 
cosmid vectors. Clone 8 harboured the 3' end of the locus and clone 9 the 5' end of 
the locus. The starting point for construction of the secondary transgene was to isolate 
a fragment containing the murine flanking DNA and an AATB transgene, from each 
clone. These fragments were obtained by digesting clones 8 and 9 with Not I. The 
15.2 kb fragment from clone 8 harboured the 3' most AATB transgene of AATB 46.2 
and all of the cloned 3' flanking murine DNA (172, figure 5.7 A). Similarly the 15.2 
kb Not I fragment of Clone 9 harboured the 5' most AATB transgene of the away and 
all of the cloned 5' flanking murine DNA (Fl figure 5.7 A). 
Each Not I fragment, Fl and F2, contained a unique Srf I restriction site within 
the BLG sequences of AATB (see figure 5.7 A). Thus Fl and F2 each generated two 
fragments when digested with Srf I. Fl gave fragments of 8.8 kb (F3, figure 5.7 B) 
and 6.4 kb, and F2 gave fragments of 11.1 kb (F4 figure 5.7 B) and 4.1 kb. Ligation 
of F3 and F4 at the Srf I site generates a single AATB transgene flanked 5' and 3' 
with the appropriate flanking murine DNA of the AATB 46.2 locus. 
Fragments F3 and F4 were gel purified before being ligated to produce the 
secondary transgene (see figure 5.7 B). The presence of the Not I complementary 
ends 5' of F3 and 3' of F4 required the ligation reaction to be carried out in the 
presence of Not I restriction enzyme. This was to reverse Not I complementary end 
ligations and thus drive the ligation reaction in the direction of the less favourable blunt 
end ligation at the Srf I site. 
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As expected, ligation of the two fragments generated a number of products 
(verified by visualisation of the reaction mix on an 0.3% agarose gel stained with 
ethidium bromide, data not shown). The predominant product was approximately 20 
kb in size. This product was assumed to be the desired secondary transgene (F5, 
figure 5.7 B). Other less abundant products both smaller and larger were present. 
These products were likely to be the products of ligation occurring between like 
fragments (i.e. F3 + F3 and F4 + 174). The 19.9 kb product of the ligation was gel 
purified and ligated into the lambda DASH II cloning vector. 
5.4.4: Phage Cloning of the Secondary Transgene 
Lambda DASH II was the cloning vector used to clone the secondary 
transgene (figure 5.7 C). The vector was prepared for ligation of F5 (see figure 5.7 B) 
by digestion with Not I (see figure 5.7 C). The Not I sites of the vector were outwith 
the multiple cloning site and digestion of this vector with Not I resulted in the loss of 
the T3 and T7 promoters. This was essential as the secondary transgene TAB (F5, 
figure 5.7 B) is flanked 5' by a T3 promoter and 3' by a T7 promoter. These 
promoters at either end of the secondary transgene originate from the Super-Cos-One 
cosmid vector in which the locus of AATB 46.2 was cloned. 
A total of 33 plaques were obtained from the phage cloning. Each of the 
phage clones were screened with probes from the 5' and 3' end of the AATB 
transgene. All but one of the phage clones hybridised with both probes indicating that 
sequences from both F3 and F4 were present in the clones. 
Two secondary transgenes were isolated from the cloning procedure. The 
intended secondary transgene (TAB): encompassing 5' murine sequences, AATB, and 
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3' murine sequences, and another transgene (TA) that contained only AATB and 3' 
murine sequences. This transgene is the same as the 15 2 kb Not I fragment of clone 
8 (F2, figure 5.7 A). It is probable that cloning of this transgene arose by carry over 
of the non digested F2 through all stages of construction of the secondary transgene. 
The size of the TAB transgene is similar to the left arm of the phage vector 
when digested with Not I. To facilitate the separation of the TAB secondary transgene 
from the vector sequences the clone was digested with both Not I and Nru I (which 
cuts at position 4592 of lambda dash II). Both secondary transgenes (TA and TAB) 
were used to generate transgenic animals. The analysis of these transgenic mice is 
detailed in chapter 6 of this thesis. 
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CHAPTER 6: EXPRESSION OF THE SECONDARY 
TRANSGENES IN THE MAMMARY GLAND OF TRANSGENIC 
MICE 
6.1 INTRODUCTION 
The previous chapters outline the genomic mapping of the high expressing 
AATB 46.2 locus, the cloning of the locus and, the construction of the TAB and TA 
transgenes. This chapter describes the generation of transgenic mice carrying the 
secondary transgenes and the analysis of their expression. 
As with the AATB studies, the secondary transgenic animals were generated 
by pro-nuclear injection, of mouse eggs collected from Fl (C57BL/6 x CBA) females, 
after mating with Fl stud males (Simons et al., 1987). The number of TAB transgenic 
mice generated was comparable with the previous AATB studies enabling a direct 
comparison to be made between the AATB and TAB transgenes. 
The analysis of the transgenic mice involved the determination of the transgene 
copy number for each animal and measurement of hAAT expression levels in Go and 
Gi animals. The copy number was estimated by comparison with plasmid copy 
number controls. The protein composition of the transgenic mouse milk was 
visualised on Coomassie stained SDS PAGE gels. These gels showed the presence of 
an additional protein in transgenic mouse milk that was not present in the non 
transgenic control. The identity of the additional protein, as hAAT, was verified by 
immunoblotting. The amount of hAAT present in the milk was quantified by radial 
immunodiffussion (RID). 
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Comparison of the TAB transgenic experiments with the previous AATB 
experiments (Archibald et al., 1990 and Carver et al., 1993) showed that both the 
frequency of expression of hAAT in the mammary gland of transgenic mice and the 
levels of expression were much higher in the TAB transgenic mice. Transgenic mice 
harbouring the TA transgene did not detectably express hAAT. The conclusion of the 
secondary transgenic experiments is that the cloned flanking murine sequences from 
the AATB 46.2 locus, that are present in the TAB transgene markedly improved the 
expression of the AATB transgene and are probably causative in the high expression 
of hAAT from the transgene array of AATB 46.2. 
6.2 EXPRESSION OF AA TB IN SECONDARY TRANSGENIC MICE 
6.2.1 Generation of Transgenic Mice 
In all twelve transgenic animals/lines were generated harbouring the TAB 
transgene (Table 6.1). Six transgenic mice/lines were generated at the Roslin Institute. 
All six founders were female and hAAT expression data was obtained from them. 
Another set of six TAB transgenic mice were generated at PPL Therapeutics Ltd. In 
this instance two of the founder mice were female and the others were male. The 
levels of hAAT in the milk of the two female founder mice were measured, and the 
males were used to establish lines. 
Of the six mice produced at the Roslin Institute five transmitted the transgene 
to their offspring. One founder failed to transmit, even after extensive breeding. This 
mouse TAB 80 was presumed not to have the transgene in its germline. Two of the 
other Go mice, TAB 14 and TAB 52, transmitted the transgene to their offspring at a 
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frequency considerably less than 50% suggesting that these founders were also 
germline mosaics. TAB 29, TAB36, and TAB 54 all transmitted the transgene at a 
frequency very close to 50 %. 
Of the six mice generated at PPL Therapeutics Ltd. only one failed to transmit 
the transgene. This founder TAB 108.22 was male and so no expression data was 
obtained. Four of the other five founders transmitted the transgene at a frequency 
close to 50 % suggesting the founder mice were not mosaic However, subsequent 
copy number determination of Go mice and their offspring suggested that at least one 
of the six founders was mosaic. The transmission frequency of TAB 111.4 is not 
known since this mouse was not bred to produce a line. 
Expression data was obtained from the eight female Go animals and from the 
offspring of five of these animals. The remaining expression data was obtained from 
the female transgenic offspring of the three male founders that transmitted the 
transgene. Thus, overall MAT expression was analysed in eight independently 
generated lines plus three Go animals. In two of the lines the transgene copy number 
rose in the first generation. The copy number of TAB 113-12-2 is double that of the 
founder male TAB 113-12 (see table 6.3). In TAB 14 a much more dramatic eight 
fold rise in copy number was seen between the Go and Gi animals (see table 6.2), 
however the transgene copy number was stable between Gi and G2 animals (data not 
shown). A small rise in copy number is also apparent between TAB 110.28 and its 
offspring. These three founder animals were presumed to be mosaic, as were the two 
Go animals that did not transmit the transgene. The percentage of mosaic Go animals 
within this study is 42%. This is slightly greater the figure of 33% obtained by Wilkie 
et al (1986). It is possible that the analysis of Go transgenic animals may not give an 
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entirely accurate picture of transgene expression because an undetermined percentage 
of the cells in a given tissue may not carry the transgene. Expression data of female 
transgenic offspring is free from such ambiguity, since the transgene is present in all 
somatic cells. 
TABLE 6 1: TAB Transgenic Mice 
Go Animal (Sex) Transgene Transmitted Offspring analysed 
14 	(F) 1/36 
29 (F) 5/9 unable to lactate 
36 	(F) 11/20 
52 (F) 2/22 
54 	(F) 2/4 
80 (F) 0/32 no offspring 
108-16 	(F) 
108-22 (IVI) 0/6 no offspring 
110-14 	(M) 
110-28 (M) 
111-4 	(F) nb no offspring 
113-12 	(M) 
Legend to Table 6.1 
(M)male, (F) =female, nb= not bred on 
6.2.2 Estimation of Copy Numbers 
The method used for the estimation of transgene copy numbers was the same 
as in the previous AATB studies. The intensity of internal fragments from the 
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transgene is estimated relative to plasmid copy number controls. In this study the 
determination of copy number is simplified by the ability to quantify the signals from 
Southern blots using a Molecular Dynamics Phosphor Imager. Loading across the 
lanes was controlled for, by using a 13-casein probe (kindly donated by S. George). 
The two sets of TAB transgenic mice were produced at different sites and 
several months apart, for this reason the copy numbers in the two sets of animals have 
been analysed separately. In each case the same plasmid controls and non transgenic 
DNA have been used so that a comparison can be made between the two sets of copy 
number results. Figures 6.2 and 6.3 show the Southern blots from which the 
transgene copy numbers were estimated. Tables 6.2 and 6.3 show the data obtained 
from the Phosphorlmager and the estimated copy number of the TAB transgenic mice. 
The transgene copy numbers in this study ranged from 5 copies (TAB 54) to greater 
than 120 (TAB 14.20). 
The copy number estimates were performed on tail DNA. This was not ideal 
as it tends to be more degraded than DNA prepared from soft tissues such as liver. 
However liver DNA could not be obtained from these animals as they were required 
for breeding to establish transgenic lines for the milk analysis. The DNA was digested 
with Eco RV generating the two expected internal fragments of 7.2 kb and 5.6 kb. 
The signal from both fragments was measured using the Phosphorimager and 
compared with the 5 copy plasmid control that was also digested with Eco RV. In 
figure 6.2 the plasmid control was loaded in 10 pg of non transgenic liver DNA. In 
figure 6.3 the plasmid control was loaded in 28 pg of the same non transgenic DNA. 
Using a -casein probe (kindly donated by S. George) the loading of each of the lanes 
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was normalised using the signal from the non transgenic DNA as the standard (see 
tables 6.2 and 63). 
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Figure 6.1 : Probe Used to Estimate the Copy Number of TAB Transgenic Mice 
The probe is the Nhe I/Hind III fragment from AA TB used for the estimation of copy 
number of the TAB transgenic mice all of the DNA for copy number estimation was 
digested with Eco R V This probe spanned the Eco R V site and detected the two 
internal Eco R Vfragments generated form the TAB transgene. 
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Figure 6.2: Southern Blot for Copy Number Estimation of Roslin Institute 
Generated TAB Transgenic Mice 
The figure shows a Southern blot used for the estimation of the copy number of the 
TAB transgenic mice generated at the Roslin Institute. The plasm Id copy control is a 
five copy equivalent oft/ic  TAB transgene loaded in 10 pg of liver DNA from a non 
transgenic mouse, digested with Eco R V. Each of the other lanes contains 10 pg of 
DNA, prepared from tail cuts, digested with Eco R V (a) Shows the signal obtained 
with a fl-casein probe (donated by S. George). The filter was laid down for 18 hours, 
at -70 'C, with intensifying  screens. The signal was quantified by 16 hour exposure 
to the Phosphorlmager (Molecular Dynamics). The data from the Phosphorimager 
is shown in Table 2. (b) shows the signal using the AATB probe in figure 6.1. As 
expected the probe hybridises with two fragments of 7.2 and 5.6 kb. The filter was 
laid down with X-ray film for 18 hours, at -70 'C, with intensf'ing screens. The 
signal from this probe was also quantified by exposure to the Phosphorimager for 3 








3-casein probe (a) Control/3-casein probe 
(b) 
AATB probe (c) Control! AATB 
 probe (d) 
Copy number (d) x 
5 (e) 
corrected copy number 
(e) x (b) 
control 	copy 16860 1 44572 1 
TAB 14 (f) 18875 0.89 154594 3.47 17.35 15 
TAB 14.20 	(f) 36878 0.46 2379203 53.37 266.85 123 
TAB 29 (f) 43784 0.38 1698799 38.11 190.55 72 
TAB 29.1 	(1) 44845 0.37 1428676 32.05 160.25 59 
TAB 36 (f 65210 0.25 1062340 23.83 119.15 30 
TAB 36.7 	(f) 34755 0.48 872099 19.56 97.8 47 
TAB 52 (f 21427 0.78 58057 1.30 6.5 5 
TAB 54 	(f) 19879 0.84 59437 1.33 6.65 6 
TAB 54.4 (f 28119 0.59 82895 1.86 9.3 5 
TAB 80 	(f) 27341 0.61 98037 2.19 10.95 7 
Table 62 
Copy number data from the Phosphorimager for Roslin generated TAB mice 
Figure 6.3; Southern Blot for Copy Number Estimation of PPL Generated TAB 
Transgenic Mice 
The figure shows a Southern blot used for the estimation of the copy number of the 
TAB transgenic mice generated at PPL Therapeutics Ltd.. The plasmid copy control 
is a five copy equivalent of the TAB transgene loaded in 28pg of liver DNA from a 
non transgenic mouse, digested with EcoRV. Each of the other lanes contains 10 pg 
of DNA, prepared from tail cuts, digested with Eco RV. (a) Shows the signal 
obtained with a /3-casein probe (donated by Sisilamina George). The filter was laid 
down for 18 hours, at -70 °C, with intensifying screens. The signal was quant/Ied by 
16 hour exposure to the Phosphorlmager (Molecular Dynamics). The data from the 
Phosphorlmager is shown in Table 2. (b) shows the signal using the AATB probe in 
figure 6.1. As expected the probe hybridises with two fragments of 7.2 and 5.6 kb. 
The filter was laid down with X-ray film for 18 hours, at -70 °C, with intensing 
screens. The signal from this probe was also quantified by exposure to the 




Copy number data from the Phosphorimager for PPL generated mice 
control 	copy 
_____ probe 










I copy number (d) x 5 
(e) 
corrected copy No. 
(e) x (b) 
108.16 (f) 10835 1.52 7675  1.32 6.58 10 
108.16.1 	(f) 29072 0.57 25312 4.34 21.7 12 
108.16.2J 32982 0.50 31363 5.38 26.89 13 
108.22 	(m) 37520 0.44 63160 10.83 54.15 24 
110.14 (m) 5963 2.78 6462 1.11 5.54 15 
110.14.4 	(f) 32064 0.51 21120 3.62 18.11 9 
110.28 (m) 17962 0.92 46137 7.91 39.55  36 
110.28.2 	(t) 18139 0.91 63348 10.86 54.3 50 
111-4 (0 28432 0.58 33863 5.81 29.03 17 
113.12 	(m) 17884 0.92 9211 1.57 7.9 7 
113.12.2 (1 11906 1.38 10876 1.86 9.32 13 
signal normalised to lOpg of control DNA (190 of control DNA loaded, The signal was divided by 19 and then multiplied by 6.8 since 6.8p1 of 
control DNA is believed to 10tg of DNA and is the volume previously loaded to determine the copy numbers of the Roslin mice) 
6.2.3 Expression of hAAT in TAB Transgenic Mice 
The milk samples of TAB animals were analysed initially by SDS PAGE. This 
technique allows the separation of the protein components of milk according to their 
size. Subsequent staining of the gel with Coomassie blue allows visualisation of the 
protein composition of the milk samples. The technique allows direct visualisation of 
the hAAT protein in the transgenic mouse milk provided the levels of expression are 
sufficiently high. The protocol used was adapted from Archibald et al., (1990). The 
SDS PAGE results are shown in Figures 6.4 and 6.5. 
From this analysis of the TAB milk samples the majority of the transgenic mice 
were shown to express the human protein at high levels. The level of expression 
between the Go animals and their offspring was generally stable. The clear exception 
was TAB 14 and TAB 14.20.6. It was plain that the expression level in the G2 animal 
far exceeded that of the Go. Interestingly this large elevation in hAAT expression 
correlated with a concomitant rise in the transgene copy number between the founder 
and her transgenic offspring (see table 6.2). 
The stained gels allow direct visualisation of a protein which is present in 
transgenic mouse milk but absent from non transgenic controls. The protein had the 
same apparent size as hAAT (54 kD). To verify that it was hAAT a Western blot was 
performed and probed with goat anti-human AAT serum and anti sheep/goat IgG 
serum conjugated to horseradish peroxidase. Only one band on the gel reacted with 
the antibody and this was the same size as the hAAT standard (figure 6.6). No 
antibody reaction was observed in the non transgenic milk samples. This contrasts 
with the results of Archibald et al., where cross reaction of the antibody with control 
mouse milk was observed (assumed to be the mouse endogenous AAT). The Western 
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blot performed in this study was less sensitive than that performed by Archibald et al., 
and was probably the reason for the observed difference. 
The hAAT in the transgenic mouse milk did not migrate as a tight band. There 
appeared to be several bands corresponding to hAAT which migrate closely in 10% 
SDS PAGE gels. AAT produced in human liver has three carbohydrate side chains. 
The various bands visualised on the Coomassie stained gels probably correspond to 
differences in the post translational modifications of hAAT produced in the mammary 
gland. This electrophoretic heterogeneity of the hAAT in transgenic mouse milk was 
also observed by Archibald et al.. The Western blot is shown in Figure 6.5 
A quantitative analysis of the hAAT level in the mouse milk was performed by 
radial immunodifflision. The minimum level of hAAT detectable using this method 
was 404ml. This method in conjunction with radio immunoassay was used to 
determine hAAT levels in the first AATB study (Archibald et al., 1990) whereas, a 
much more sensitive ELISA was used in the second AATB study (Carver et al., 
1993). The levels of hAAT in the TAB transgenic mouse milks are tabulated in Table 
6.4 
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Figure 6.4: SDS PAGE of Roslin Institute TAB Transgenic Mouse Milks 
The figure shows a 10 % SDS Poly Acrylamide gel following the electrophoresis of 
milk samples from a non transgenic mouse and the TAB transgenic mice generated 
at the Roslin Institute. Lane 2 contains 2.5,ug of human A/iT standard (Sigma). 
Lane 4 contains the milk sample of AATB 46.2 (the mouse from which the murine 
sequences in the TAB transgene were cloned). AATB 46.2 is known to express hAAT 
at 6.25 mg/mi. All of the milk samples were deJtted following a] in 5 dilution with 
sterile distilled 1-120. They were then further diluted 1 in five with reducing buffer to 
give a total dilution of] in 25. 5 p1 of each sample was loaded in the gel in 30 p1 of 
loading buffer. An additional protein (not present in non transgenic milk) is visible 
in almost all of the transgenic milk samples. This protein had the same apparent 
size as the h4AT standard (54 kD). The level of expression of the additional protein 
in TAB 14.20.6 is considerably higher than the level in the founder mouse TAB 14. 
The levels of expression of the extra protein in TAB 14.20.6 also exceed those of 
AATB 46.2. The level of MAT in TAB 29 and TAB 36 also appear to be more than 
that ofA/i TB 46.2. 
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Figure 6.5: SDS PAGE of PPL TAB Transgeuic Mouse Milks 
The figure shows a 10 % SDS Poly Aciylamide gel following the electrophoresis of 
milk samples from a non transgenic mouse and the TAB transgenic mice generated 
at PPL Therapeutics. Lane 2 contains 2.5pg of human AAT standard (Sigma). Lane 
4 contains the milk sample of J4ATB 46.2 (the mouse from which the murine 
sequences in the TAB transgene were cloned). AATB 46.2 is known to express JL4AT 
at 6.25 mg/mi. All of the milk samples were defatted following a 1 in 5 dilution with 
sterile distilled H20. They were then further diluted I in five with reducing buffer to 
give a total dilution of I in 25. 5 yl of each sample was loaded in the gel in 30 p1 of 
loading buffer. An additional protein (not present in non transgenic milk) is visible 
in almost all of the transgenic milk samples. This protein has the same apparent size 
as the k4A T standard (54 kD).All of the mice except line TAB 110.14 appear to 
express MAT at a level greater than that of AA TB 46.2. The level of expression of 
hAA Tin line TAB 110.28 appears to be very high. 
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TABLE 64 
Expression Of hAAT In TAB Transgenic Mice 




TAB 14 Go 3.48 ±0.65 
TAB 14.20.6 G2 24.6 ±3.37 
TAB 29 Go 14.16 ±0.48 
TAB 36 Go 5.25 ±0.67 
TAB 36.2 Gi 7.57 ±0.73 
TAB 52 Go nd 
TAB 52.1 Gi nd - 
TAB 54 Go 0.596 ±0.05 
TAB 54.2 Gi 0.553 ±0.02 
TAB 80 Go 0.46 ±0.06 
108-16 Go 7.95 ±0.4 
- 108-16-1 Gi 7.51 +0.4 
110-14-4 Gi 0.21 ±0.01 
110-28-2 Gi 34.86 ±1.5 
111-14 Go 13.5 ±1 
113-12-2 Gi 6.7 ±0.5 
(c5) = average of three independent readings 
nd = none detected (limit of detection 40 pg/mi) 
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Figure 6.6: Western Blot of TAB Milk Samples 
The figure shows a Western blot of a 10 % SDS polyaciylamide gel after 
electrophoresis of the TAB transgenic milk samples. Lane one contains 2.5 ug of 
MA T standard (Sigma). Lane 2 contains a sample of non transgenic milk and Lane 
3 contains a sample of milk from AATB 46.2. All other lanes contain TAB milk 
samples from the lines/mice indicated. The proteins were transferred to a 
nitrocellulose filter by electroblotting. The filter was probed using goat anti-ajAT 
serum [Protein Reference Unit (PRU), Royal I-Iallamshire Hospital, Sheffield, $10 
2JFJ and anti sheep/ goat IgG serum conjugated to horseradish peroxidase. 
Only one protein hybridises with the antibody. This is the additional protein 
visualised on the coomassie stained SDS polyacrylamide gels in figures 6.4 and 6.5. 
The sensitivity of the blot was poor due to poor transfer of the proteins on 
electroblotting. Nevertheless this western blot verifies the 54 kD additional protein 















Figure 6.7: Comparing hAAT Expression of TAB Transgenic Mice With AATB 
Transgenic Mice 
The figure shows a plot of the expression levels of MAT from the two previous 
studies oJAATB mice (Archibald et al., 1990 and Carver et al., 1993) and this study 
of TAB mice. For each group of data the mice expressing MAT at less than 40 
jig/ml are grouped together as are those that express between 40 pg/mi and 1 mg/mi. 
The column on the left gives the expression level in mg/mi. 
This figure demonstrates that the levels of MAT expression in the TAB mice 
are on the whole greater than that observed in AATB mice. The numbers of TAB 
mice expressing h.4AT at greater than 40 pg/mi is much improved over the AATB 
transgenic mice. Only one of eleven TAB mice expressed MAT at less 40 pg/mi, 
whereas half of the AATB mice from each of the previous studies were frund to 
express MAT below this level. 
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Figure 6.6 shows the levels of MAT expression in the AATB transgenic mice 
(Archibald et al., 1990 and Carver et al., 1993) and the TAB transgenic mice (this 
study). The MAT expression levels in the TAB mice are generally high. Only one of 
the lines TAB 52 did not express the human protein. With the exception of this line 
the lowest level of expression was 0.2 mg/W. By contrast more than half of the mice 
in both AATB studies expressed the transgene at less than 404ml. 
Seven of the eleven TAB transgenic founders/lines expressed the human 
protein at levels considerably greater than 1mg/mi whereas only one of thirteen of the 
Archibald AATB mice and two of eleven of the Carver AATB mice expressed MAT 
at greater than 1 mg/nil. Thus the levels of hAAT expression from the AATB 
transgene appeared to have been much improved by the presence of the 5' and 3' 
murine genomic sequences from the AATB 46.2 locus. 
6.2.4 Lactation Difficulties in TAB Trausgenic Mice 
It proved impossible to obtain milk samples from the offspring of TAB 29. 
The Go animal expressed the human protein at 14.16 mg/mi. Two female offspring 
were obtained and bred. One of the daughters TAB 29.4 destroyed two consecutive 
litters only hours after giving birth. Such behaviour is not particularly unusual but is 
considered important in this instance because the sibling TAB 29.5 was unable to let 
down her milk. The mammary gland of TAB 29.5 became engorged and she had to 
be destroyed because she was clearly in distress. Although a large volume of milk was 
present in the mammary gland, this animal was unable to feed her pups. The reasons 
for this are not clear. No milk sample was obtained from either of the Gi animals, 
thus it is not possible to tell whether the levels of MAT expression remained steady or 
277 
rose in first generation. The transgene copy number in this line remained constant 
from Go to Gi thus it would seem unlikely that the level of hAAT expression in the 
milk has significantly increased. Yet the Go animal was able to lactate and feed her 
pups. No explanation can be given for the lactation difficulties of this line. 
Interestingly TAB 14.20.6 also had difficulty feeding her pups. Dining 
lactation the Gz animal had a dishevelled appearance and her pups were failed to thrive 
despite the litter being small. The milk sample obtained from this animal following 
oxytocin administration was smaller than usual. 
Both TAB 29 and TAB 14 express the human protein in their milk at high 
levels (14.16 mg/ml and 24.6 mg/nil respectively). It is possible that high levels of 
expression of this foreign protein in the milk can impair lactation. Nevertheless the 
high expression of the human protein does not appear to have a major detrimental 
effect on the expression of other major mouse milk proteins (McClenaghan et al., 
1990). The levels of the endogenous milk proteins appear to be consistent between 
the transgenic and non-transgenic animals. Moreover TAB 110-28-2 was able to 
express hAAT in her milk at almost 35 mg/mi. The lactation difficulties of TAB mice 
has not been further studied in this work. 
6.2.5 The Tissue Specificity Of The TAB Transgene 
The AATB transgene is expressed in the mammary gland. Many of the 
transgenic mice harbouring this transgene also exhibit minimal ectopic expression in 
the salivary gland (Archibald et al., 1990). The ectopic expression may in part be a 
property of the ovine BLG promoter in transgenic mice. In depth studies of ovine 
BLG transgene expression in a range of tissues in transgenic mice have demonstrated 
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low level ectopic expression in tissues other than the mammary gland (Farini & 
Whitelaw 1995). The expression of the transgene in these tissues is considerably lower 
than the expression of the transgene in the mammary gland. The reason for the 
ectopic expression is currently not known. 
It was important to establish whether the murine genomic sequences included 
in the TAB transgene had an effect on the tissue specificity of the BLG promoter, 
which drives the expression of this transgene. In order to investigate this, the levels of 
hAAT transcript were analysed by Northern blotting. The filters were probed with an 
SOObp Barn HUEco RV fragment from p8alppg (Ciliberto et al., 1985). This probe 
encompasses most of the hAAT cDNA sequences. 
The levels of hAAT mRNA were examined in a range of tissues of AATB 
46.2 and a first generation transgenic mouse of line TAB 36. Both lines expressed 
MAT at similar levels: AATB 46.2 giving 6.4 mg/mI and TAB 36 giving 7.5 mg/mi. 
These high levels of mammary expression were borne out by the Northern blot. On 
long exposures of the probed northern blots low level ectopic expression of the hAAT 
transcript was detected in the spleen of AATB 46.2 (figure 6.7) and in the salivary 
gland and kidney of TAB 36 (figure 6.8) but the levels of hAAT mRNA in these 
tissues was minimal compared with that in the mammary gland. The size of the 
transcript in the spleen of AATB 46.2 appears to be the same as that of the major 
transcript in the mammary gland, however, the transcript in the kidney of TAB 36 
appears to be smaller. Both the larger and smaller mRNA species are present in the 
salivary gland of TAB 36. The production of the smaller transcript in the kidney and 
salivary gland may reflect differences between trans-acting splicing factors in the 
mammary gland and the kidney and salivary gland (YulI et al., 1995(b)). 
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Figure 6.8 Nothern Blot Analysis Of Total RNA From Transgenic Mice AATB 
46.2 And TAB 36.2 
The figure shows total RNA extracted from a range of tissues from AA TB 46.2 and 
TAB 36. The tissues analysed were mammary (m), liver (Li), salivary (sa), kidney 
(k), spleen (sp), lung ('lu) and muscle (m). Ten micrograms of total RNA were loaded 
from each tissue. The filter was probed with an 800 bp Barn IJI/Eco R V fragment 
from p8a1ppg (Ciliberto et al., 1985). This fragment encompasses most of the 
cDNA sequences of IIAAT. The lack of hybridisation in liver: the primary site of 
mouse endogenous AAT, suggested that the probe does not cross hybridise with the 
endogenous mouse AAT transcript. In both AATB 46.2 and TAB 36 the mammary 
gland is the major site of production of the MAT transcript. Both mice express 
IL4AT protein at similar levels and this is reflected in the similar abundance of the 
MAT transcript in this tissue. Low level ectopic expression is exhibited in the spleen 
ofAA TB 46.2 and in the kidney of TAB 36. The levels of transcript in these tissues 
are minimal compared with the mammary expression. 
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Figure 6.9: Northern Blot Analysis of Total RNA from Transgenic Mouse TAB 
36.2 
The figure shows total RNA extracted from four tissues of TAB 36.2. The tissues 
analysed were mammary (M), salivary gland (S), pancreas (P), and Kidney (K). Ten 
micrograms of total RNA from each tissue were loaded. (a) is an autoradiograph of 
the filter following hybridisation of the filter with the radiolabelled Barn IJI/Eco R V 
fragment of p8alppg and laying down with X-ray film for 1 hour, at -70 U, with 
intensifying screens. At this exposure h4AT transcript is only detected in the 
mammary gland. (b) shows a longer exposure of the same filter. It was exposed to 
X-ray film for 18 hours, at -70 9C, with intensifying screens. At this exposure ectopic 
expression is detected in the kidney and salivary gland Two species of IV4AT 
transcript were detected in the salivary gland one is the same size as the major 
mammary transcript the other is slightly smaller. Only the smaller species is 




The AATB and TAB transgenes are expressed mainly in the mammary gland 
of transgenic mice. Low level ectopic expression of both the BLG transgene and the 
AATB transgene has been demonstrated in previous studies. The tissue profile of 
expression of the AATB transgene (which forms the central part of the TAB 
transgene) does not appear to have been affected by the presence of the munne DNA 
of the AATB 46.2 locus. The appearance of ectopic expression of the TAB transgene 
demonstrated these murine sequences were unable to insulate the AATB transgene 
from positive position effects in tissues other than the mammary gland 
6.2.6 hAAT Expression Per Copy Of The TAB Transgene. 
The expression levels of the TAB transgene were significantly improved 
compared to the AATB transgene. To investigate if the expression levels in each of 
the lines/founders correlated with the transgene copy number the total expression for 
each line (Table 6.4) was plotted against the estimated transgene copy number (Tables 
6.2 and 6.3). This plot is shown in figure 6.9. This analysis demonstrated that the 
TAB transgene shows a strong trend towards copy number dependent expression. 
The trend for each of the two sets of mice generated appears to be almost linear. 
However there appeared to be a difference between the mice generated at the Roslin 
Institute and those generated at PPL Therapeutics Ltd. It is possible since the copy 
numbers of these two sets of mice were analysed separately that the difference in 
expression per copy between the two groups is the result of errors in the estimation of 
copy number. This was unlikely since the same copy number controls were used in 
the estimation of copy number. Estimating copy number using plasmid copy number 
controls is subject to errors (see Chapter 3 of this thesis) even with the aid of a 
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Phosphorimager. The extent of the error in copy number estimation using tail DNA 
and plasmid controls is difficult to quantify. However the discrepancy in the 
expression per copy between the two sets of mice is perhaps greater than would be 
expected from this sort of measurement error. 
TAB 36 2 expressed the protein at 7.5 mg/nil and had an estimated copy 
number of 47, whereas TAB 110.28.2 expresses the protein at nearly 35 mg/nil yet 
had a similar estimated copy number of 50. The estimated copy numbers of these two 
mice are very similar yet the expression level of MAT between the two mice shows an 
almost 5 fold difference. Similarly TAB 14.20.2 gave expression of 24.6 mg/nil and 
had an estimated copy number of approximately 120 but TAB 110 28.2 expresses 
MAT at 10mg/mi higher but has an estimated copy number of 50 (2.4 times less than 
TAB 14.20.2). It is unlikely that the errors involved in measuring copy number are so 
very large and thus the difference in expression per copy number between the Roslin 
generated mice and the PPL generated mice probably reflects a real difference. No 
explanation can be given for this observed difference since the genetic background of 
the mice is the same. 
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Figure 6.10 Plot of Copy Number Against hAAT Expression Level in TAB 
Transgenic Mice 
The figure shows a graph of the estimated copy number of the TAB transgenic mice 
against the measured level of MA T expressed in the milk of each line/founder. The 
two sets of mice have been entered on the same graph. The graph shows that the 
IIAAT levels in the transgenic mouse milk rise with rising TAB transgene copy 
number. The level of expression per copy seems to vary between the two sets of 
transgenic mice generated for this study. It is not possible to tell if this difference  is 
real or apparent with the data generated in this work as the error involved in 
calculating the copy numbers has not been quantified. Nevertheless it is quite clear 
that for both sets of TAB transgenic mice the expression is highest in mice/lines with 
high transgene copy number and lowest in mice/ lines with low copy number. The 
figure demonstrates that the murine sequences included in the TAB transgene confer 
copy number dependent expression on the AATB transgene. Copy number dependent 
expression was not seen in either of the two previous studies using the AATB 
transgene. 
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6.3 Analysis of the TA lines 
Two secondary transgenes were obtained from the phage cloning. The 
analysis of the transgenic mice harbouring the TAB construct was detailed previously 
in this chapter. The other secondary transgene designated TA contained the same 
AATB transgene sequences but only the 4.7 kb of 3' flanking murine DNA from 
Clone 8. Three transgenic founder animals were produced from one round of 
injections of this construct. The female founder died in mid gestation leaving only two 
male founders from which to establish transgenic lines. Analysis of the milk samples 
from second generation females of both TA founder mice found that hAAT was not 
detectably expressed in the milk of either line. A further twenty TA transgenic females 
have been analysed. None of the were found to express detectable levels of hAAT in 
their milk (D. Cheng, unpublished observations). Thus it would appear that the 
improved profile of expression of the TAB transgene requires the 5' murine 
sequences. It is not clear whether the 5' sequences alone would confer the improved 
expression level or if the improved expression is only conferred on the AATB 
transgene when both the 5' and 3' murine flanking sequences are present. 
6.4 Discussion 
The profile of expression of the TAB secondary transgene is very predictable. 
The human protein encoded by the transgene is expressed in practically all of the TAB 
transgenic mice, and at a level that correlates with the transgene copy number (Figure 
6.10). This contrasts with the apparent position dependent expression of the original 
AATB transgene. No linear relationship is observed between the AATB transgene 
copy number and hAAT expression. 
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The findings of the two previous studies of the AATB transgene were similar. 
The main difference between the studies was the method used for the detection of the 
MAT protein in mouse milk. Carver et al. (1993) were able to detect very low levels 
of the human protein using a sensitive ELISA assay. These workers found expression 
of hAAT in the milk of all eleven transgenic, founder mice. Nevertheless the levels of 
expression in many of the transgenic mice were extremely low. Archibald et al. 
(1990), could detect as little as 5.wJ4l of the human protein using Radio Jmmuno 
Assay (RIA). Only half of the transgenic mice generated by Archibald et al., (1990) 
detectably expressed hAAT compared with all of the Go mice in analysed by Carver et 
al., (1993). However this difference is merely a reflection of the lesser sensitivity of 
RIA compared with ELISA. 
In both studies expression of hAAT per copy of the AATB transgene was 
generally low, and varied considerably between the lines. By contrast the expression 
of the TAB transgene was much more consistent and showed a relationship between 
copy number and level of expression for each line generated. 
Of the five transgenic lines/animals generated for this work at PPL 
Therapeutics Ltd., four of them expressed hAAT at a similar level per transgene copy 
to AATB 46.2 (the line from which the secondary transgene was cloned). Five of the 
six TAB transgenic lines/animals generated at the Roslin Institute expressed the 
transgene at approximately 0.2 mg/nil/copy. This level of expression is similar to the 
level of expression of AATB 69 (Archibald et al. 1990). The published copy number 
for AATB 69 is two fransgenes. The presence of a low copy number locus in this line 
is verified by the Southern blot shown in figure 3 6 in Chapter 3 of this work. The 
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published copy number for AATB 35 (Archibald et al. 1990) is one. It has been 
demonstrated in this work that the published copy number is an under estimate (See 
Chapter 3 of this work). The copy number has not been quantitatively determined but 
has been shown to be in excess of eleven copies. Comparing the copy number of 
AATB 35 with AATB 46.2 (Figure 4, Chapter 3 of this work) the copy number would 
appear to be considerably in excess of eleven copies. it is possible that the maximum 
levels of expression of AATB mice generated by Archibald et al., were in the region of 
0.2 to 0.3 mg/ml/copy. Thus the difference in the average MAT between the TAB 
mice generated at the Roshin Institute and those generated at PPL Therapeutics Ltd., 
may reflect the difference in maximum levels of expression displayed previously by the 
AATB transgenic mice generated at the two different sites. The genetic background of 
the mice at the two sites is, apparently, similar and there is no obvious explanation for 
the observed difference in transgene expression. 
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CHAPTER 7: DISCUSSION 
7.1 A Summary of This Work 
The promoter of AATB is that of the ovine BLG gene. The entire ovine BLG 
gene was shown to be expressed efficiently in the mammary gland of mice and moreover 
appeared to be expressed in a position independent and copy number dependent manner 
(Whitelaw et a! 1992). This profile of expression is a remarkable quality displayed by only 
a small sub-set of transgenes and, is thought to result from the introduction of an entire 
regulatory unit. 
However, expression of constructs comprising the BLG promoter linked to 
heterologous protein coding regions were generally disappointing. One such transgene is 
AATB, which comprises the BLG promoter and a human a1-antitrypsin minigene 
(Archibald et al., 1990). Studies performed with AATB demonstrated the transgene was 
capable of driving high levels of expression in the mammary gland of both sheep and 
mice. But, high levels of expression were exceptional and the mouse studies clearly 
demonstrated that AATB was susceptible to position effects (Archibald et al., 1990; 
Carver et al., 1993). Unusually high levels of expression of MAT were exhibited by only 
three murine AATB lines. Two of these lines were stable AATB 35 and AATB 46.2 and 
appeared to harbour low copy number loci. The high levels of expression in these lines 
were thought to be the result of integration into a permissive chromosomal site. The aim 
of this work was to investigate the role of the flanking murine chromosomal DNA in 
directing high level expression of AATB. 
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The locus of AATB 46.2 was restriction mapped and cloned. In all 4.6 kb of the 
5' and 4.7 kb of the 3' murine flanking DNA was obtained from the library. The flanking 
murine DNA was incorporated in a secondary transgene (TAB) comprising a single 
AATB transgene flanked 5' and 3' with the appropriate cloned murine DNA. Analysis of 
transgenic mice harbouring the TAB secondary transgene demonstrated clearly that the 
presence of both 5' and 3' murine DNA significantly improved expression of AATB. 
Only one TAB line did not express hAAT in their milk. The others all expressed more 
than 0.2 mg/ml. Moreover expression levels of hAAT increased with transgene copy 
number. 
Transgenic animals were also generated carrying another secondary transgene 
(TA) that comprised AATB and the 3' flanking DNA only. Numerous transgenic mice 
harbouring this construct have now been generated and surprisingly no hAAT expression 
was detected in any of the lines generated. The presence of the 3' flanking DNA only; 
appears to be inhibitory as the TA transgene was less efficient than AATB. This indicates 
that either the improved AATB expression observed in the TAB transgenic mice require 
both the 5' and 3' flanking DNA, or the sequences responsible for position independence 
reside in the 5' flanking DNA. 
The aim of this work was to establish whether the DNA sequences flanking an 
efficiently expressed transgene locus were responsible for the unusually high expression of 
the transgene locus. The secondary transgenic mice that harboured the transgene 
exhibited position independent and copy number dependent expression suggesting that the 
high expression of AATB observed in AATB 46.2 was the result of interaction of the 
292 
transgene with sequences at the site of integration The levels of expression per copy of 
AATB in the secondary transgenic mice generated at PPL Therapeutics Ltd. appear to be 
very similar to the expression per copy of AATB in the original transgenic mouse from 
which the locus was cloned. Thus it would seem that rather than increase the maximal 
expression per AATB transgene copy, the murine sequences insulate the transgene from 
repressive position effects. Many questions arise from this work and further studies will 
be required to establish (a) the precise location of the sequences which confer the effect, 
(b) their ability to confer position independent copy number dependent expression on a 
range of other transgenes and (c) mechanism of action 
7.2 Further transgenic experiments 
It is however unknown if the murine sequences isolated in this study will be 
capable of driving efficient expression of other constructs. Experiments are currently 
underway in cultured cells to establish if these sequences can improve expression of (a) 
constructs comprising the BLG promoter and heterologous coding sequences (eDNA and 
genomic) of genes other than human od-antitrypsin and (b) constructs driven by 
promoters other than that of the ovine BLG gene (D. Cheng). The effect of these 
sequences on promoters which drive gene expression in other tissues (i.e. liver) can be 
reliably tested in the first instance in well characterised cultured cell lines. Although 
experiments in cultured cells can give useful information about transgene expression no 
mammary cultured cell has been shown to retain all of the functions associated with the 
secretory mammary epithelium. Further transgenic experiments will ultimately be required 
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to establish the capabilities of the flanking murine sequences of AATB 46.2 to confer 
position independence on transgenes expressed in the mammary gland and other tissues of 
transgenic mice. 
It is as yet uncertain whether both the 5' and 3' murine flanking DNA or just the 5' 
flanking DNA alone are required to for position independent and copy number dependent 
AATB expression. The generation of transgenic mice harbouring the 15.2 kb Not I 
fragment of clone 9 (AATB plus the 5' flanking DNA only, see figure 5.7 A) will answer 
this question. Once this question has been answered it should be possible to carry out a 
deletion analysis in transgenic mice to determine more accurately the location of sequences 
involved in conferring the observed position independence and copy number dependence. 
A range of constructs, that have previously been analysed in transgenic mice are 
available to test the ability of the murine sequences to confer position independent 
expression. Yull et al., (1995 a) have recently demonstrated expression of factor IX in the 
mammary gland of transgenic mice harbouring the FIXDA3' construct. This construct has 
the same BLG promoter region as AATB and the cDNA sequences of human Factor IX. 
This construct was co-injected with the entire BLG gene and shown to be expressed at 
low levels (100ng/ml-60 ug/ml) in the milk of all lines generated. This transgene did not 
exhibit copy number dependence. This transgene or similar constructs comprising the 
same BLG promoter as AATB but different protein coding sequences could be used to 
further test the function of the murine sequences isolated in this work. These sequences 
can also be tested for their ability to confer position independent copy number dependent 
expression upon transgenes that are expressed from other tissue specific promoters such as 
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that of the human o 1-antitrypsin gene (Yull et al., 1995 b). Such experiments will 
establish whether the sequences isolated in this work confer position independent 
expression on transgenes generally or the observed effect of these murine sequences is 
limited to the AATB transgene. 
7.3: The Tissue Specificity of TAB is the Same as AA TB 
This work has demonstrated that the murine sequences cloned from AATB 46.2 
can confer position independent copy number dependent expression of AATB. The 
mechanism by which these sequences act is unknown. Position independent copy number 
dependent expression of transgenes has been associated principally, to date, with the 
presence of Locus Control Regions. A number of transgenes exhibit this type of 
expression and have been reported to have LCR activity (see Introduction, section 1.4.4 
and references therein). However the flanking murine DNA is not normally associated 
with either the ovine promoter (mice have no endogenous BLG gene) or the human AAT 
gene. Association of these sequences with AATB is the result of a random insertion 
event. LCR's that have been identified to date confer their effect on gene expression in a 
tissue specific fashion. The -globin LCR (Grosveld et al., 1987) drives expression of the 
f3-globin genes and heterologous genes in haemopoetic cells, and the CDC2 LCR ( 
Greaves et al., 1989) drives expression of CDC2 and heterologous genes in lymphoid 
cells. However the mammary specific expression of AATB remains unchanged in the 
presence of the murine sequences suggesting that the observed enhancement of expression 
is not the result of integration next to either an LCR or enhancer. It cannot be ruled out 
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that the transgene array may have integrated next to a mammary specific enhancer but this 
is considered unlikely especially in the light of the sequences having no significant 
homology with known sequences in the EMBL database. Furthermore, although 
enhancers are capable of driving high levels of expression they are often unable to direct 
position independent and copy number dependent expression. 
74: The Murine Sequences May Contain Boundary Elements 
Another possible explanation for the position independent expression of the TAB 
transgene is the presence of boundary elements in the flanking murine DNA. The 
presence of such elements could allow the BLG promoter to establish and maintain an 
open chromatin domain that is buffered from possible repressive effects of chromatin 
lying outwith the boundary elements Putative boundary elements in both Drosophila 
(Gasser and Laenunli, 1986) and mammals (SteW et al., 1989) have been proposed to be 
regions of DNA that bind the nuclear scaffold/matrix. SiMAR's have been demonstrated 
to be located at the ends of genes at the boundary between DNAse I sensitive and 
insensitive DNA. It has been proposed that they allow for the formation of independent 
regulatory domains, buffering genes within their boundaries from the effects of 
neighbouring chromatin. The presence of boundary elements would explain how the 
flanking DNA can confer its effect when flanking an array of approximately 7 transgenes 
(AATB 46.2) and when flanking individual lransgenes within an array (TAB mice). 
Matrix binding assays have not been performed in this work and the extent of DNAse I 
sensitivity of the TAB transgene in the mammary gland during lactation has not been 
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investigated. Thus it is unknown if the murine DNA binds the nuclear matrix or even 
contains regions that are relatively refractory to DNAse I. Although it has been proposed 
that S/MARs can function as boundary elements they have not been conclusively 
demonstrated to do so in vivo. However it does appear from the literature that S/MARs 
may have a role in the regulation of transcription by exerting an effect on local chromatin 
structure (see Introduction, section 1.4.5 and references therein). 
The sequence of 2.6 kb of the 3' flanking DNA contains some motifs that have 
previously been associated with S/MAR's but contains no topoisomerase II sites. The 5' 
end is 80% AT rich over 145 bp but contains very little in the way of motifs that have 
previously been identified in MARS. The 5' murine DNA does however contain some 
AT runs which have been shown to bind proteins that have only recently been isolated on 
the basis of their ability to bind MARS. Two such proteins Bright (Hen-Scher et at, 1995) 
and CHD 1 (Stokes and Perry, 1995) have regions that are homologous with proteins of 
the SWI SNF family and have been proposed to be involved in transcriptional regulation 
possibly via chromatin remodelling. It is possible that the enhanced expression observed 
with the TAB secondary transgene could result from the binding of similar proteins to the 
AT rich region immediately 5' of AATB. 
7.5: Can these Murine Sequences Confer their effect in Dairy Animals? 
The ability of these murine sequences to confer a position independent and copy 
number dependent expression on a heterologous construct driven by this promoter is an 
important result. An increasing number of transgenes have been shown to exhibit position 
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independent copy number dependent expression. Generally this type of expression is the 
result of inclusion of sequences outwith the coding region that are normally associated 
with the gene of interest. Analysis of these transgenes has been informative about aspects 
of transcriptional control that are currently poorly understood. In this work the sequences 
that bring about this type of transgene expression are not normally associated with the 
gene The BLG promoter is an important promoter that is currently used to drive the 
expression of biomedical proteins in the milk of transgenic sheep.. Currently all transgenic 
large animals are generated by pro-nuclear injection. Transgenic experiments with large 
animals are expensive. The availability of a promoter that can drive expression of 
biomedical proteins in a position independent manner may significantly reduce the cost of 
such experiments. 
Further studies will establish the capabilities of these sequences to drive the 
expression of transgenes comprising the BLG promoter and other heterologous protein 
coding sequences in mice. However to be useful for the commercial production of 
economically important proteins in transgenic animals these sequences will need to confer 
position independent copy number dependent expression in dairy animals (the sheep in 
particular). It is plausible that these sequences will be able to do this since they have been 
isolated as result of their ability to confer position independent and copy number 
dependent expression upon a construct driven by an ovine milk protein gene promoter. 
Currently it is not known how the murine sequences confer this effect. However, the 
effect is like!y to be mediated by specific DNA binding proteins and if the factors involved 
are conserved between the mouse and sheep then it is possible that expression level of 
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BLG constructs in transgenic sheep could also be improved by the inclusion of these 
munne sequences in transgene constructs whose expression is driven by the BLG 
promoter. 
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